UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 30, ~~2020~~2021

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-36454



KIMBALL ELECTRONICS, INC.
(Exact name of registrant as specified in its charter)
Indiana						35-2047713
(State or other jurisdiction of						(I.R.S. Employer Identification No.)
incorporation or organization)
1205 Kimball Boulevard, Jasper, Indiana						47546
(Address of principal executive offices)						(Zip Code)
(812) 634-4000
Registrant’s telephone number, including area code



Securities registered pursuant to Section 12(b) of the Act:
Title of each Class	Trading Symbol	Name of each exchange on which registered
Common Stock, no par value	KE	The ~~NASDAQ~~Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: None



Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes o No x
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes o No x
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o	Accelerated filer x	Emerging growth company o
Non-accelerated filer o	Smaller reporting company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The aggregate market value of the common stock held by non-affiliates, as of December 31, ~~2019~~2020 (the last business day of the Registrant’s most recently completed second fiscal quarter), was ~~$419.8~~$379.4 million based on ~~95.8%~~95.7% of common stock held by non-affiliates.

The number of shares outstanding of the Registrant’s common stock as of August 13, ~~2020~~2021 was ~~24,987,321~~24,957,061 shares.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Proxy Statement for the Annual Meeting of Share Owners to be held on November ~~10, 2020,~~9, 2021, are incorporated by reference into Part III.

KIMBALL ELECTRONICS, INC.

FORM 10-K INDEX



		Page No.

PART I

Item 1.	Business	3
Item 1A.	Risk Factors	910
Item 1B.	Unresolved Staff Comments	1718
Item 2.	Properties	1718
Item 3.	Legal Proceedings	1718
Item 4.	Mine Safety Disclosures	1718
Information about Our Executive Officers		1819

PART II

Item 5.	Market for Registrant’s Common Equity, Related Share Owner Matters and Issuer Purchases of Equity Securities	1920
Item 6.	~~Selected Financial Data~~[Reserved]	21
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2122
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	3331
Item 8.	Financial Statements and Supplementary Data	3432
Item 9.	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	6964
Item 9A.	Controls and Procedures	6964
Item 9B.	Other Information	6964
Item 9C.	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	64
~~PART III~~
PART III

Item 10.	Directors, Executive Officers and Corporate Governance	7065
Item 11.	Executive Compensation	7065
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Share Owner Matters	7065
Item 13.	Certain Relationships and Related Transactions, and Director Independence	7166
Item 14.	Principal Accounting Fees and Services	7166

PART IV

Item 15.	Exhibits, Financial Statement Schedules	7267
Item 16.	Form 10-K Summary	7267
SIGNATURES		7570

PART I

Item 1 - Business

General

As used herein, the terms “Company,” “Kimball Electronics,” “we,” “us,” or “our” refer to Kimball Electronics, Inc., the Registrant, and its subsidiaries. Reference to a year relates to a fiscal year, ended June 30 of the year indicated, rather than a calendar year unless the context indicates otherwise. Additionally, references to the first, second, third, and fourth quarters refer to those respective quarters of the fiscal year indicated.

Forward-Looking Statements

This document contains certain forward-looking statements. These are statements made by management, using their best business judgment based upon facts known at the time of the statements or reasonable estimates, about future results, plans, or future performance and business of the Company. Such statements involve risk and uncertainty, and their ultimate validity is affected by a number of factors, both specific and general. They should not be construed as a guarantee that such results or events will, in fact, occur or be realized as actual results may differ materially from those expressed in these forward-looking statements. The statements may be identified by the use of words such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects,” “estimates,” “forecasts,” “seeks,” “likely,” “future,” “may,” “might,” “should,” “would,” “will,” and similar expressions. It is not possible to foresee or identify all factors that could cause actual results to differ from expected or historical results. We make no commitment to update these factors or to revise any forward-looking statements for events or circumstances occurring after the statement is issued, except as required by law.

The risk factors discussed in Item 1A - Risk Factors of this report could cause our results to differ materially from those expressed in forward-looking statements. There may be other risks and uncertainties that we are unable to predict at this time or that we currently do not expect to have a material adverse effect on our business. Any such risks could cause our results to differ materially from those expressed in forward-looking statements.

At any time when we make forward-looking statements, we desire to take advantage of the “safe harbor” which is afforded such statements under the Private Securities Litigation Reform Act of 1995 where factors could cause actual results to differ materially from forward-looking statements.

Overview

Kimball Electronics was founded in 1961 and was incorporated in 1998. We are a global, multifaceted manufacturing solutions provider. We provide contract electronics manufacturing services (“EMS”) and diversified manufacturing services, including engineering and supply chain support, to customers in the automotive, medical, industrial, and public safety end markets. We offer a package of value that begins with our core competency of producing ~~“durable electronics”~~durable electronics and have expanded into diversified contract manufacturing services for non-electronic components, medical disposables, precision molded plastics, and production automation, test, and inspection equipment. This package of value includes our set of robust processes and procedures that help us ensure that we deliver the highest levels of quality, reliability, and service throughout the entire life cycle of our customers’ products. We believe our customers appreciate our body of knowledge as it relates to the design and manufacture of their products that require durability, reliability, the highest levels of quality control, and regulatory compliance. We deliver award-winning service from our highly integrated global footprint which is enabled by a largely common operating system, a standardization strategy, global procedures, and teamwork. Our Customer Relationship Management (“CRM”) model is key to providing our customers convenient access to our global footprint and all of our services throughout the entire product life cycle. Because our customers are in businesses where engineering changes must be tightly controlled and long product life cycles are common, our track record of quality, financial stability, social responsibility, and commitment to long-term relationships is important to them.

We have been producing safety critical electronic assemblies for our automotive customers for over 35 years. During this time, we have built up a body of knowledge that has not only proven to be valuable to our automotive customers, but to our medical, industrial, and public safety customers as well. We have been successful in growing and diversifying our business by leveraging our automotive experience and know-how in the areas of design and process validation, traceability, process and change control, and lean manufacturing to create valuable and innovative solutions for customers in the medical, industrial, and public safety end market verticals. These solutions include diversified contract manufacturing services for medical disposables, precision molded plastics, and design, production, and servicing of automation, test, and inspection equipment for industrial applications. We have harmonized our quality systems to be compliant with various important industry certifications and regulatory requirements. This allows us to take advantage of other strategic points of leverage in the supply chain and within

our operations so we can cost-effectively manufacture electronic and non-electronic products in the same production facility for customers from all four of our end market verticals.

Many of our customers are multinational companies that sell their products in multiple regions of the world. For these customers, it is important for them to be able to leverage their investment in their supply partner relationships such that the same partner provides them with engineering, manufacturing, and supply chain support in multiple regions of the world. It is common for us to manufacture the same product for the same customer in multiple locations. Our strategy for expanding our global footprint has aligned us with the preferences of the customers in our four end market verticals and has positioned us well to support their global growth initiatives. Our global systems, procedures, processes, and teamwork combined with our CRM model have allowed us to accomplish this goal for many of our largest customers.

Our global processes and central functions that support component sourcing, procurement, quoting, and customer pricing provide commonality and consistency among the various regions in which we operate. We have a central, global sourcing organization that utilizes procurement processes and practices to help secure sources from around the world and to ensure sufficient availability of components and a uniform approach to pricing while leveraging the purchase volume of the entire organization. Customer pricing for the products we produce is primarily managed centrally utilizing a standardized quoting model regardless of where our customers request their products to be produced.

Our CRM model combines members of our team from within our manufacturing facilities and members of our business development team who reside remotely and nearer to our customers around the world. We also have cross-functional teams in the areas of quality, operational excellence, quoting, and design engineering with representatives from our various locations that provide support to our teams on a global basis. The skill sets of these team members and the clarity in their roles and responsibilities help provide our customers with a strong conduit that is critical to execution and forming a strong relationship. We have institutionalized a customer scorecard process that provides all levels of our company with valuable feedback that helps us drive the actions for continuous improvement. Our customer scorecard process has helped us deliver award-winning service and build loyalty with our customers.

Our corporate headquarters is located at 1205 Kimball Boulevard, Jasper, Indiana. Production occurs in our facilities located in the United States, China, Mexico, Poland, Romania, Thailand, and Vietnam.

Our services are sold globally on a contract basis, and we produce products to our customers’ specifications. Our manufacturing services primarily include:

•Design services and support;

•Supply chain services and support;

•Rapid prototyping and new product introduction support;

•Product design and process validation and qualification;

•Industrialization and automation of manufacturing processes;

•Reliability testing (testing of products under a series of extreme environmental conditions);

•Production and testing of printed circuit board assemblies (PCBAs);

~~Assembly, production,~~•Production and ~~packaging~~assembly of medical devices, medical disposables including packaging, and other non-electronic products;

•Drug delivery devices and solutions with and without electronics;

•Design engineering and manufacturing of automation, test, and inspection equipment;

•Design engineering and production of precision molded plastics;

•Software design capabilities; and

•Complete product life cycle management.

We pride ourselves on the fact that we pay close attention to the evolving needs and preferences of our customers. As we have done in the past, we will continue to look for opportunities to grow and diversify our business by expanding our package of value and our global footprint.

Reporting Segment

Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Each of our business units qualifies as an operating segment with its results regularly reviewed by our chief operating decision maker. Our chief operating decision maker is our Chief Executive Officer. Our operating segments meet the aggregation criteria under the current accounting guidance for segment reporting. As of June 30, ~~2020,~~2021, all of our business units provide contract manufacturing services for electronic and other assemblies or components primarily in

automotive, medical, industrial, and public safety applications, all to the specifications and designs of our customers. The nature of the products, the production process, the type of customers, and the methods used to distribute the products, all have similar characteristics. Each of our business units service customers in multiple markets and many of our customers’ programs are manufactured and serviced by multiple business units. We leverage global processes such as component procurement and customer pricing that provide commonality and consistency among the various regions in which we operate. All of our operating segments have similar long-term economic characteristics and, as such, have been aggregated into one reportable segment.

Our Business Strategy

We intend to achieve sustained, profitable growth in the markets we serve by supporting the global growth initiatives of our customers, and we will continue our development into a multifaceted manufacturing solutions company. Key elements of executing our strategy include:

•Leveraging Our Global Footprint – continue our strategy of utilizing our presence in key global regions, including new potential country locations and/or facility expansion as our customer demands dictate;

•Expanding Our Package of Value – enhance our core strengths and expand upon our package of value through diversified contract manufacturing services in areas such as complex system assembly, specialized processes, precision molded plastics; and

•Expanding Our Markets – explore opportunities that will broaden existing or establish new markets, capabilities, or technologies such as automation, test, and inspection equipment for industrial applications.

We expect to make investments that will strengthen or add new capabilities to our package of value as a multifaceted manufacturing solutions company, including through acquisitions. As part of this strategy, in fiscal year 2019, we acquired GES Holdings, Inc., Global Equipment Services and Manufacturing, Inc., and its subsidiaries (collectively referred to as “GES”). GES specializes in design, production, and servicing of automation, test, and inspection equipment for industrial applications in the semiconductor, electronics, and life sciences industries. See Item 1A - Risk Factors for risks associated with ~~this acquisition and~~ ~~Note 2 - Acquisitions~~ ~~of Notes to Consolidated Financial Statements for more information on this acquisition.~~acquisitions.

Our Business Offerings

We offer contract electronics manufacturing services, including engineering and supply chain support, to customers in the automotive, medical, industrial, and public safety end market verticals. We further offer diversified contract manufacturing services for non-electronic components, medical disposables, precision molded plastics, as well as production automation, test, and inspection equipment. Our services support the complete product life cycle of our customers’ products, and our processes and capabilities cover a range of products from high volume-low mix to high mix-low volume. We collaborate with third-party design services companies to bring innovative, complete design solutions to our customers. We offer Design for Excellence input to our customers as a part of our standard package of value. We use sophisticated software tools to integrate the supply chain in a way that provides our customers with the flexibility their business requires. Our robust new product introduction process and our extensive manufacturing capabilities give us the ability to execute to the various quality and reliability expectations of our customers in each of our end market verticals.

We value our customers and their unique needs and expectations. Our customer focus and dedication to unparalleled excellence in engineering and manufacturing has resulted in proven success in the contract manufacturing industry. Personal relationships are important to us. We strive to build long-term global partnerships. Our commitment to support our customers is backed by our history and demonstrated performance for ~~almost~~the past 60 years.

Marketing Channels

Manufacturing services, including engineering and supply chain support, are marketed by our business development team. We use a CRM model to provide our customers with convenient access to our global footprint and all of our services throughout the entire product life cycle.

Major Competitive Factors

Key competitive factors in the markets we serve include competitive pricing, quality and reliability, engineering design services, production flexibility, on-time delivery, customer lead time, test capability, and global presence. Numerous contract manufacturing service providers compete globally for business from existing and potential customers. We also face competition from our customers’ own capacity and capabilities to in-source production. Growth in the EMS industry is created through the proliferation of electronic components in today’s advanced products and the continuing trend of original equipment

manufacturers in the electronics industry subcontracting the assembly process to companies with a core competency in this area. The nature of the EMS industry is such that the start-up of new customers and new programs to replace expiring programs occurs frequently. New ~~customer~~customers and program start-ups generally cause ~~losses~~margin dilution early in the life of a program, which ~~are~~is generally recovered as the program becomes established and matures. Our continuing success depends upon our ability to replace expiring customers/programs with new customers/programs.

We do not believe that we, or the industry in general, have any special practices or special conditions affecting working capital items that are significant for understanding our business other than fluctuating inventory levels which may increase in conjunction with the start-up of new programs and component availability.

Our Competitive Strengths

Our competitive strengths derive from our experience of producing safety critical electronic assemblies for automotive customers for over 35 years and leveraging this experience to create valuable and innovative solutions for customers in different industries. Our core strengths include:

•Our core competency of producing durable electronics;

•Our body of knowledge as it relates to the design and manufacture of products that require high levels of quality control, reliability, and durability;

•Our highly integrated, global footprint;

•Our capability to provide our customers diversified contract manufacturing services for non-electronic components, medical disposables, precision molded plastics, and automation, test, and inspection equipment;

•Our CRM model and our customer scorecard process;

•Our ability to provide our customers with valuable input regarding designs for improved manufacturability, reliability, and cost;

•Our quality systems, industry certifications, and regulatory compliance;

•Our integrated supply chain solutions and competitive bid process resulting in competitive raw material pricing; and

•Complete product life cycle management.

Competitors

The EMS industry is very competitive as numerous manufacturers compete for business from existing and potential customers. Our competition includes EMS companies such as Benchmark Electronics, Inc., Flex Ltd., Jabil Inc., ~~and~~ Plexus Corp., and Sanmina Corporation. We do not have a significant share of the EMS market and were ranked the 19^20th largest global EMS provider for calendar year ~~2019~~2020 by Manufacturing Market Insider in the March ~~2020~~2021 edition published by New Venture Research.

Locations

As of June 30, ~~2020,~~2021, we have eleven manufacturing facilities with two located in Indiana, two in China, and one located in each of California, Florida, Mexico, Poland, Romania, Thailand, and Vietnam. Our software design services are primarily performed at our location in India. We continually assess our capacity needs and evaluate our operations to optimize our service levels for supporting our customers’ needs around the globe. ~~During fiscal year 2019, we acquired GES which has manufacturing facilities in California, China, and Vietnam.~~ See Item 1A - Risk Factors for information regarding financial and operational risks related to our international ~~operations and acquisitions.~~operations.

Seasonality

Consolidated sales revenue is generally not affected by seasonality.

Customers

While the total electronic assemblies market has broad applications, our customers are concentrated in the automotive, medical, industrial, and public safety industries.

Sales by industry as a percent of net sales for each of the three years in the period ended June 30, ~~2020~~2021 were as follows:


	Year Ended June 30				Year Ended June 30
	2020	2019	2018		2021	2020	2019
Automotive	38%	40%	44%	Automotive	43%	38%	40%
Medical	33%	31%	29%	Medical	30%	33%	31%
Industrial	23%	22%	20%	Industrial	23%	23%	22%
Public Safety	5%	6%	6%	Public Safety	3%	5%	6%
Other	1%	1%	1%	Other	1%	1%	1%
Total	100%	100%	100%	Total	100%	100%	100%

Included in our sales were a significant amount to ~~Philips, ZF, and~~ Nexteer Automotive, Philips, and ZF, which accounted for the following portions of net sales:

The nature of the contract manufacturing business is such that start-up of new programs to replace expiring programs occurs frequently. Our agreements with customers are often not for a definitive term and are amended and extended, but generally continue for the relevant product’s life cycle, which can be difficult to predict at the beginning of a program. Typically, our customer agreements do not commit the customer to purchase our services until a purchase order is provided, which are generally short term in nature. Our customers generally have the right to cancel a particular program subject to contractual provisions governing termination, the final product runs, excess or obsolete inventory, and end-of-life pricing, which reduces the additional costs that we incur when a manufacturing services agreement is terminated.

The aggregate sales price of production pursuant to unfulfilled customer orders, which in certain cases may be delayed or canceled by the customer subject to contractual termination provisions, was $421.0 million and $417.8 million as of June 30, 2020 and 2019, respectively. Substantially all of the open orders as of June 30, 2020 are expected to be filled within the next fiscal year. Open orders may not be indicative of future sales trends due to the contract nature of our business and the short-term nature of customer orders.

Raw materials utilized in the manufacture of contract electronic products are generally readily available from both domestic and foreign sources, although from time to time the industry experiences shortages of certain components due to supply and demand forces, combined with rapid product life cycles of certain components. In addition, unforeseen events such as natural disasters and the COVID-19 global pandemic can and have disrupted portions of the supply chain. We believe that maintaining close communication with suppliers helps minimize potential disruption in our supply chain.

The EMS industry is currently experiencing component shortages, component allocations, and shipping delays, particularly with semiconductors, driven by the strong demand in consumer electronics and the beginning of a global recovery, and complicated by the continued impact of COVID-19. Component shortages or allocations could increase component costs and potentially interrupt our operations and negatively impact our ability to meet commitments to customers. The semiconductor shortage has adversely impacted global manufacturing, including the automotive industry, leading to automakers temporarily suspending production in recent months. We have taken various actions to mitigate the risk and minimize the impact to our customers as well as the adverse effect component shortages or allocations could have on our results.

Raw materials are normally acquired for specific customer orders and may or may not be interchangeable among products. Inherent risks associated with rapid technological changes within this contract industry are mitigated by procuring raw materials, for the most part, based on firm orders. In certain instances, such as when lead times dictate, we enter into contractual agreements for material in excess of the levels required to fulfill customer orders. In turn, material authorization agreements with customers cover a portion of the exposure for material which is purchased prior to having a firm order. We may also purchase additional inventory to support new product introductions, transfers of production between manufacturing facilities, and to mitigate the potential impact from component shortages.

Intellectual Property

Our primary intellectual property is our proprietary manufacturing technology and processes ~~which~~that allow us to provide competitive contract manufacturing and design services to our customers. As such, this intellectual property is complex and normally contained within our facilities. ~~The nature~~To protect our trade secrets, our manufacturing technology and processes, and other proprietary rights, we rely primarily on a combination of ~~this know-how does not lend itself well to traditional patent protection. In addition, we feel the best protection strategy involves maintaining our~~ intellectual property aslaws pertaining to trade secrets and copyrights; non-disclosure agreements with our customers, employees, and suppliers; and our internal security procedures and systems. We feel that relying on trade secret or copyright protections is a superior strategy because there is no disclosure of the information to outside parties, and ~~there is no expiration on the~~protections do not expire after a length of ~~protection. For these reasons, we do not at this time own any~~time. We currently have or are pursuing a modest number of patents for some of our innovations and technologies in the United States and foreign countries.We also maintain trademark rights (including registrations) for “Kimball Electronics,” “GES” and other wordmarks and trademarks that we ~~consider significant to~~use in our business ~~but do~~in the United States and around the world.We have ~~some designs on which we are currently exploring patent protection. Our registered trademarks consist~~policies and procedures to identify and protect our own intellectual property and that of ~~the “Kimball Electronics” name~~our customers and ~~“Ball Logo” as registered in certain categories relating to our electronics manufacturing and design services, and the “GES and Design” trademark acquired through the GES acquisition.~~suppliers.

Corporate Social Responsibility

We are committed to our environmental, social, and governance philosophies and practices, which have been a part of who we are since our founding in 1961. To showcase how our employees around the world share a strong sense of responsibility to protect the environment, sustain a safety focus at our facilities, and give back in meaningful ways to the communities where we live and work, we issued our ~~first~~latest annual Environmental, Social & Governance Report (“ESG Report”) in December ~~2019.~~2020. The ESG Report highlights the long-term environmental, social, and governance principles, and practices designed to support the Company’s commitment to sustaining “lasting relationships” and achieving “global success” with its stakeholders wherever Kimball Electronics’ touch is felt throughout the world. The ESG Report reflects several long-standing Guiding Principles of the Company: Our customer is our business; our people are the company; the environment is our home; we strive to help our communities be great places to live; profitability and financial resources give us the freedom to shape our future and achieve our vision. The ESG Report is posted on our website.

Environment and Energy Matters

Our operations are subject to various foreign, federal, state, and local laws and regulations with respect to environmental matters. We believe that we are in substantial compliance with present laws and regulations and that there are no material liabilities related to such items.

We are dedicated to excellence, leadership, and stewardship in protecting the environment and communities in which we have operations. We believe that continued compliance with foreign, federal, state, and local laws and regulations which have been enacted relating to the protection of the environment will not have a material effect on our capital expenditures, earnings, or competitive position. Management believes capital expenditures for environmental control equipment ~~during the two fiscal years ending June 30, 2022~~ will not represent a material portion of total capital ~~expenditures during those years.~~expenditures.

Our operations require significant amounts of energy, including natural gas and electricity. Federal, foreign, and state regulations may control the allocation of fuels available to us, but to date we have experienced no interruption of production due to such regulations.

~~Employees~~Our People are the Company: Human Capital Management

We believe our people are the company. We believe in creating quality for life. We believe lasting relationships create our global success. We believe our people are the competitive edge for our service, quality and value. Kimball Electronics has been built upon the tradition of pride in craftsmanship, mutual trust, personal integrity, respect for dignity of the individual, a spirit of cooperation, and a sense of family and good humor. We seek to enhance this culture as we grow. We believe in the inherent value of all individuals.

To raise awareness of our commitment to human rights and to foster compliance with our Global Human Rights Policy, we have incorporated it as an integral part of our Code of Conduct, train all of our employees worldwide on human rights issues, and require our suppliers, vendors, contractors, and partners to meet the same standards. To this end, through our Guiding Principles, we champion transparency and accountability for ourselves.

Because our people are the reason for our success, central to our long-term strategy is attracting, developing, and retaining the best talent globally and strengthening collaboration. We are committed to pay equity and apply the principle of equal pay for work of equal value in all regions where we operate. As of June 30, ~~2020,~~2021, Kimball Electronics employed approximately 6,400 people worldwide, with approximately ~~1,400~~1,300 located in the United States and approximately ~~5,000~~5,100 located in foreign countries. Approximately fifty percent of our worldwide workforce is female, including fifty percent of our executive officers. Ten

percent of our executive officers are African American and ten percent are Hispanic or Latino. We continue to execute on our commitment to diversity, equity, and inclusion, and exhibit our commitment to gender, racial, and ethnic diversity by striving toward the corporate goals we outline in our Global Human Rights Policy, including by:

•Increasing female representation globally at the executive and senior management levels;

•Increasing racial and ethnic diversity at the executive and senior management levels so our leadership will reflect our organization and the communities in which we operate;

•Holding leadership accountable for diversity, equity, and inclusion outcomes.

The average tenure within our workforce is 6.6 years, and we work hard to mitigate turnover risk by consistently and formally surveying our workforce about how well we are living up to our People Guiding Principles by asking them to anonymously rate us on a scale from 1 (low) to 10 (high). We currently have a score of 8.15 across our enterprise. We believe this is evidence that we truly operate our business as our people are the company. We consistently have a participation rate in our Guiding Principles survey that exceeds 90%. Upon completion of this survey every year, each local management team receives qualitative and quantitative feedback and are responsible for crafting improvement plans based on our people’s inputs.

Our U.S. operations are not subject to collective bargaining arrangements. Certain foreign operations are subject to collective bargaining arrangements, many mandated by government regulation or customs of the particular countries. We believe that our employee relations are good.

For additional information, see the Company’s Proxy Statement to be filed for its annual meeting of Share Owners to be held November 9, 2021 under the caption “Our People are the Company: Human Capital Management.”

Available Information

The Company makes available free of charge through its website, http://investors.kimballelectronics.com, its annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission (“SEC”). All reports the Company files with the SEC are also available via the SEC website, http://www.sec.gov. The Company’s website and the information contained therein, or incorporated therein, are not intended to be incorporated into this Annual Report on Form 10-K.

Item 1A - Risk Factors

The following important risk factors, among others, could affect future results and events, causing results and events to differ materially from those expressed or implied in forward-looking statements made in this report and presented elsewhere by management from time to time. Such factors, among others, may have a material adverse effect on our business, financial condition, and results of operations and should be carefully considered. Many of the risk factors could be exacerbated by the COVID-19 pandemic and any worsening of the global business and economic environment as a result. Additional risks and uncertainties that we do not currently know about, we currently believe are immaterial, or we have not predicted may also affect our business, financial condition, or results of operations. Because of these and other factors, past performance should not be considered an indication of future performance.

Business and Operational Risks ~~Relating to Our Business~~

~~Uncertain macroeconomic and industry conditions could adversely impact demand for our products and services and adversely affect operating results.~~

~~Market demand for our products and services, which impacts revenues and gross profit, is influenced by a variety of economic and industry factors such as:~~

~~instability of the global financial markets;~~

~~uncertainty of worldwide economic conditions;~~

~~tariffs and international trade relations;~~

~~volatile energy costs;~~

~~erosion of global consumer confidence;~~

~~general corporate profitability of our end markets;~~

~~credit availability to our customers and our customers’ end markets;~~

~~demand fluctuations in the industries we currently serve, including automotive, medical, industrial, and public safety;~~

~~demand for end-user products that contain assemblies or components produced by us; and~~

~~changes in customer order patterns, including changes in product quantities, delays in orders, or cancellation of orders.~~

We must make decisions based on order volumes in order to achieve efficiency in manufacturing capacities. These decisions include determining what level of additional business to accept, production schedules, component procurement commitments, and personnel requirements, among various other considerations. We must constantly monitor the changing economic landscape and may modify our strategic direction based upon the changing business environment. If we do not react quickly enough to the changes in market or economic conditions, it could result in lost customers, decreased market share, and increased operating costs.

The COVID-19 pandemic has adversely impacted the global economy, disrupted global supply chains and workforce participation, and created significant volatility and disruption of financial markets. The economic expansion of recent years has been interrupted as a result of the COVID-19 pandemic and recessionary conditions may occur, which could result in our customers or potential customers reducing or delaying orders as well as a number of other negative effects on our business, such as increased pricing pressures, the insolvency of suppliers, which could cause production delays, the inability of customers to obtain credit, or the insolvency of customers. In addition, the uncertainties of the market and economic conditions caused by strained international trade relations, such as the relations between the United States and China and the United Kingdom’s exit from the European Union, could have an adverse effect on our business and results of operations.

~~We are exposed to the credit risk of our customers.~~

The instability of market conditions drives an elevated risk of potential bankruptcy of customers resulting in a greater risk of uncollectible outstanding accounts receivable. Accordingly, we intensely monitor our receivables and related credit risks. The realization of these risks could have a negative impact on our profitability.

Reduction of purchases by, or the loss of, one or more key customers could reduce revenues and profitability.

Losses of key customers within specific industries or significant volume reductions from key customers are both risks. If one of our current customers merges with or is acquired by a party that currently is aligned with a competitor, or the combination creates excess capacity, we could lose future revenues. Our continuing success is dependent upon replacing expiring contract customers/programs with new customers/programs. See “Customers” in Item 1 - Business for disclosure of the net sales as a percentage of consolidated net sales for each of our significant customers during fiscal years 2021, 2020, ~~2019,~~ and ~~2018.~~2019. Regardless of whether our agreements with our customers, including our significant customers, have a definite term, our customers typically do not have an obligation to purchase a minimum quantity of products or services as individual purchase orders or other product or project specific documentation are typically entered into from time to time. Our customers generally have the right to cancel a particular product, subject to contractual provisions governing the final product runs, excess or obsolete inventory, recovery of dedicated investments, and end-of-life pricing. As such, our ability to continue the relationships with such customers is uncertain.

Significant declines in the level of purchases by key customers or the loss of a significant number of customers could have a material adverse effect on our business. In addition, the nature of the contract manufacturing industry is such that the start-up of new customers and new programs to replace expiring programs occurs frequently, and new ~~customer~~customers and program start-ups generally cause ~~losses~~margin dilution early in the life of a program. We can provide no assurance that we will be able to fully replace any lost sales, which could have an adverse effect on our financial position, results of operations, or cash flows.

We may be unable to purchase a sufficient amount of materials, parts, and components for use in our products at competitive prices, in a timely manner, or at all.

We depend on suppliers globally to provide timely delivery of materials, parts, and components for use in our products. The financial stability of suppliers is monitored by us when feasible as the loss of a significant supplier could have an adverse impact on our operations. Suppliers adjust their capacity as demand fluctuates, and component shortages and/or component allocations could occur in addition to longer lead times. Certain components purchased by us are primarily manufactured in select regions of the world and issues in those regions could cause manufacturing delays. Maintaining strong relationships with key suppliers of components critical to the manufacturing process is essential. Price increases of commodity components, including increased tariffs, could have an adverse impact on our profitability if we cannot offset such increases with other cost reductions or by price increases to customers. Materials utilized in our manufacturing process are generally available, but future availability is unknown and could impact our ability to meet customer order requirements. The EMS industry is currently experiencing component shortages, component allocations, and shipping delays, particularly with semiconductors, driven by the strong demand in consumer electronics and the beginning of a global recovery, and complicated by the continued impact of COVID-19. Component shortages or allocations could increase component costs and potentially interrupt our operations and negatively impact our ability to meet commitments to customers. If suppliers fail to meet commitments to us in terms of price, delivery, or quality, or if the supply chain is unable to react timely to increases in demand, it could interrupt our operations and negatively impact our ability to meet commitments to customers.

We are subject to manufacturing inefficiencies or underutilization due to start-up or expansion of facilities, programs, transfers of production, personnel turnover and shortages, and other related factors.

We are currently expanding our global operations by increasing our product and service offerings and scaling our infrastructure at certain facilities to support our business. This expansion increases the complexity of our business and places significant strain on our management, personnel, operations, systems, technical performance, financial resources, and internal financial control and reporting functions. We may not be able to manage these expansions effectively, which could damage our reputation, limit our growth, and negatively affect our operating results.

The start-up of new programs requires the coordination of the design and manufacturing processes. The design and engineering required for certain new programs can take an extended period of time, and further time may be required to achieve customer acceptance. Accordingly, the launch of any particular program may be delayed, less successful than we originally anticipated, or not successful at all. Additionally, most of our customers do not commit to long-term production schedules, and we are unable to forecast the level of customer orders with certainty over a given period of time. As a result, at times it can be difficult for us to schedule production and maximize utilization of our manufacturing capacity. Fluctuations and deferrals of customer orders may have a material adverse effect on our ability to utilize our fixed capacity. All of these types of manufacturing inefficiencies could have an adverse impact on our financial position, operating margins, results of operations, or cash flows.

The high demand for manufacturing labor in certain geographic areas in which we operate makes recruiting new production employees and retaining experienced production employees difficult. Shortages of production workers could adversely impact our ability to complete our customers’ orders on a timely basis, which could adversely affect our relations with customers, potentially resulting in reduction in orders from customers or loss of customers. Turnover in personnel could result in additional training and inefficiencies that could adversely impact our operating results.

Our international operations make us vulnerable to financial and operational risks associated with doing business in foreign countries.

We have operations outside the United States, primarily in China, India, Mexico, Poland, Romania, Thailand, and Vietnam. Our international operations are subject to a number of risks, which may include the following:

•economic and political instability, including the uncertainties caused by the United Kingdom’s exit from the European Union;

•foreign governments’ measures taken in response to the COVID-19 pandemic;

•warfare, riots, terrorism, and other forms of violence or geopolitical disruption;

•compliance with laws, such as the Foreign Corrupt Practices Act, applicable to U.S. companies doing business outside the United States;

•changes in U.S. or foreign policies, regulatory requirements, and laws;

•tariffs and other trade barriers, including tariffs imposed by the United States as well as responsive tariffs imposed by China, the European Union, or Mexico;

•potentially adverse tax consequences, including changes in tax rates and the manner in which multinational companies are taxed in the United States and other countries; and

•foreign labor practices.

These risks could have an adverse effect on our financial position, results of operations, or cash flows. In addition, fluctuations in exchange rates could impact our operating results. Our risk management strategy includes the use of derivative financial instruments to hedge certain foreign currency exposures. Any hedging techniques we implement contain risks and may not be entirely effective. Exchange rate fluctuations could also make our products more expensive than competitors’ products not subject to these fluctuations, which could adversely affect our revenues and profitability in international markets.

Certain foreign jurisdictions restrict the amount of cash that can be transferred to the United States or impose taxes and penalties on such transfers of cash. To the extent we have excess cash in foreign locations that could be used in, or is needed by, our operations in the United States, we may incur significant penalties and/or taxes to repatriate these funds.

We operate in a highly competitive ~~environment~~industry and may not be able to compete successfully.

Numerous manufacturers within the contract manufacturing industry compete globally for business from existing and potential customers. Some of our competitors have greater resources and more geographically diversified international operations than we do. We also face competition from the manufacturing operations of our customers, who are continually evaluating the merits of manufacturing products internally against the advantages of outsourcing to contract manufacturing service providers. In the past, some of our customers have decided to in-source a portion of their manufacturing from us in order to utilize their excess internal manufacturing capacity. The competition may further intensify as more companies enter the markets in which we operate, as existing competitors expand capacity, and as the industry consolidates.

In relation to customer pricing pressures, if we cannot achieve the proportionate reductions in costs, profit margins may suffer. The high level of competition in the industry impacts our ability to implement price increases or, in some cases, even maintain prices, which also could lower profit margins. In addition, as end markets dictate, we are continually assessing excess capacity and developing plans to better utilize manufacturing operations, including consolidating and shifting manufacturing capacity to lower cost venues as necessary.

If our engineering and manufacturing services do not meet our customers’ quality standards, our sales, operating results, and reputation could suffer.

We ~~may be unable~~make substantial investments of capital and operating expenses to ~~purchase a sufficient amount of materials, parts,~~implement comprehensive, company-wide quality systems, certifications, and ~~components for use~~controls in our ~~products at competitive prices,~~operations in ~~a timely manner,~~an effort to ensure sustained compliance with various product and quality system regulations and requirements, and to meet the needs of our customers. However, in the event we fail to adhere to these requirements, we become subject to costs associated with product defects, interruptions in production, and reputational harm. Our failure to comply with applicable quality system standards could, in turn, adversely affect our customers through failures to supply product to them. Quality or ~~at all.~~

~~We depend~~noncompliance failures could have an adverse effect on ~~suppliers globally~~our reputation in addition to provide timely delivery of materials, parts, and components for use in our products. The financial stability of suppliers is monitored by us when feasible as the loss of a significant supplier could have an adverse impact on our financial position, results of operations, or cash flows. While we maintain product liability and other insurance coverage that we believe to be generally in accordance with industry practices, our insurance coverage may not be adequate to protect us fully against substantial claims and costs that may arise from liabilities related to product defects.

Our business may be harmed due to failure to successfully implement information technology solutions or a lack of reasonable safeguards to maintain data security, including adherence to data privacy laws and physical security measures.

The operation of our business depends on effective information technology systems, which are subject to the risk of security breach or cybersecurity threat, including misappropriation of assets or other sensitive information, such as confidential business information and personally identifiable data relating to employees, customers, and other business partners, or data corruption which could cause operational disruption. As we could be the target of cyber and other security threats, which are becoming increasingly sophisticated, we must continuously monitor and develop our information technology networks and infrastructure to prevent, detect, address, and mitigate the risk of unauthorized access, misuse, computer viruses, and other events that could have a security impact. Information systems require an ongoing commitment of significant resources to research new technologies and processes, maintain and enhance existing systems, and develop new systems in order to keep pace with changes in information processing technology and evolving industry standards as well as to protect against cyber risks and security breaches. While we provide employee awareness training around phishing, malware, and other cyber threats to help protect against these cyber and security risks, we cannot ensure the measures we take to protect our information technology systems will be sufficient.

Implementation delays, poor execution, or a breach of information technology systems could disrupt our operations, damage our reputation, or increase costs related to the mitigation of, response to, or litigation arising from any such issue. Similar risks exist with our third-party vendors. Any problems caused by these third parties, including those resulting from disruption in communications services, cyber attacks, or security breaches, have the potential to hinder our ability to conduct business. In addition, data privacy laws and regulations, such as the European Union General Data Protection Regulation and similar legislation in jurisdictions in which we operate, pose increasingly complex compliance challenges and potentially elevate costs, and any failure to comply with these laws and regulations could result in significant penalties.

The cost of providing employee healthcare benefits could increase and reduce our profitability.

We are self-insured up to certain limits for certain domestic employee health benefits. For these self-insured health plans, we incur the cost of claims, which may include catastrophic claims, with the employees bearing a limited portion of the cost through insurance premiums and deductibles. Accordingly, increases in employee healthcare benefit costs, including as a result of the high costs associated with treatments and prescriptions for rare diseases could have an adverse effect on our profitability.

Regulatory and Litigation Risks

Litigation or legal proceedings could expose us to significant liabilities and have a negative impact on our reputation.

We are or may become party to various claims and legal proceedings in the ordinary course of our business. These claims and legal proceedings may include lawsuits or claims relating to contracts, intellectual property, product recalls, product liability, employment matters, environmental matters, regulatory compliance, or other aspects of our business. Even when not merited, the defense of these claims and legal proceedings may divert our management’s attention, and we may incur significant expenses in defending these claims and proceedings. In addition, we may be required to pay damage awards or settlements or become subject to injunctions or other equitable remedies, which could have a material adverse effect on our financial position, cash flows, or results of operations. ~~Suppliers adjust~~The outcome of litigation is often difficult to predict, and the outcome of pending or future claims and legal proceedings may have a material adverse effect on our financial position, cash flows, or results of operations. We evaluate these claims and legal proceedings to assess the likelihood of unfavorable outcomes and to estimate, if possible, the amount of potential losses. Based on these assessments and estimates, we establish reserves or disclose the relevant litigation claims or legal proceedings, as appropriate. These assessments and estimates are based on the information available to management at the time and involve a significant amount of management judgment. Actual outcomes or losses may differ materially from our current assessments and estimates. If actual outcomes or losses differ materially from our current assessments and estimates or additional claims or legal proceedings are initiated, we could be exposed to significant liabilities.

Failure to protect our intellectual property could undermine our competitive position.

Competing effectively depends, to a significant extent, on maintaining the proprietary nature of our intellectual property. We attempt to protect our intellectual property rights worldwide through a combination of keeping our proprietary information secret and utilizing trademark, copyright, and trade secret laws, as well as licensing agreements and third-party non-disclosure and assignment agreements. Because of the differences in foreign laws concerning proprietary rights, our intellectual property rights do not generally receive the same degree of protection in foreign countries as they do in the United States, and therefore, in some parts of the world, we have limited protections, if any, for our intellectual property. If we are unable to adequately protect our intellectual property embodied in our solutions, designs, processes, and products, the competitive advantages of our proprietary technology could be reduced or eliminated, which would harm our business and could have a material adverse effect on our results of operations and financial position.

Anti-takeover provisions in our organizational documents and Indiana law could delay or prevent a change in control.

We have adopted Amended and Restated Articles of Incorporation and Amended and Restated Bylaws. Certain provisions of the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws may delay or prevent a merger or acquisition that a Share Owner may consider favorable. For example, the Amended and Restated Articles of Incorporation authorizes our Board of Directors to issue one or more series of preferred stock, prevents Share Owners from acting by written consent without unanimous consent, and requires a supermajority Share Owner approval for certain business combinations with related persons. These provisions may discourage acquisition proposals or delay or prevent a change in control, which could harm our stock price. Indiana law also imposes some restrictions on potential acquirers.

Our failure to maintain applicable registrations for our manufacturing facilities could negatively impact our ability to produce products for our customers.

We make substantial investments of capital and operating expenses to implement comprehensive, company-wide quality systems, certifications, and controls in our operations in an effort to ensure sustained compliance with various product and quality system regulations and requirements, and to meet the needs of our customers. However, in the event we fail to adhere to these requirements, we become subject to potential investigations and fines and penalties. Our failure to comply with applicable regulations and quality system standards could, in turn, adversely affect our customers through failures to supply product to them or delays in their ~~capacity as demand fluctuates,~~ability to obtain and ~~component shortages and/~~maintain product approvals. As a medical device manufacturer, we also have additional compliance requirements. The U.S. Food and Drug Administration (“FDA”) extensively regulates all aspects of product and manufacturing quality for medical products under its current Good Manufacturing Practices (cGMP) regulations. Outside the U.S., our operations and our customers’ products are subject to similar regulatory requirements, notably by the European Medicines Agency and the Safe Food and Drug Administration in China. For instance, we are required to register with the FDA and are subject to periodic inspection by the FDA for compliance with the FDA’s Quality System Regulation (“QSR”) requirements, which require manufacturers of medical devices to adhere to certain regulations, including testing, quality control and documentation procedures. Any determination by the FDA or ~~component allocations~~other regulatory authorities of manufacturing or other deficiencies could ~~occur~~adversely affect our business. Failure or noncompliance could have an adverse effect on our reputation in addition to longer lead times. Certain components purchased by us are primarily manufactured in select regions of the world and issues in those regions could cause manufacturing delays. Maintaining strong relationships with key suppliers of components critical to the manufacturing process is essential. Price increases of commodity components, including increased tariffs, could have an adverse impact on our ~~profitability if~~financial position, results of operations, or cash flows.

We are subject to extensive environmental regulation and significant potential environmental liabilities.

The past and present operation and ownership by Kimball Electronics of manufacturing plants and real property are subject to extensive and changing federal, state, local, and foreign environmental laws and regulations, including those relating to discharges in air, water, and land, the handling and disposal of solid and hazardous waste, the use of certain hazardous materials in the production of select products, and the remediation of contamination associated with releases of hazardous substances. In addition, the increased prevalence of global climate change concerns may result in new regulations that may negatively impact us. We cannot predict what environmental legislation or regulations will be enacted in the future, how existing or future laws or regulations will be administered or interpreted, or what environmental conditions may be found to exist. Compliance with more stringent laws or regulations, or stricter interpretation of existing laws, may require additional expenditures, some of which could be material. In addition, any investigations or remedial efforts relating to environmental matters could involve material costs or otherwise result in material liabilities.

The long-term effects of climate change on the global economy and our industry in particular are unclear. Changes in climate where we, ~~cannot offset such increases with other cost reductions~~our customers, and our supply chain operate could have a long-term adverse impact on our business, results of operations, and financial condition. In addition, we have committed to cut our greenhouse gas emissions, water usage, electrical usage, and air emissions significantly by 2025 as part of our long-term sustainability strategy, and we may take additional voluntary steps to mitigate our impact on the environment. Environmental regulations or ~~by price increases to customers. Materials utilized~~changes in our manufacturing process are generally available, but future availability is unknown and could impact our ability to meet customer order requirements. Recently, the COVID-19 pandemic has increased the demand for certain medical components. If suppliers fail to meet commitments to us in terms of price, delivery, or quality, or if the supply, ~~chain is unable to react timely to increases in~~ demand, ~~it could interrupt our operations and negatively impact our ability to meet commitments to customers.~~

~~Our operating results could be adversely affected by increases in~~or available sources of energy or other resources may affect the availability or cost of ~~fuel~~goods and ~~other energy sources.~~

services, including natural resources, necessary to run our business. The cost of energy is a critical component of freight expense and the cost of

operating manufacturing facilities. Increases in the cost of energy could reduce our profitability. Given the political significance and uncertainty around these issues, we cannot predict how legislation, regulation, and increased awareness of these issues will affect our operations and financial condition.

Compliance with government legislation and regulations may significantly increase our operating costs in the United States and abroad.

Legislation and regulations promulgated by the U.S. federal and foreign governments could significantly impact our profitability by burdening us with forced cost choices that either cannot be recovered by increased pricing or, if we increase our pricing, could negatively impact demand for our products. For example:

•Changes in policies by the U.S. or other governments could negatively affect our operating results due to changes in duties, tariffs or taxes, or limitations on currency or fund transfers, as well as government-imposed restrictions on producing certain products in, or shipping them to, specific countries. For example, our facility in Mexico operates under the Mexican Maquiladora (“IMMEX”) program. This program provides for reduced tariffs and eased import regulations. We could be adversely affected by changes in the IMMEX program or our failure to comply with its requirements. As another example, the U.S. government has imposed tariffs on certain products imported from China. China has imposed tariffs on certain U.S. products in retaliation. These tariffs could force our customers or us to consider various strategic options including, but not limited to, looking for different suppliers, shifting production to facilities in different geographic regions, absorbing the additional costs, or passing the cost on to customers. Ultimately, these tariffs could adversely affect the competitiveness of our domestic operations, which could lead to the reduction or exit of certain U.S. manufacturing capacity. Depending on the types of changes made, demand for our foreign manufacturing facilities could be reduced, or operating costs in our manufacturing facilities could be increased, which could negatively impact our financial performance. Moreover, any retaliatory actions by other countries where we operate could also negatively impact our financial performance.

•The Dodd-Frank Wall Street Reform and Consumer Protection Act contains provisions to improve transparency and accountability concerning the supply of certain minerals, known as “conflict minerals,” originating from the Democratic Republic of Congo (“DRC”) and adjoining countries. These rules could adversely affect the sourcing, supply, and pricing of materials used in our products, as the number of suppliers who provide conflict-free minerals may be limited. We may also suffer reputational harm if we determine that certain of our products contain minerals not determined to be conflict-free or if we are unable to modify our products to avoid the use of such materials. We may also face challenges in satisfying customers who may require that our products be certified as containing conflict-free minerals or that we adopt more stringent guidelines like those fostered by the Responsible Materials Initiative (“RMI”).

•We are subject to a variety of federal, state, local and foreign environmental, health and safety, product stewardship and producer responsibility laws and regulations, including those arising from global pandemics or relating to the use, generation, storage, discharge and disposal of hazardous chemicals used during our manufacturing ~~inefficiencies due~~process, those governing worker health and safety, those requiring design changes, supply chain investigation or conformity assessments, and those relating to ~~start-up~~the recycling or reuse of products we manufacture. These include EU regulations and directives, such as the Restrictions on Hazardous Substances (RoHS), the Waste Electrical and Electronic Equipment (“WEEE”) directives, and the Registration, Evaluation, Authorization, and Restriction of Chemicals (“REACH”) regulation, and similar regulations in China (the Management Methods for Controlling Pollution for Electronic Information Products or “China RoHS”). In addition, new ~~programs, transfer~~technical classifications of e-Waste being discussed in the Basel Convention technical working group could affect both our customers’ abilities and obligations in electronics repair and refurbishment. If we fail to comply with any present or future regulations or timely obtain any needed permits, we could become subject to liabilities, and we could face fines or penalties, the suspension of production, ~~and~~or prohibitions on sales of products we manufacture. In addition, such regulations could restrict our ability to expand our facilities or could require us to acquire costly equipment, or to incur other ~~factors.~~

~~At times, we may experience labor~~significant expenses, including expenses associated with the recall of any non-compliant product or other manufacturing inefficiencies due to factors such as start-up of new programs, transfers of production among our manufacturing facilities, a sudden decline in sales, a new operating system, or turnover in personnel. Manufacturing inefficiencies could have an adverse impact on our financial position, results of operations, or cash flows.

~~A change~~with changes in our ~~sales mix among~~operational, procurement and inventory management activities.

In addition, there is an increasing governmental focus around the world on global warming and environmental impact issues, which may result in new environmental, health and safety regulations that may affect us, our suppliers and our customers. This could cause us to incur additional direct costs for compliance, as well as increased indirect costs resulting from our customers, suppliers or both incurring additional compliance costs that are passed on to us. These costs may adversely impact our operations and financial condition.

Social and environmental responsibility policies and guidelines may increase our costs and impose difficult and expensive compliance requirements.

Along with our stakeholders and our broader industry, we have increased our focus on sustainability and measurement of our progress against Environmental, Social, and Governance (“ESG”) criteria. Our customers have adopted, and may continue to adopt, procurement policies that require us to comply with social, and environmental responsibility provisions. In addition, an increasing number of investors have adopted, and may continue to adopt, ESG policies for their portfolio companies, and various ~~products~~voluntarily sustainability initiatives and organizations have promulgated different social and environmental responsibility and sustainability guidelines. These practices, policies, provisions, and initiatives are under active development, subject to change, can be unpredictable and conflicting, and may prove difficult and expensive for us to comply with. These costs may adversely impact our operations and financial condition.

Financial Risks

We are exposed to the credit risk of our customers.

Changes in product sales mix could negatively impact our gross margin as margins of different products vary. We strive to improve the margins of all products, but certain products have lower margins in order to price the product competitively or in connection with the start-up of a new program. An increase in the proportion of sales of products with lower margins could have an adverse impact on our financial position, results of operations, or cash flows.

~~We may implement future restructuring efforts and those efforts may not be successful.~~

We continually evaluate our manufacturing capabilities and capacities in relation to current and anticipated market conditions. We may implement restructuring plans in the future, and the successful execution of those restructuring initiatives will be dependent on various factors and may not be accomplished as quickly or effectively as anticipated.

~~We will face risks commonly encountered with growth through acquisitions.~~

~~Our sales growth plans may occur through both organic growth and acquisitions. Acquisitions involve many risks, including:~~

~~difficulties in identifying suitable acquisition candidates and in negotiating and consummating acquisitions on terms attractive to us;~~

~~difficulties in the assimilation of the operations of the acquired company;~~

~~difficulties in bringing internal control over financial reporting into compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 in a timely manner;~~

~~the diversion of resources, including diverting management’s attention from our current operations;~~

~~risks of entering new geographic or product markets in which we have limited or no direct prior experience;~~

~~the potential loss of key customers of the acquired company;~~

~~the potential loss of key employees of the acquired company;~~

~~the potential incurrence of indebtedness to fund the acquisition;~~

~~the potential issuance of common stock for some or all of the purchase price, which could dilute ownership interests of our current Share Owners;~~

~~the acquired business not achieving anticipated revenues, earnings, cash flow, or market share;~~

~~excess capacity;~~

~~the assumption of undisclosed liabilities;~~

~~potential adverse tax effects; and~~

~~dilution of earnings.~~

~~We may not be successful in launching start-up operations.~~

We are committed to growing our business, and therefore, from time to time, we may determine that it would be in our best interest to start up a new operation. Start-up operations involve a number of risks and uncertainties, such as funding the capital expenditures related to the start-up operation, developing a management team for the new operation, diversion of management focus away from current operations, and creation of excess capacity. Any of these risks could have a material adverse effect on our financial position, results of operations, or cash flows.

~~If efforts to start-up new programs are not successful, this could limit sales growth or cause sales to decline.~~

As we depend on industries that utilize technologically advanced electronic components which often have short life cycles, we must continue to invest in advanced equipment and product development to remain competitive in this area. The start-up of new programs requires the coordination of the design and manufacturing processes. The design and engineering required for certain new programs can take an extended period of time, and further time may be required to achieve customer acceptance. Accordingly, the launch of any particular program may be delayed, less successful than we originally anticipated, or not successful at all. Difficulties or delays in starting up new programs or lack of customer acceptance of such programs could limit sales growth or cause sales to decline and adversely impact our operating results.

~~Our international operations involve financial and operational risks.~~

We have operations outside the United States, primarily in China, Mexico, Poland, Romania, Thailand, and Vietnam. Our international operations are subject to a number of risks, which may include the following:

~~economic and political instability, including the uncertainties caused by the United Kingdom’s exit from the European Union;~~

~~foreign governments’ measures taken in response to the COVID-19 pandemic;~~

~~warfare, riots, terrorism, and other forms of violence or geopolitical disruption;~~

~~compliance with laws, such as the Foreign Corrupt Practices Act, applicable to U.S. companies doing business outside the United States;~~

~~changes in U.S. or foreign policies, regulatory requirements, and laws;~~

~~tariffs and other trade barriers, including tariffs imposed by the United States as well as responsive tariffs imposed by China, the European Union, or Mexico;~~

~~potentially adverse tax consequences, including changes in tax rates and the manner in which multinational companies are taxed in the United States and other countries; and~~

~~foreign labor practices.~~

~~If customers do not perceive our engineering and manufacturing services to be innovative and of high quality, our reputation could suffer.~~

We believe that establishing and maintaining a good reputation is critical to our business. Promotion and enhancement of our name will depend on the effectiveness of marketing and advertising efforts and on successfully providing innovative and high-quality engineering and manufacturing services. If customers do not perceive our services to be innovative and of high quality, our reputation could suffer, which could have a material adverse effect on our business.

Failure to effectively manage working capital may adversely affect our cash flow from operations.

We closely monitor inventory and receivable efficiencies and continuously strive to improve these measures of working capital, but customer financial difficulties, cancellation or delay of customer orders, shifts in customer payment practices, transfers of production among our manufacturing facilities, additional inventory purchases to mitigate potential impact from component shortages, or manufacturing delays could adversely affect our cash flow from operations.

~~We may not be able to achieve maximum utilization of our manufacturing capacity.~~

Most of our customers do not commit to long-term production schedules, and we are unable to forecast the level of customer orders with certainty over a given period of time. As a result, at times it can be difficult for us to schedule production and maximize utilization of our manufacturing capacity. Fluctuations and deferrals of customer orders may have a material adverse effect on our ability to utilize our fixed capacity and thus negatively impact our operating margins.

We could incur losses due to asset impairment.

As business conditions change, we must continually evaluate and work toward the optimum asset base. It is possible that certain assets such as, but not limited to, facilities, equipment, intangible assets, or goodwill could be impaired at some point in the future depending on changing business conditions. Such impairment could have an adverse impact on our financial position and results of operations.

~~As a result of an impairment test we conducted as of June 30,~~For example, in fiscal year 2020, we recorded a $7.9 million impairment charge associated with the goodwill of our GES reporting unit. See Note 6 - Goodwill and Other Intangible Assets of Notes to Consolidated Financial Statements for further discussion of the ~~impairment test and associated~~ charge.

Fluctuations in our effective tax rate could have a significant impact on our financial position, results of operations, or cash flows.

Our effective tax rate is highly dependent upon the geographic mix of earnings across the jurisdictions where we operate. Changes in tax laws or tax rates in those jurisdictions could have a material impact on our operating results. Judgment is required in determining the worldwide provision for income taxes, other tax liabilities, interest, and penalties. We base our tax position upon the anticipated nature and conduct of our business and upon our understanding of the tax laws of the various countries in which we have assets or conduct activities. Our tax position, however, is subject to review and possible challenge by taxing authorities and to possible changes in law (including adverse changes to the manner in which the United States and other countries tax multinational companies or interpret their tax laws). We cannot determine in advance the extent to which some jurisdictions may assess additional tax or interest and penalties on such additional taxes. In addition, our effective tax rate may be increased by changes in the valuation of deferred tax assets and liabilities, changes in our cash management strategies, changes in local tax rates, or countries adopting more aggressive interpretations of tax laws.

Several countries where we operate provide tax incentives to attract and retain business. We have obtained incentives where available and practicable. Our taxes could increase if: certain incentives were retracted, they were not renewed upon expiration, we no longer qualify for such programs, or tax rates applicable to us in such jurisdictions were otherwise increased. In addition, further acquisitions may cause our effective tax rate to increase. Given the scope of our international operations and our international tax arrangements, changes in tax rates and the manner in which multinational companies are taxed in the United States and other countries could have a material impact on our financial results and competitiveness. For example, on December 22, 2017, the United States enacted the Tax Cuts and Jobs Act (“Tax Reform”), which includes a number of significant changes to previous U.S. tax laws that impact us, including provisions for a one-time transition tax on deemed repatriation of undistributed foreign earnings and a reduction in the corporate tax rate from 35% to 21%, among other changes. Tax Reform also transitions U.S. international taxation from a worldwide system to a modified territorial system and includes base erosion prevention measures on non-U.S. earnings.

Certain of our subsidiaries provide financing, products, and services to, and may undertake certain significant transactions with, other subsidiaries in different jurisdictions. Moreover, several jurisdictions in which we operate have tax laws with detailed

transfer pricing rules which require that all transactions with non-resident related parties be priced using arm’s length pricing

principles and that contemporaneous documentation must exist to support such pricing. Due to inconsistencies among jurisdictions in the application of the arm’s length standard, our transfer pricing methods may be challenged and, if not upheld, could increase our income tax expense. Risks associated with transfer pricing adjustments are further highlighted by the global initiative from the Organization for Economic Cooperation and Development (“OECD”) known as the Base Erosion and Profit Shifting (“BEPS”) project. The BEPS project is challenging longstanding international tax norms regarding the taxation of profits from cross-border business. Given the scope of our international operations and the fluid and uncertain nature of how the BEPS project might ultimately lead to future legislation, it is difficult to assess how any changes in tax laws would impact our income tax expense.

~~Changes in financial accounting standards or policies have affected, and in the future may affect, our reported financial condition or results of operations.~~

We prepare our financial statements in conformity with U.S. GAAP. These principles are subject to interpretation by the Financial Accounting Standards Board (“FASB”), the American Institute of Certified Public Accountants, the SEC, and various bodies formed to interpret and create appropriate accounting policies. A change in these policies can have a significant effect on our reported results and may affect our reporting of transactions that are completed before a change is announced. Changes to those rules or questions as to how we interpret or implement them may have a material adverse effect on our reported financial results or on the way we conduct business. See ~~Note 1 - Business Description and Summary of Significant Accounting Policies~~ ~~of Notes to Consolidated Financial Statements for more information on the adoption of the new accounting guidance.~~

A failure to comply with the financial covenants under our credit facilities could adversely impact us.

Our primary credit facility ~~and the 364-day revolving credit facility established in May 2020 require~~requires us to comply with certain financial covenants. We believe the most significant covenants under ~~these~~our credit facilities are the ratio of consolidated total indebtedness minus unencumbered U.S. cash on hand in the United States in excess of $15 million to adjusted consolidated EBITDA, as defined in ~~the~~our primary credit ~~facilities,~~facility, and the fixed charge coverage ratio. More detail on these financial covenants is discussed in Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations. As of June 30, ~~2020,~~2021, we had ~~$111.4~~$66.2 million in borrowings under ~~these~~our credit facilities and had total cash and cash equivalents of ~~$65.0~~$106.4 million. In the future, a default on the financial covenants under our credit facilities could cause an increase in the borrowing rates or make it more difficult for us to secure future financing, which could adversely affect our financial condition.

We are exposed to interest rate risk on our borrowings.

We have exposure to interest rate risk on our borrowings under our credit facilities. The interest rates of these borrowings are based on a spread plus applicable base rate, including the London interbank offered rate (“LIBOR”), the prime rate of a reference bank, or the federal funds rate. An adverse change in the base rates upon which our interest rates are determined could have a material adverse effect on our financial position, results of operations, or cash flows.

In addition, the United Kingdom’s Financial Conduct Authority has announced that after 2021 it would no longer persuade or compel panel banks to submit the rates required to calculate LIBOR. In March 2021, the administrator of LIBOR, ~~and~~the ICE Benchmark Administration, publicly announced that it ~~is unclear whether~~will cease publication of LIBOR settings, either on December 31, 2021 or June 30, 2023, subject to the ~~banks currently reporting information used to set~~ LIBOR ~~will stop doing so after 2021. If~~settings. As LIBOR is discontinued ~~or if the method of calculating LIBOR changes from its current form,~~and we transition to a new rate, interest rates on our current or future indebtedness may be adversely affected.

General Risk Factors

We will face risks commonly encountered with growth through acquisitions.

Our ~~business~~sales growth plans may ~~be harmed due~~occur through both organic growth and acquisitions. Acquisitions involve many risks, including:

•difficulties in identifying suitable acquisition candidates and in negotiating and consummating acquisitions on terms attractive to ~~failure~~us;

•difficulties in the assimilation of the personnel, processes, and operations of the acquired company;

•difficulties in bringing internal control over financial reporting into compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 in a timely manner;

•the diversion of resources, including diverting management’s attention from our current operations;

•risks of entering new geographic or product markets in which we have limited or no direct prior experience;

•the potential loss of key customers of the acquired company;

•the potential loss of key employees of the acquired company;

•the potential incurrence of indebtedness to ~~successfully implement information technology solutions~~fund the acquisition;

•the potential issuance of common stock for some or ~~a lack~~all of ~~reasonable safeguards to maintain data security, including adherence to data privacy laws and physical security measures.~~

~~The operation~~the purchase price, which could dilute ownership interests of our current Share Owners;

•the acquired business ~~depends~~not achieving anticipated revenues, earnings, cash flow, or market share;

•excess capacity;

•the assumption of undisclosed liabilities;

•potential adverse tax effects; and

•dilution of earnings.

We may implement future restructuring efforts and those efforts may not be successful.

We continually evaluate our manufacturing capabilities and capacities in relation to current and anticipated market conditions. We may implement restructuring plans in the future, and the successful execution of those restructuring initiatives will be dependent on ~~effective information technology systems, which~~various factors and may not be accomplished as quickly or effectively as anticipated.

Changes in financial accounting standards or policies have affected, and in the future may affect, our reported financial condition or results of operations.

We prepare our financial statements in conformity with U.S. GAAP. These principles are subject to interpretation by the ~~risk~~Financial Accounting Standards Board (“FASB”), the American Institute of ~~security breach or cybersecurity threat, including misappropriation of assets or other sensitive information, such as confidential business information~~Certified Public Accountants, the SEC, and ~~personally identifiable data relating~~various bodies formed to ~~employees, customers,~~interpret and other business partners, or data corruption which could cause operational disruption. As we could be the target of cyber and other security threats, which are becoming increasingly sophisticated, we must continuously monitor and develop our information technology networks and infrastructure to prevent, detect, address, and mitigate the risk of unauthorized access, misuse, computer viruses, and other events that couldcreate appropriate accounting policies. A change in these policies can have a ~~security impact. Information systems require an ongoing commitment~~significant effect on our reported results and may affect our reporting of ~~significant resources~~transactions that are completed before a change is announced. Changes to research new technologies and processes, maintain and enhance existing systems, and develop new systems in order to keep pace with changes in information processing technology and evolving industry standards as wellthose rules or questions as to ~~protect against cyber risks and security breaches. While~~how we provide employee awareness training around phishing, malware, and other cyber threats to help protect against these cyber and security risks, we cannot ensure the measures we take to protect our information technology systems will be sufficient.

~~Implementation delays, poor execution,~~interpret or a breach of information technology systems could disrupt our operations, damage our reputation, or increase costs related to the mitigation of, response to, or litigation arising from any such issue. Similar risks exist with our third-party vendors. Any problems caused by these third parties, including those resulting from disruption in

communications services, cyber attacks, or security breaches, have the potential to hinder our ability to conduct business. In addition, data privacy laws and regulations, such as the European Union General Data Protection Regulation and similar legislation in jurisdictions in which we operate, pose increasingly complex compliance challenges and potentially elevate costs, and any failure to comply with these laws and regulations could result in significant penalties.

~~Failure to protect our intellectual property could undermine our competitive position.~~

Competing effectively depends, to a significant extent, on maintaining the proprietary nature of our intellectual property. We attempt to protect our intellectual property rights worldwide through a combination of trademark, copyright, and trade secret laws, as well as licensing agreements and third-party non-disclosure and assignment agreements. Because of the differences in foreign laws concerning proprietary rights, our intellectual property rights do not generally receive the same degree of protection in foreign countries as they do in the United States, and therefore, in some parts of the world, we have limited protections, if any, for our intellectual property. If we are unable to adequately protect our intellectual property embodied in our solutions, designs, processes, and products, the competitive advantages of our proprietary technology could be reduced or eliminated, which would harm our business and couldimplement them may have a material adverse effect on our reported financial results or on the way we conduct business. See Note 1 - Business Description and Summary of ~~operations and financial position.~~

~~We may be sued by third parties~~Significant Accounting Policies of Notes to Consolidated Financial Statements for ~~alleged infringement of their intellectual property rights and incur substantial litigation or other costs.~~

We may be sued by third parties who allege that our products or services infringe their intellectual property rights. Such claims, regardless of their merits, could result in substantial costs and diversion of resources inmore information on the defense or settlement of such claims. In the event of a claim upheld against us, we may be required to spend a significant amount of money and effort to develop non-infringing alternatives or obtain and maintain licenses. We may not be successful in developing such alternatives or obtaining or maintaining such licenses on reasonable terms or at all, which could have a material adverse effect on our results of operations, financial position, or cash flows.

~~Our insurance may not adequately protect us from liabilities related to product defects.~~

We maintain product liability and other insurance coverage that we believe to be generally in accordance with industry practices. However, our insurance coverage may not be adequate to protect us fully against substantial claims and costs that may arise from liabilities related to product defects, particularly if we have a large number of defective products or if the root cause is disputed.

Our failure to maintain Food and Drug Administration (FDA) registration of one or more of our registered manufacturing facilities could negatively impact our ability to produce products for our customers in the medical industry.

~~To maintain FDA registration, Kimball Electronics is subject to FDA audits~~adoption of the manufacturing process. FDA audit failure could result in a partial or total suspension of production, fines, or criminal prosecution. Failure or noncompliance could have an adverse effect on our reputation in addition to an adverse impact on our financial position, results of operations, or cash flows.

~~We are subject to extensive environmental regulation and significant potential environmental liabilities.~~

Our failure to retain the existing management team, maintain our engineering, technical, and manufacturing process expertise, or continue to attract qualified personnel could adversely affect our business.

We depend significantly on our executive officers and other key personnel. The unexpected loss of the services of any one of these executive officers or other key personnel may have an adverse effect on us.

Our success also depends on keeping pace with technological advancements, including Industry 4.0, and adapting services to provide manufacturing capabilities which meet customers’ changing needs. Therefore, we must retain our qualified engineering and technical personnel and successfully anticipate and respond to technological changes in a cost effective and timely manner. Our culture and guiding principles focus on continuous training, motivating, and development of employees, and we strive to attract, motivate, and retain qualified personnel. Failure to retain and attract qualified personnel could adversely affect our business.

~~Availability of manufacturing labor and turnover~~A change in ~~personnel~~our sales mix among various products could ~~cause manufacturing inefficiencies and increase operating costs.~~have a negative impact on our gross profit margin.

~~The demand for manufacturing labor~~Changes in ~~certain geographic areas in which we operate make recruiting new production employees and retaining experienced production employees difficult. Shortage of production workers~~product sales mix could ~~adversely~~negatively impact our ~~ability~~gross margin as margins of different products vary. We strive to ~~complete our customers’ orders on a timely basis, which could adversely affect our relations with customers, potentially resulting~~improve the margins of all products, but certain products have lower margins in ~~reduction~~order to price the product competitively or in ~~orders from customers or loss of customers. Turnover in personnel could result in additional training and inefficiencies that could adversely impact our operating results.~~

~~The cost of providing employee healthcare benefits could increase and reduce our profitability.~~

~~We are self-insured up to certain limits for certain domestic employee health benefits. For these self-insured health plans, we incur the cost of claims, which may include catastrophic claims,~~connection with the ~~employees bearing~~start-up of a ~~limited portion~~new program. An increase in the proportion of ~~the cost through insurance premiums and deductibles. The cost~~sales of ~~providing employee healthcare benefits may increase, including as a result of the high costs associated~~products with ~~rare-disease drug prescriptions, and~~lower margins could have an adverse ~~effect~~impact on our ~~profitability.~~financial position, results of operations, or cash flows.

Natural disasters or other catastrophic events such as the COVID-19 pandemic may impact our production schedules and, in turn, negatively impact profitability.

Natural disasters or other catastrophic events, including severe weather, terrorist attacks, power interruptions, fires, and pandemics, could disrupt operations and likewise our ability to produce or deliver products. Our manufacturing operations require significant amounts of energy, including natural gas and oil, and governmental regulations may control the allocation of such fuels to Kimball Electronics. Employees are an integral part of our business, and events such as a pandemic could reduce the availability of employees reporting for work. In the event we experience a temporary or permanent interruption in our ability to produce or deliver product, revenues could be reduced, and business could be materially adversely affected. In addition, catastrophic events, or the threat thereof, can adversely affect U.S. and world economies, and could result in reduced demand for our customers’ products and delayed or lost revenue for our services. Further, any continuing disruption in our computer systems could adversely affect the ability to receive and process customer orders, manufacture products, and ship products on a timely basis, and could adversely affect relations with customers, potentially resulting in reduction in orders from customers or loss of customers. We maintain insurance to help protect us from costs relating to some of these matters, but such may not be sufficient or paid in a timely manner to us in the event of such an interruption.

For example, the COVID-19 pandemic poses the risk that we or our employees, suppliers, customers, and others may be restricted or prevented from conducting business activities as normal for indefinite or intermittent periods of time, which has impacted and will continue to impact our global operations. ~~We have experienced and are experiencing sales declines in certain product categories, especially in the automotive market as a result of temporary suspensions of production by automakers.~~ Several of our facilities have experienced temporary suspensions of operations due to the COVID-19 outbreak. While all facilities have since resumed normal operations, further temporary suspensions could occur. All of our operations have been, and will continue to be, impacted to varying degrees by government measures worldwide to contain or mitigate the spread of the virus, including travel restrictions, restrictions on operation of businesses, shelter in place orders, and mandatory closures of schools and child-care facilities, which in turn can have adverse

impacts on the availability of critical components, our supply chain, capacity utilization at our facilities, and the ability of certain employees to return to work. We have modified our business practices for the continued health and safety of our employees and may take further actions, or be required to take further actions, that are in the best interests of our employees. Our suppliers and customers have also implemented, or may implement, similar practices in response to the pandemic. The implementation of health and safety practices by us or our suppliers or customers could adversely impact deliveries and productivity and increase costs. In addition, responding to the continuing pandemic could divert management’s attention from our key strategic priorities or cause us to divert or delay the application of our resources toward initiatives that may otherwise increase our long-term value. We cannot reasonably predict the full extent to which the COVID-19 pandemic will impact our financial position, results of operations, and cash flows, which will depend on future developments that are highly uncertain and continuously evolving, including, the duration of the COVID-19 pandemic and its severity, new medical and other information that may emerge concerning COVID-19, further actions by governmental entities or others in response to the pandemic, and how quickly and to what extent normal economic and operating conditions can resume.

~~Imposition of government regulations may significantly increase our operating costs in the United States and abroad.~~

Legislative and regulatory reforms by the U.S. federal and foreign governments could significantly impact the profitability of Kimball Electronics by burdening us with forced cost choices that cannot be recovered by increased pricing or, if we increase our pricing, this could negatively impact demand for our products. For example:

~~Foreign regulations are increasing in many areas such as data privacy, hazardous waste disposal, labor relations, and employment practices.~~

Changes in policies by the U.S. or other governments could negatively affect our operating results due to changes in duties, tariffs or taxes, or limitations on currency or fund transfers, as well as government-imposed restrictions on producing certain products in, or shipping them to, specific countries. For example, our facility in Mexico operates under the Mexican Maquiladora (“IMMEX”) program. This program provides for reduced tariffs and eased import regulations. We could be adversely affected by changes in the IMMEX program or our failure to comply with its requirements. As another example, the U.S. government has imposed tariffs on certain products imported from China as well as steel and aluminum imported from the European Union. China and the European Union have imposed tariffs on certain U.S. products in retaliation. These tariffs could force our customers or us to consider various strategic options including, but not limited to, looking for different suppliers, shifting production to facilities in different geographic regions, absorbing the additional costs, or passing the cost on to customers. Ultimately, these tariffs could adversely affect the competitiveness of our domestic operations, which could lead to the reduction or exit of certain U.S. manufacturing capacity. The U.S. government may impose additional tariffs on automotive imports from the European Union. Depending on the types of changes made, demand for our foreign manufacturing facilities could be reduced, or operating costs in our manufacturing facilities could be increased, which could negatively impact our financial performance. Moreover, any retaliatory actions by other countries where we operate could also negatively impact our financial performance.

~~SEC “Conflict Minerals” regulation may increase our costs and reduce our sales levels.~~

As a result of the Dodd-Frank Act, the SEC adopted rules establishing due diligence, disclosure, and reporting requirements for public companies which manufacture products that include components containing certain minerals referred to as “conflict minerals.” Since certain products we manufacture for our customers contain such minerals, we are required to determine, disclose, and report whether or not such minerals in our products originate from the Democratic Republic of Congo (“DRC”) and adjoining countries. Such regulations could decrease the availability and increase the prices of components used in our products, particularly if we choose (or are required by our customers) to source such components from different suppliers. In addition, as our supply chain is complex and the process to comply with the SEC rules is cumbersome, the ongoing compliance process is both time consuming and costly. We may face reduced sales if we are unable to timely verify the origins of minerals contained in the components included in our products, or supply disruptions if our due diligence process reveals that materials we source contain minerals that originated in the DRC or adjoining countries.

~~Risks Relating to Our Common Stock~~

~~Our stock price may fluctuate significantly.~~

~~The market price of our common stock may fluctuate widely, depending on many factors, some of which may be beyond our control, including:~~

~~actual or anticipated fluctuations in our operating results due to factors related to our business;~~

~~wins and losses on contract competitions and new business pursuits;~~

~~success or failure of our business strategy;~~

~~our quarterly or annual earnings, or those of other companies in our industry;~~

~~our ability to obtain financing as needed;~~

~~announcements by us or our competitors of significant acquisitions or dispositions;~~

~~successful integration of acquisitions or greenfield start-ups;~~

~~changes in accounting standards, policies, guidance, interpretations or principles;~~

~~the failure of securities analysts to cover our common stock;~~

~~changes in earnings estimates by securities analysts or our ability to meet those estimates;~~

~~the operating and stock price performance of other comparable companies;~~

~~the changes in customer requirements for our products and services;~~

~~natural disasters or other catastrophic events, such as the COVID-19 pandemic, that investors believe may affect us;~~

~~overall market fluctuations;~~

~~results from any material litigation or government investigation;~~

~~changes in laws and regulations affecting our business; and~~

~~general economic conditions and other external factors.~~

Stock markets in general have experienced volatility that has often been unrelated to the operating performance of a particular company. These broad market fluctuations, coupled with changes in results of operations and general economic, political, and market conditions, could adversely affect the trading price of our common stock.

~~Anti-takeover provisions in our organizational documents and Indiana law could delay or prevent a change in control.~~

We have adopted Amended and Restated Articles of Incorporation and Amended and Restated Bylaws. Certain provisions of the Amended and Restated Articles of Incorporation and the Amended and Restated Bylaws may delay or prevent a merger or acquisition that a Share Owner may consider favorable. For example, the Amended and Restated Articles of Incorporation authorizes our Board of Directors to issue one or more series of preferred stock, prevents Share Owners from acting by written consent, and requires a supermajority Share Owner approval for certain business combinations with related persons. These provisions may discourage acquisition proposals or delay or prevent a change in control, which could harm our stock price. Indiana law also imposes some restrictions on potential acquirers.

~~We cannot assure you that we will pay dividends on our stock in the future.~~

We have not paid any dividends on our common stock. The timing, declaration, amount, and payment of future dividends to our Share Owners will fall within the discretion of our Board of Directors and will depend on many factors, including our financial condition, results of operations and capital requirements, industry practice, and other business considerations that our Board of Directors considers relevant from time to time. In addition, our ability to declare or the amount of any future dividends may be restricted by the provisions of Indiana law and covenants in our primary credit facility. We do not have a plan to pay future dividends at this time. There can be no assurance that we will pay a dividend in the future or continue to pay any dividend if we do commence the payment of dividends. To the extent that expectations by market participants regarding the potential payment, or amount, of any dividend prove to be incorrect, the price of our common stock may be materially and negatively affected, and investors that bought shares of our common stock based on those expectations may suffer a loss on their investment.

Item 1B - Unresolved Staff Comments

None.

Item 2 - Properties

As of June 30, ~~2020,~~2021, we had eleven manufacturing facilities with two located in Indiana, two in China, and one located in each of California, Florida, Mexico, Poland, Romania, Thailand, and Vietnam. These facilities occupy approximately ~~1,358,000~~1,374,000 square feet in aggregate, substantially all of which are owned. We lease a facility in India that accommodates our software design services. In addition, we own a 42,000 square-foot building to house our headquarters located in Jasper, Indiana.

Generally, our manufacturing facilities are utilized at normal capacity levels on a multiple shift basis. At times, certain facilities utilize reduced ~~shifts. Due~~shifts due to ~~sales fluctuations caused by changes in~~ demand and ~~the impacts of COVID-19, not all facilities were utilized at normal capacity during fiscal year 2020.~~sales fluctuations. We continually assess our capacity needs and evaluate our operations to optimize our service levels by geographic region. See Item 1A - Risk Factors for information regarding financial and operational risks related to our international operations.

Significant loss of income resulting from a facility catastrophe would be partially offset by business interruption insurance coverage.

~~The Company holds~~We hold land leases for our facilities in China, Thailand, and Vietnam with these leases expiring from fiscal year 2030 to ~~2057~~.2057. See Note 201 - ~~Leases~~Business Description and Summary of Significant Accounting Policies of Notes to Consolidated Financial Statements for additional information concerning leases. In addition, we own approximately 97109 acres of land which includes land where our facilities reside.

Item 3 - Legal Proceedings

We and our subsidiaries are not parties to any pending legal proceedings, other than ordinary routine litigation and claims incidental to the business. The outcome of current routine pending litigation and claims, individually and in the aggregate, is not expected to have a material adverse impact on our business or financial condition.

Item 4 - Mine Safety Disclosures

Not applicable.

Information about Our Executive Officers

Our executive officers as of August 27, ~~2020~~2021 are as follows:

(Age as of August 27, ~~2020)~~

2021)

Name

Age

Office and Area of Responsibility

Donald D. Charron

5657

Chairman of the Board and Chief Executive Officer

Desiree L. Castillejos

4950

Vice President, Corporate Development and M&A, and Chief Strategy Officer

Jana T. Croom

Vice President, Chief Financial Officer

Jessica L. DeLorenzo

3536

Vice President, Human Resources

John H. Kahle

6364

Vice President, General Counsel, Chief Compliance Officer, and Secretary

LeRoy W. Kemper

4950

Vice President, Diversified Contract Manufacturing Services

Steven T. Korn

5657

President, Global Electronics Manufacturing Services Operations

~~Michael K. Sergesketter~~

~~Vice President, Chief Financial Officer~~

Sandy A. Smith

5758

Vice President, Information Technology

Kathy R. Thomson

5152

Vice President, Global Business Development and Design Services

Christopher J. Thyen

5758

Vice President, New Platforms

Executive officers are appointed annually by the Board of Directors. The following is a brief description of the business experience during the past five or more years of each of our executive officers. ~~Prior to becoming a stand-alone public company on October 31, 2014, the Company was a wholly-owned subsidiary of Kimball International, Inc. (“former Parent”).~~

Mr. Charron is our Chairman of the Board and Chief Executive Officer. Mr. Charron has served in this role since October 2014. Previously, he served as an Executive Vice President of former Parent, a member of the Board of Directors of former Parent, and the President of the Kimball Electronics Group that now comprises Kimball Electronics. Mr. Charron had led the EMS segment of former Parent since joining former Parent in 1999.

Ms. Castillejos was appointed Vice President, Corporate Development and M&A, and Chief Strategy Officer in August 2018. Prior to joining Kimball Electronics, she held the position of Vice President, Corporate Development for Nokia Technology since 2016. Prior to Nokia Technology, she served as the Vice President, Corporate Development for Persistent Systems since 2010.

Ms. Croom was appointed Vice President, Chief Financial Officer effective July 1, 2021. Ms. Croom joined Kimball Electronics in January 2021 in the role of Vice President, Finance. Prior to joining Kimball Electronics, she held the position of Vice President, Financial Planning and Analysis for NiSource Inc. since August 2019. Previously at NiSource Inc., she served as Director of Operations Planning since March 2017 and Director of Regulatory Affairs since April 2014.

Ms. DeLorenzo was appointed Vice President, Human Resources in June 2018. Ms. DeLorenzo joined Kimball Electronics in 2015 in the position of Director, Organizational Development. ~~Before joining Kimball Electronics, she held the position of Director, Student Services at Vincennes University since 2011.~~

Mr. Kahle is our Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Kahle has served as our Vice President, General Counsel, and Secretary since October 2014 and was appointed Chief Compliance Officer in April 2016. ~~Previously, he served as Executive Vice President, General Counsel and Secretary of former Parent and had served in this role with former Parent since 2001.~~

Mr. Kemper was appointed Vice President, Diversified Contract Manufacturing Services, effective July 1, 2020. Previously, Mr. Kemper held the position of General Manager, Kimball Electronics Indianapolis since 2018. Prior to joining Kimball Electronics, he held the position of President for iScribeMD since 2017. Prior to iScribeMD, he served as the Vice President of Operations for Fresh Products since 2012.

Mr. Korn was appointed President, Global Electronics Manufacturing Services Operations, effective July 1, 2020. Previously, Mr. Korn held the position of Vice President, North American Operations and had served in this role since 2007.

Mr. Sergesketter is our Vice President, Chief Financial Officer. Mr. Sergesketter has served in this role since October 2014. Previously, he served as Vice President, Chief Financial Officer for Kimball Electronics Group that now comprises Kimball Electronics. Mr. Sergesketter had served in this role with former Parent since 1996.

Ms. Smith is our Vice President, Information Technology and has served in this role since 2004.

Ms. Thomson was appointed Vice President, Global Business Development and Design Services in August 2018. Previously Ms. Thomson held the position of Vice President of Business Development for Creation Technologies since 2012.

Mr. Thyen was appointed our Vice President, New Platforms, in August 2018. Prior to this, he served as Vice President, Business Development since 2008.

PART II

Item 5 - Market for Registrant’s Common Equity, Related Share Owner Matters and Issuer Purchases of Equity Securities

Market Information

The Company’s common stock trades on the ~~NASDAQ~~Nasdaq Global Select Market of The ~~NASDAQ~~Nasdaq Stock Market LLC (“~~NASDAQ”~~Nasdaq”) under the symbol: KE.

Dividends

WeSince inception, we have not paid any dividends on our common stock, ~~since~~and we ~~became a stand-alone public company on October 31, 2014. We~~currently do not have ~~a plan at this time~~plans to pay dividends in ~~the future.~~fiscal year 2022. Our Board of Directors (the “Board”) regularly reviews our capital allocation strategy.

Share Owners

On August 13, ~~2020,~~2021, the Company’s common stock was owned by approximately ~~1,205~~1,151 Share Owners of record.

Securities Authorized for Issuance Under Equity Compensation Plans

The information required by this item concerning securities authorized for issuance under equity compensation plans is incorporated by reference to Item 12 - Security Ownership of Certain Beneficial Owners and Management and Related Share Owner Matters of Part III.

Issuer Purchases of Equity Securities

On October 21, 2015, our Board ~~of Directors (the “Board”)~~ approved an 18-month stock repurchase plan (the “Plan”), authorizing the repurchase of up to $20 million worth of our common stock. Then, separately on each of September 29, 2016, August 23, 2017, ~~and~~ November 8, 2018, and November 10, 2020, the Board extended and increased the Plan to allow the repurchase of up to an additional $20 million worth of common stock with no expiration date, which brought the total authorized stock repurchases under the Plan to ~~$80~~$100 million.

During the three months ended June 30, ~~2020,~~2021, the Company did not repurchase any common stock. During fiscal year ~~2020,~~2021, the Company has repurchased ~~$8.8~~$3.0 million of common stock under the Plan. The Company’s maximum value of remaining shares that may be purchased under the Plan was ~~$3.3~~$20.3 million at June 30, ~~2020. On March 30, 2020, the Plan was temporarily suspended as a result of the COVID-19 environment.~~

2021.

Performance Graph

The following performance graph is not deemed to be “soliciting material” or to be “filed” with the SEC or subject to Regulation 14A or 14C under the Exchange Act or to the liabilities of Section 18 of the Exchange Act and will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent the Company specifically incorporates it by reference into such a filing.

The graph below compares the cumulative total return to Share Owners of the Company’s common stock for the five-year period commencing June 30, ~~2015~~2016 and ending June 30, ~~2020~~2021 to the cumulative total return of the ~~NASDAQ~~Nasdaq Stock Market (U.S.) and a peer group index for the same period of time. The peer group index is comprised of publicly traded companies in the EMS industry and includes: Benchmark Electronics, Inc., Flex Ltd., Jabil Inc., Plexus Corp., and Sanmina Corporation. The public companies included in the peer group each have a larger revenue base than we do.

The graph assumes $100 is invested in the Company’s stock and each of the two indexes at the closing market quotations on June 30, ~~2015~~2016 and that dividends, if any, are reinvested. The performances shown on the graph are not necessarily indicative of future price performance.


	06/30/2016		06/30/2017		06/30/2018		06/30/2019		06/30/2020		06/30/2021
Kimball Electronics, Inc.	$	100.00	$	144.98	$	146.99	$	130.44	$	108.76	$	174.62
Nasdaq Stock Market (U.S.)	$	100.00	$	128.32	$	158.64	$	170.97	$	217.05	$	315.26
Peer Group Index	$	100.00	$	143.73	$	129.92	$	117.57	$	120.46	$	201.01

06/30/2015 06/30/2016 06/30/2017 06/30/2018 06/30/2019 06/30/2020
Kimball Electronics, Inc. $ 100.00
$ 85.83
$ 123.71
$ 125.43
$ 111.31
$ 92.80
NASDAQ Stock Market (U.S.) $ 100.00
$ 98.26
$ 126.07
$ 155.85
$ 167.93
$ 213.18
Peer Group Index $ 100.00
$ 102.20
$ 146.73
$ 132.06
$ 119.36
$ 121.80

Item 6 - ~~Selected Financial Data~~[Reserved]

~~This information should be read in conjunction with~~ ~~Item 8 - Financial Statements and Supplementary Data~~ ~~and~~ ~~Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations~~. Effective for fiscal year ended June 30, 2019, the Company adopted the new accounting standard on Revenue from Contracts with Customers on a modified retrospective basis, and the prior periods were not restated and continue to be reported under the accounting standards in effect for those periods.

Year Ended June 30
(Amounts in Thousands, Except for Per Share Data)
2020 2019 2018 2017 2016
Consolidated Statements of Income Data:
Net Sales $ 1,200,550
$ 1,181,844
$ 1,072,061
$ 930,914
$ 842,060
Net Income ⁽¹⁾
$ 18,196
$ 31,558
$ 16,752
$ 34,179
$ 22,287
Earnings Per Share:

Basic $ 0.72
$ 1.22
$ 0.63
$ 1.25
$ 0.77
Diluted $ 0.71
$ 1.21
$ 0.62
$ 1.24
$ 0.76

As of June 30
(Amounts in Thousands)
2020 2019 2018 2017 2016
Consolidated Balance Sheet Data:
Total Assets $ 774,829
$ 764,111
$ 608,758
$ 554,944
$ 510,565
Long-Term Debt, Less Current Maturities $ 91,500
$ 91,500
$ —
$ —
$ —

(1) Fiscal year 2020 net income included $6.9 million ($0.28 per diluted share) of after-tax expense related to goodwill impairment of the GES reporting unit and after-tax expense of $2.9 million ($0.11 per diluted share) from the final net working capital adjustment recorded after the measurement period of the GES acquisition.

Fiscal year 2018 net income included income tax expense of $17.9 million ($0.66 per diluted share) due to the U.S. Tax Cuts and Jobs Act (“Tax Reform”) that was enacted into law in December 2017 and relates to the deemed repatriation of unremitted foreign earnings and the revaluation of net deferred tax assets.

Fiscal year 2017 net income included $2.5 million ($0.09 per diluted share) of after-tax income resulting from settlements received related to an antitrust class action lawsuit in which the Company was a member and $0.9 million ($0.03 per diluted share) of after-tax income resulting from the bargain purchase gain recognized in the acquisition of Aircom Manufacturing, Inc.

Fiscal year 2016 net income included a foreign income tax benefit of $1.8 million ($0.06 per diluted share) as a result of a favorable tax ruling related to the fiscal year 2015 capitalization of the Company’s Romania subsidiary.

Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations

Business Overview

We are a global, multifaceted manufacturing solutions provider. We provide contract electronics manufacturing services (“EMS”) and diversified manufacturing services, including engineering and supply chain support, to customers in the automotive, medical, industrial, and public safety end markets. Our core competency is producing durable electronics, and we further offer diversified contract manufacturing services for non-electronic components, medical devices, medical disposables, drug delivery devices and solutions, precision molded plastics, and production automation, test, and inspection equipment. Our manufacturing services, including engineering and supply chain support, utilize common production and support capabilities globally. We are well recognized by our customers and the industry for our excellent quality, reliability, and innovative service. For the third time in ~~six~~four years, we were recognized in ~~2020~~2021 for achieving the Highest Overall Customer Rating in CIRCUITS ASSEMBLY’s ~~2020~~2021 Service Excellence Awards. CIRCUITS ASSEMBLY is a leading brand and technical publication for electronics manufacturers worldwide.

The contract manufacturing services industry is very competitive. As a mid-sized player, we can expect to be challenged by the agility and flexibility of the smaller, regional players, and we can expect to be challenged by the scale and price competitiveness of the larger, global players. We enjoy a unique market position between these extremes which allows us to compete with the larger scale players for high-volume projects, but also maintain our competitive position in the generally

lower volume durable electronics market space. We expect to continue to effectively operate in this market space; however, one significant challenge will be maintaining our profit margins while we continue our revenue growth. Price increases are uncommon in the market as production efficiencies and material pricing advantages for most projects drive costs and prices down over the life of the projects. This characteristic of the contract electronics marketplace is expected to continue.

The ~~June 2020 edition of~~Worldwide Manufacturing Services Market ~~Insider published by NVR highlighted some key findings published in its annual report~~- 2021 Edition, a comprehensive study on the worldwide EMS ~~industry,~~ ~~The Worldwide Electronics Manufacturing Services - 2020 Edition.~~ ~~It was noted that the~~market published by New Market Research (“NVR”), provided worldwide ~~contract manufacturing market experienced revenue growth of 2.5% during calendar year 2019. During calendar year 2019, we experienced growth of approximately 13%. In addition,~~forecast trends through 2025. NVR projects the worldwide assembly market for electronics products to grow at a compound annual growth rate (“CAGR”) of ~~1.9%~~3.4% over the next five years, ~~calendar years 2020 through 2024,~~ with the EMS industry projected to grow at a CAGR of ~~5.6%~~7.1%.

We continue to monitor the current economic and industry conditions for uncertainties that may pose a threat to our future growth or cause disruption in business strategy, execution, and timing in the markets in which we compete. WeThe COVID-19 pandemic continues to impact the global economy, and we are actively monitoring ~~the global COVID-19 pandemic and~~ its impact on all our ~~operations, including the effect on customers, the supply chain, the availability of critical components, and the health and availability of our workforce. Our primary focus is the~~operations. The well-being and safety of our employees remains our number one priority, and we are following ~~current~~ guidelines suggested by applicable authorities, including utilizing protective shields, face masks, body temperature scanning, social distancing, and proper ~~hygiene.~~hygiene as appropriate for our operations. Our response to each positive case in our facilities follows our procedures for communication to our employees, contact tracing, self-quarantining, testing, and sanitization of the affected work areas. Because of the variety of critical medical device assemblies we manufacture around the world, our facilities ~~are~~were classified as “essential businesses” or otherwise ~~have been~~ permitted to operate under shelter in place orders or other similar orders during government-mandated COVID-19 shutdowns, but all have been affected to varying degrees by COVID-19. We ~~are maintaining~~continue to maintain close contact and communication with our customers and our supply chain to ensure safety measures follow appropriate guidelines for the health and safety of all parties and to minimize disruption of operations. ~~Significant~~While the availability of vaccines is encouraging, significant uncertainties and risks still exist related to the effectiveness and uptake of the various vaccines and the severity and duration of the impact of COVID-19 on our end markets, the supply chain, the health and availability of our workforce, and global macroeconomic conditions; therefore, its financial impact on our future results cannot be reasonably estimated but could be material.

The ~~COVID-19 pandemic~~EMS industry is currently experiencing component shortages and component allocations, particularly with semiconductors driven by the strong demand in consumer electronics and the beginning of a global recovery. Component shortages or allocations could increase component costs and potentially interrupt our operations and negatively impact our ability to meet commitments to customers. The semiconductor shortage has adversely impacted global manufacturing, including the automotive industry, ~~by disrupting the supply chain from China and~~ leading to automakers ~~in the U.S. and Europe~~ temporarily suspending production ~~during April~~in recent months. We have taken various actions to mitigate the risk and ~~May. Although we experienced growth~~minimize the impact to our customers as well as the adverse effect component shortages or allocations could have on our results; however, the duration or severity of the semiconductor shortage is unknown, and its financial impact on our results cannot be reasonably estimated but could be material.

Demand from customers in the automotive market ~~in the first nine months of fiscal year 2020 when compared to the nine-month period of the prior fiscal year, led~~is gaining momentum, after recently being adversely impacted by ~~the continued ramp-up of new programs including programs for fully electric vehicles,~~COVID-19, as we experienced a ~~43% decline~~record sales quarter in ~~sales~~our automotive vertical in the ~~automotive market in the last~~second quarter of fiscal year ~~2020 when compared to~~2021 and growth in the ~~fourth quarter~~second half of ~~the prior~~ fiscal year ~~due to~~2021 over the second half of fiscal year 2020. We are monitoring, however, the current shortage of semiconductors and the continuing impact ~~of COVID-19.~~on global automobile production. We anticipate ~~sales to~~demand from customers in the automotive market to ~~return to pre-COVID-19 levels by the middle~~remain strong during fiscal year 2022, but we expect a stronger second half of fiscal year ~~2021.~~2022 than

the first half as we expect the supply to catch up with the demand. In the medical market, ~~we experienced year-over-year~~ sales ~~growth,~~returned to the pre-COVID-19 pandemic levels starting with ~~a 23% increase in~~ the ~~fourth~~second quarter of fiscal year ~~2020 when compared to~~2021 after we experienced a record sales quarter in the ~~fourth~~first quarter of ~~the prior~~ fiscal year 2021 due to the significant increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products, as a direct result of COVID-19. ~~We expect growth to continue~~Sales were adversely impacted in the medical market ~~in the upcoming quarters.~~due to lower demand for non-critical medical products, but we believe this demand will increase as elective procedures resume to pre-COVID-19 levels. In the industrial market, ~~growth was driven~~we had record sales in the current fiscal year in large part due to ~~increased demand for smart metering products and~~ improved sales ~~at our GES reporting unit.~~

The EMS industry previously experienced certain component shortages and component allocations. Component shortages or allocations could increase component costs and potentially interrupt our operations and negatively impact our ability to meet commitments to customers. We have taken various actions to mitigate the risk and minimize the adverse effect the component shortages or allocations could have on our results and the impact to our customers. In addition, the impact from tariffs and additional proposed tariffs on components we utilize in our domestic manufacturing process, of which many currently can only be sourced from China, may adversely affect the competitiveness of our domestic operations.

We expect to make investments that will strengthen or add new capabilities to our package of value as a multifaceted manufacturing solutions company, including through acquisitions. In fiscal year 2019, we acquired GES, which specializes in design, production, and servicing of automation, test, and inspection equipment and higher end market demand for ~~industrial applications~~climate control products. Sales to customers in the ~~semiconductor, electronics, and life sciences industries. See~~ ~~Item 1A - Risk Factors~~ ~~for risks associated with this acquisition and~~ ~~Note 2 - Acquisitions~~public safety market were lower in fiscal year 2021 compared to fiscal year 2020 primarily due to the phase out of ~~Notes to Consolidated Financial Statements for more information on this acquisition.~~certain programs.

We have a strong focus on cost control and closely monitor market changes and our liquidity in order to proactively adjust our operating costs and discretionary capital spending as needed. We expect to make investments that will strengthen or add new capabilities to our package of value as a multifaceted manufacturing solutions company, including through acquisitions and capacity expansions. Managing working capital in conjunction with fluctuating demand levels is likewise key. In an effort to meet the increased demand for medical assemblies in the short term, we increased our liquidity by entering into a secondary domestic credit facility in May 2020. See the “Liquidity and Capital Resources” section for more discussion on this new credit facility. In addition, a long-standing component of our ~~profit sharing~~profit-sharing incentive bonus plan is that it is linked to our financial performance which results in varying amounts of compensation expense as profits change.

We continue to maintain a strong balance sheet as of the end of fiscal year ~~2020,~~2021, which included a current ratio of ~~2.0,~~1.9, a debt-to-equity ratio of ~~0.3,~~0.1, and Share Owners’ equity of ~~$379~~$442 million. Our short-term liquidity available, represented as cash and cash equivalents plus the unused amount of our credit facilities, some of which are uncommitted, totaled ~~$142.5~~$206.7 million at June 30, ~~2020.~~2021.

In addition to the above discussion related to the current market conditions, management currently considers the following events, trends, and uncertainties to be most important to understanding our financial condition and operating performance:

•Employees throughout our business operations are an integral part of our ability to compete successfully, and the stability of the management team is critical to long-term Share Owner value. Our talent management and succession planning processes help to maintain stability in management.

•Due to the contract and project nature of the contract manufacturing industry, fluctuation in the demand for our products and variation in the gross margin on those programs is inherent to our business. Effective management of manufacturing capacity is, and will continue to be, critical to our success.

•The nature of the EMS industry is such that the start-up of new customers and new programs to replace expiring programs occurs frequently. While our agreements with customers generally do not have a definitive term and thus could be canceled at any time with little or no notice, we generally realize relatively few cancellations prior to the end of the product’s life cycle. We attribute this to our focus on long-term customer relationships, meeting customer expectations, required capital investment, and product qualification cycle times. As such, our ability to continue contractual relationships with our customers, including our principal customers, is not certain. New customers and program start-ups generally cause ~~losses~~margin dilution early in the life of a program, which are generally recovered as the program becomes established and matures.

•

•Risk factors within our business include, but are not limited to, general economic and market conditions, component availability, customer order delays, globalization, global health emergencies including the COVID-19 pandemic, impact related to tariffs and other trade barriers, foreign currency exchange rate fluctuations, rapid technological changes, ~~component availability,~~ supplier and customer financial stability, the contract nature of this industry, the concentration of sales to large customers, and the potential for customers to choose a dual sourcing strategy or to in-source a greater portion of their manufacturing. The continuing success of our business is dependent upon our ability to replace expiring customers/programs with new customers/programs. We monitor our success in this area by tracking the number of customers and the percentage of our net sales generated from them by years of service as depicted in the table below. While variation in the size of program awards makes it difficult to directly correlate this data to our sales trends, we believe it does provide useful information regarding our customer loyalty and new business growth. ~~Additional risk factors that could have an effect on our performance are located within~~ ~~Item 1A - Risk Factors~~.

Year End
Customer Service Years 2020 2019 2018
More than 10 Years
% of Net Sales 76 % 78 % 61 %
# of Customers 38
37
28
5 to 10 Years
% of Net Sales 11 % 11 % 28 %
# of Customers 19
17
18
Less than 5 Years
% of Net Sales 13 % 11 % 11 %
# of Customers 21
21
30
Total
% of Net Sales 100 % 100 % 100 %
# of Customers 78
75
76

Employees throughout our business operations are an integral part of our ability to compete successfully, and the stability of the management team is critical to long-term Share Owner value. Our talent management and succession planning processes help to maintain stability in management.

Certain preceding statements could be considered forward-looking statements under the Private Securities Litigation Reform Act of 1995 and are subject to certain risks and uncertainties including, but not limited to, successful integration of acquisitions and new operations, adverse changes in the global economic conditions, the geopolitical environment, global health emergencies including the COVID-19 pandemic, loss of key customers or suppliers, or similar unforeseen events. Additional risk factors that could have an effect on our performance are located within Item 1A - Risk Factors.


	Year End
Customer Service Years		2021		2020		2019
More than 10 Years
% of Net Sales		81	%	76	%	78	%
# of Customers		33		38		37
5 to 10 Years
% of Net Sales		16	%	11	%	11	%
# of Customers		23		19		17
Less than 5 Years
% of Net Sales		3	%	13	%	11	%
# of Customers		16		21		21
Total
% of Net Sales		100	%	100	%	100	%
# of Customers		72		78		75

Presentation of Results of Operations and Liquidity and Capital Resources

A discussion regarding our financial condition and results of operations for fiscal year ~~2020~~2021 compared to fiscal year ~~2019~~2020 is presented below. A discussion regarding our financial condition and results of operations for fiscal year ~~2019~~2020 compared to fiscal year ~~2018~~2019 can be found under captions entitled “Results of Operations - Fiscal Year ~~2019~~2020 Compared with Fiscal Year ~~2018”~~2019” and “Liquidity and Capital Resources” in the section entitled “Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended June 30, ~~2019~~2020 filed with the SEC on August 27, ~~2019,~~2020, which is available free of charge through the SEC’s website at http://www.sec.gov or the Company’s website, http://investors.kimballelectronics.com. The Company’s website and the information contained therein, or incorporated therein, are not intended to be incorporated into this Annual Report on Form 10-K.

Results of Operations - Fiscal Year ~~2020~~2021 Compared with Fiscal Year ~~2019~~2020



	At or For the Year Ended
	June 30
(Amounts in Millions, Except for Per Share Data)	2021		as a % of Net Sales		2020		as a % of Net Sales		% Change
Net Sales	$	1,291.8			$	1,200.6			8	%
Gross Profit	$	118.0	9.1	%	$	83.8	7.0	%	41	%
Selling and Administrative Expenses	$	52.7	4.0	%	$	43.9	3.7	%	20	%
Other General Income	$	0.4			$	—
Goodwill Impairment	$	—	—	%	$	7.9	0.6	%
Operating Income	$	65.7	5.1	%	$	32.0	2.7	%	105	%

Net Income	$	56.8			$	18.2			212	%
Diluted Earnings per Share	$	2.24			$	0.71
Open Orders	$	749.0			$	421.0			78	%

At or For the Year Ended
June 30
(Amounts in Millions, Except for Per Share Data) 2020 as a % of Net Sales 2019 as a % of Net Sales % Change
Net Sales $ 1,200.6
$ 1,181.8
2 %
Gross Profit $ 83.8
7.0 % $ 88.4
7.5 % (5 )%
Selling and Administrative Expenses $ 43.9
3.7 % $ 46.7
3.9 % (6 )%
Goodwill Impairment $ 7.9
0.6 % $ —
— %
Operating Income $ 32.0
2.7 % $ 42.1
3.6 % (24 )%
Net Income $ 18.2
$ 31.6
(42 )%
Diluted Earnings per Share $ 0.71
$ 1.21

Open Orders $ 421.0
$ 417.8
1 %


Net Sales by Vertical Market	For the Year Ended						Net Sales by Vertical Market	For the Year Ended
	June 30							June 30
(Amounts in Millions)	2020		2019		% Change		(Amounts in Millions)	2021		2020		% Change
Automotive	$	457.4	$	474.3	(4	)%	Automotive	$	551.5	$	457.4	21	%
Medical	397.8		367.5		8	%	Medical	384.8		397.8		(3)	%
Industrial	271.0		255.9		6	%	Industrial	293.7		271.0		8	%
Public Safety	56.2		66.2		(15	)%	Public Safety	48.1		56.2		(14)	%
Other	18.2		17.9		1	%	Other	13.7		18.2		(25)	%
Total Net Sales	$	1,200.6	$	1,181.8	2	%	Total Net Sales	$	1,291.8	$	1,200.6	8	%

Net sales in fiscal year ~~2020~~2021 increased by 2%8% compared to net sales in fiscal year ~~2019 and were unfavorably impacted by 1%~~2020 including a favorable impact of 3% from foreign exchange fluctuations. By end market vertical, our market verticals fluctuated as follows:

~~Sales~~•We experienced record sales to customers in the automotive market during the current fiscal year ~~decreased slightly~~as the automotive industry was returning to more normalized levels from the prior fiscal year, during which many automakers suspended production in our fourth fiscal quarter due to the ~~negative impact the~~ COVID-19 ~~pandemic had on the automotive industry, leading~~pandemic. Sales to ~~automakers in the U.S. and Europe temporarily suspending production during April and part of May 2020, which in turn unfavorably impacted our current fiscal year fourth quarter demand from~~ customers in the automotive ~~market. The unfavorable impact~~market also improved from ~~the COVID-19 pandemic was partially offset by~~ the ramp-up of certain programs, including programs for fully electric vehicles.

•Sales to customers in the medical market ~~experienced record sales during~~were down slightly in the current fiscal year ~~largely driven by~~when compared to the prior fiscal year due to the lower demand for non-critical medical products due to the COVID-19 pandemic. Fiscal years 2021 and 2020 benefited from the temporary increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products as a direct result of the COVID-19 pandemic and related global shortage of respiratory equipment.

~~Sales~~•We also experienced record sales to customers in the industrial market ~~also experienced record sales~~ during the current fiscal year, ~~primarily due to increased demand for smart metering products and~~as a result of improved sales of automation, test, and inspection equipment ~~which were partially offset by lower~~and higher end market demand for climate control products, ~~and the phase out of certain programs.~~which were partially offset by decreased demand for smart metering products.

•Sales to customers in the public safety market ~~decreased~~were lower in ~~the current~~ fiscal year ~~when~~2021 compared to ~~the prior~~ fiscal year 2020 primarily due to the phase out of certain ~~programs and lower overall demand.~~

Open orders were up 1%78% as of June 30, ~~2020~~2021 compared to June 30, ~~2019 as the significant~~2020, primarily from an increase ~~in open orders in the medical market was primarily offset by a large decrease in open orders~~ in the automotive ~~market.~~vertical. The increase in open orders in the medical market is a direct result of the COVID-19 pandemic as we have experienced an increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products. The decrease in open orders in the automotive market is driven by the overall increase in demand coupled with the global semiconductor and other component shortages, which has limited our ability to fulfill customer orders. Open orders in the automotive market were down at June 30, 2020 due to the severe impact of the COVID-19 pandemic on the automotive ~~industry.~~industry in the prior year. Open orders are the aggregate sales price of production pursuant to unfulfilled customer orders, which may be delayed or canceled by the customer subject to contractual termination provisions. Substantially all of the open orders as of June 30, ~~2020~~2021 are expected to be filled within the next twelve months. Open orders at a point in time may not be indicative of future sales trends due to the contract nature of our business. Additionally, COVID-19 could impact the timing of fulfillment of open orders.

Gross profit as a percent of net sales ~~declined~~improved to 9.1% in fiscal year 2021 from 7.0% in fiscal year 2020 ~~from 7.5% in fiscal year 2019~~ primarily due to ~~unfavorable~~improved operating execution, favorable product mix ~~higher depreciation expense largely~~within our automotive vertical driven by a shift to ~~support new~~more mature and larger programs, and ~~additional costs incurred as a result of the COVID-19 pandemic,~~favorable foreign currency fluctuations, which were partially offset by ~~lower~~higher profit-sharing incentive bonus ~~expense, governmental benefits in certain countries to assist with payroll expenses during the COVID-19 pandemic, and lower travel expense as a result of the COVID-19 pandemic restrictions.~~expense.

For fiscal year ~~2020,~~2021, selling and administrative expenses ~~decreased~~increased both as a percent of net sales and in absolute dollars compared to fiscal year ~~2019.~~2020. The current fiscal year selling and administrative expenses ~~decreased~~increased in absolute dollars from the prior fiscal year primarily due to ~~lower incentive-based compensation, lower travel~~an increase in profit-sharing incentive bonus expense, ~~due to the COVID-19 pandemic restrictions,~~higher salary and ~~reduced warranty expense, which were partially offset by~~related payroll costs, and the increase in the fair value of the liability for the supplemental employee retirement plan (“SERP”) ~~and higher salary costs.~~.

Other General Income in fiscal year ~~2019~~2021 of ~~$0.3~~$0.4 million resulted from payments received related to ~~the settlement of~~ class action lawsuits in which Kimball Electronics was a class ~~member.~~member, partially offset by lawsuit settlement accruals and payments. No Other General Income was recorded during fiscal year 2020.

We recorded a non-cash pre-tax goodwill impairment charge of $7.9 million during fiscal year 2020 related to our GES reporting unit. See Note 6 - Goodwill and Other Intangible Assets of Notes to Consolidated Financial Statements for more information on goodwill impairment. No goodwill impairment charge was recorded during fiscal year 2021.


Other Income (Expense)	Year Ended
	June 30
(Amounts in Thousands)	2021		2020
Interest Income	$	102	$	60
Interest Expense	(2,165)		(4,421)
Foreign Currency/Derivative Gain	4,806		420
Gain on SERP Investments	2,073		848


Adjustments after Measurement Period of GES Acquisition	53		(3,785)
Other	(518)		39
Other Income (Expense), net	$	4,351	$	(6,839)

Other Income (Expense) Year Ended
June 30
(Amounts in Thousands) 2020 2019
Interest Income $ 60
$ 62
Interest Expense (4,421 ) (4,069 )
Foreign Currency/Derivative Gain (Loss) 420
(376 )
Gain on SERP Investments 848
327
Foreign Government Subsidies 341
580
Net Working Capital Adjustment on GES Acquisition (3,785 ) —
Other (302 ) (99 )
Other Income (Expense), net $ (6,839 ) $ (3,575 )

The Foreign Currency/Derivative Gain ~~(Loss)~~ resulted from net foreign currency exchange rate movements during the period. The revaluation of the fair value of the supplemental employee retirement plan (“SERP”) investments recorded in Other Income (Expense) is offset by the revaluation of the SERP liability recorded in Selling and Administrative Expenses, and thus there is no effect on net income. The ~~Net Working Capital Adjustment on~~Adjustments after Measurement Period of GES Acquisition isare amounts recorded after the twelve-month measurement period which ended on September 30, 2019, with the fiscal year 2020 amount reflecting the final net working capital adjustment on the GES acquisition as determined by the dispute resolution procedure provided for under the terms of the asset purchase agreement. ~~The twelve-month measurement period ended on September 30, 2019.~~ See Note 2 - ~~Acquisitions~~Acquisition of Notes to Consolidated Financial Statements for more information on this ~~acquisition~~acquisition. The decrease in interest expense was driven by lower borrowings on credit facilities and ~~the net working capital adjustment.~~

lower interest rates. Other includes fees associated with our credit facilities, amortization of actuarial gains (losses), and other miscellaneous items that are not directly related to operations.

Our income before income taxes and effective tax rate were comprised of the following U.S. and foreign components:


	Year Ended June 30, 2021				Year Ended June 30, 2020
(Amounts in Thousands)	Income Before Taxes		Effective Tax Rate		Income (Loss) Before Taxes		Effective Tax Rate
United States	$	10,439	11.4	%	$	(6,117)	28.7	%
Foreign	$	59,615	20.2	%	$	31,274	27.9	%
Total	$	70,054	18.9	%	$	25,157	27.7	%

Year Ended June 30, 2020 Year Ended June 30, 2019
(Amounts in Thousands) Income Before Taxes Effective Tax Rate Income Before Taxes Effective Tax Rate
United States $ (6,117 ) 28.7 % $ 11,191

4.7 %
Foreign $ 31,274
27.9 % $ 27,294

23.5 %
Total $ 25,157
27.7 % $ 38,485

18.0 %
When compared to the statutory rate, the domestic effective tax rate for fiscal year 2021 was favorably impacted by research and development credits. The consolidated effective tax rate was also favorably impacted by the mix of taxable earnings within our various tax jurisdictions and foreign exchange rate movements.

The domestic effective tax rate and the consolidated effective tax rate for fiscal year 2020 were unfavorably impacted by tax expense due to the global intangible low-taxed income tax provisions of the Tax Cuts and Jobs Act (“Tax Reform”) and the valuation allowance recorded related to state tax credits, partially offset by favorable tax credits.

When compared to the statutory rate, the domestic effective tax rate and the consolidated effective tax rate for fiscal year 2019 were favorably impacted by domestic tax credits, adjustments to provisions related to the Tax Reform prior to the end of the measurement period, provision to return adjustments, and the excess tax benefit on stock-based compensation granted during the period.

Our overall effective tax rate will fluctuate depending on the geographic distribution of our worldwide earnings. See Note 11 - Income Taxes of Notes to Consolidated Financial Statements for more ~~information, including additional information on Tax Reform.~~information.

We recorded net income of ~~$18.2~~$56.8 million in fiscal year ~~2020,~~2021, or ~~$0.71~~$2.24 per diluted share, ~~a decrease~~an increase of ~~42%~~212% from fiscal year ~~2019~~2020 net income of ~~$31.6~~$18.2 million, or ~~$1.21~~$0.71 per diluted share. Fiscal year 2020 results include the following non-recurring charges previously discussed: a $6.9 million after-tax non-cash goodwill impairment charge, or $0.28 per diluted share, and the $2.9 million after-tax net working capital adjustment on the GES acquisition, or $0.11 per diluted share.

Comparing the balance sheet as of June 30, ~~2020~~2021 to June 30, ~~2019,~~2020, Receivables ~~decreased $45.4~~increased $23.2 million largely due to increased ~~utilization of our accounts receivable factoring arrangements and lower~~ sales volumes ~~in the last quarter~~and customer sales mix. Contract assets decreased $24.5 million as a result of the impact of timing of shipments and related billings to our customers. Our inventory balance decreased $18.7 million due to the consumption of the inventory build at the end of the prior fiscal ~~year. Contract assets, which reflect the unbilled accounts receivable that occur when we recognize revenue over time, increased $18.4 million~~year to support the increased demand for medical assemblies ~~in addition to certain contracts with customers beginning to meet the criteria to recognize revenue over time during the current fiscal year. Our inventory balance increased $15.2 million due to~~and changes in customers’ forecasts as a result of COVID-19 in addition to the ~~COVID-19 pandemic and~~current component shortages reducing our inventory levels. Also contributing to ~~support~~ the ~~increased demand~~inventory balance decrease was the reimbursement from certain customers for ~~medical assemblies. Property and equipment, net, increased $10.9 million primarily~~the excess raw material inventory we purchased based on their forecasts during the ramp-up due to capital expenditures for capacity purposes and to support new business awards. Goodwill has decreased $6.1 million due to the increase of $1.8 million from the purchase accounting adjustment and the decrease of $7.9 million from the goodwill impairment charge, all related to the GES acquisition.COVID-19. Borrowings under credit facilities decreased ~~$8.1~~$51.9 million largely due to payments on the U.S. primary credit facility. ~~See~~ ~~Note 6 - Goodwill and Other Intangible Assets~~ ~~of Notes to Consolidated Financial Statements for further discussion of goodwill.~~

Liquidity and Capital Resources

Working capital at June 30, ~~2020~~2021 was ~~$285.8~~$282.6 million compared to working capital of ~~$280.4~~$285.8 million at June 30, ~~2019.~~2020. The current ratio was 1.9 and 2.0 at ~~both~~June 30, 2021 and June 30, 2020, ~~and June 30, 2019.~~respectively. The debt-to-equity ratio was 0.1 and 0.3 at ~~both~~June 30, 2021 and June 30, 2020, ~~and June 30, 2019.~~respectively. Our short-term liquidity available, represented as cash and cash equivalents plus the unused amount of our credit facilities, some of which are uncommitted, totaled $206.7 million at June 30, 2021 and $142.5 million at June 30, ~~2020 and $110.7 million at June 30, 2019.~~2020.

We define DSO as the average of monthly trade accounts and notes receivable divided by an average day’s net sales, CAD as the average monthly contract assets divided by an average day’s net sales, PDSOH as the average of monthly gross inventory divided by an average day’s cost of sales, and APD as the average of monthly accounts payable divided by an average day’s cost of sales.

The following table reflects the major categories of cash flows for the fiscal years ended June 30, ~~2020~~2021 and ~~2019.~~2020.

Cash Flows from Operating Activities

Net cash provided by operating activities for the fiscal year ended June 30, 2021 was driven both by net income adjusted for non-cash items and changes in operating assets and liabilities. Net cash provided by operating activities for the fiscal year ended June 30, 2020 was primarily driven by net income adjusted for non-cash items. Net cash used for operating activities for the fiscal year ended June 30, 2019 was primarily driven by cash used from changes in operating assets and liabilities which more than offset the cash provided by net income adjusted for non-cash items. Changes in operating assets and liabilities provided ~~$7.9~~$40.4 million ~~of cash~~ and ~~used $71.8~~$7.9 million of cash for the fiscal years ended June 30, 2021 and 2020, respectively.

The cash provided of $40.4 million from changes in operating assets and ~~2019, respectively.~~liabilities in fiscal year 2021 was primarily due to a decrease in contract assets, which provided cash of $24.5 million as a result of the impact of timing of shipments and related billings to our customers, the decrease in inventory, which provided cash of $18.6 million primarily due to the consumption of the inventory build at the end of the prior fiscal year in addition to the reimbursement from certain customers for the excess raw material inventory we purchased based on their forecasts during the ramp-up due to COVID-19, and the increase in accounts payable, which provided cash of $14.6 million. Partially offsetting cash provided by contract assets and inventory was an increase in accounts receivable, which used cash of $28.4 million primarily resulting from increased sales volumes and customer sales mix.

The cash provided of $7.9 million from changes in operating assets and liabilities in fiscal year 2020 was primarily due to a decrease in accounts receivable, which provided cash of $41.9 million largely due to the increased utilization of accounts receivable factoring arrangements. Partially offsetting cash provided by the decrease in accounts receivable was an increase in contract assets, which used cash of $18.4 million to support the increased demand for medical assemblies in addition to certain contracts with customers beginning to meet the criteria to recognize revenue over time during the ~~current~~ fiscal year, and an increase in inventory, which used cash of $15.1 million primarily to support the increased demand for medical assemblies.

The $71.8 million usage of cash from changes in operating assets and liabilities in fiscal year 2019 was largely due to an increase in accounts receivable, which used cash of $36.5 million primarily due to increased sales volumes, and an increase in inventory, which used cash of $35.1 million primarily to support increased production volumes and for increased purchases to mitigate the potential impact of component shortages.

Cash Flows from Investing Activities

Net cash used for investing activities during fiscal year 2021 includes $39.4 million cash used for capital investments. The capital investments were primarily for machinery and equipment for capacity purposes and to support new business awards in addition to capital investments for the beginning of expansions at our Thailand and Mexico facilities.

Net cash used for investing activities during fiscal year 2020 includes $38.7 million cash used for capital investments. The capital investments were primarily for machinery and equipment for capacity purposes and to support new business awards.

During fiscal year 2019, net cash used for investing activities includes cash used of $43.9 million, net of cash acquired, for the GES acquisition and $25.8 million cash used for capital investments. See ~~Note 2 - Acquisitions~~ of Notes to Consolidated Financial Statements for more information on cash paid, net of cash acquired, and the purchase price allocation to assets acquired and liabilities assumed for this acquisition. The capital investments were primarily for machinery and equipment for capacity purposes to support new business awards, replacement of older machinery and equipment, and improvements to our facilities.

Cash Flows from Financing Activities

Net cash used by financing activities for the fiscal year ended June 30, 2021 resulted largely from net payments on our credit facilities of $52.3 million.

Net cash used by financing activities for the fiscal year ended June 30, 2020 resulted largely from net payments on our primary credit facility of $11.4 million, repurchases of our common stock under an authorized stock repurchase plan, and the remittance of tax withholdings on share-based payments, which were partially offset by borrowings of $3.3 million on our Netherlands facility.

Net cash provided by financing activities for the fiscal year ended June 30, 2019 resulted from net borrowings on our primary credit facility of $116.8 million and borrowings of $1.1 million on our Netherlands facility, partially offset by repurchases of our common stock under an authorized stock repurchase plan. The borrowings on our primary credit facility in fiscal year 2019 were used to primarily fund the GES acquisition that occurred on October 1, 2018 in addition to other domestic cash needs. Also included in the financing activities for fiscal year 2019 were $12.8 million of payments on the Vietnam credit facility that was assumed with the GES acquisition. See ~~Note 2 - Acquisitions~~ ~~of Notes to Consolidated Financial Statements for more information on the GES acquisition.~~

The Company maintains a U.S. primary credit facility (the “primary credit facility”) among the Company, the lenders party thereto, and JPMorgan Chase Bank, National Association, as Administrative Agent, and Bank of America, N.A., as Documentation Agent, scheduled to mature July 27, 2023. The primary credit facility provides for $150 million in borrowings, with an option to increase the amount available for borrowing to $225 million at the Company’s request, subject to the consent of each lender participating in such increase.

The proceeds of the loans on the primary credit facility are to be used for working capital and general corporate purposes of the Company including capital expenditures and acquisitions. A portion of the credit facility, not to exceed $15 million of the principal amount, was available for the issuance of letters of credit. A commitment fee on the unused portion of the principal amount of the credit facility was payable at a rate that ranged from 20.0 to 25.0 basis points per annum as determined by the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA.

The interest rate on borrowings is dependent on the type of borrowings and will be one of the following two options:

•the London Interbank Offered Rate (“LIBOR”) in effect two business days prior to the advance (adjusted upwards to reflect bank reserve costs) for such interest period as defined under the primary credit facility, plus the Eurocurrency Loans spread which can range from 125.0 to 175.0 basis points based on the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA; or

•the Alternate Base Rate (“ABR”), which is defined as the highest of the fluctuating rate per annum equal to the higher of

a.JPMorgan’s prime rate;

b.1% per annum above the Adjusted LIBO Rate (as defined under the primary credit facility); or

c.1/2 of 1% per annum above the Federal Funds Effective Rate (as defined under the primary credit facility);

plus the ABR Loans spread which can range from 25.0 to 75.0 basis points based on the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA.

At June 30, ~~2020,~~2021, we had ~~$111.4~~$62.7 million in borrowings under the primary credit facility and $0.4 million in letters of credit against the primary credit facility. ~~The borrowings under the primary credit facility were used as the primary source of funding for the GES acquisition as well as for domestic cash needs.~~ At June 30, ~~2020 and June 30, 2019, $91.5~~2021, $40.0 million of the borrowings were classified as long term as the Company intends, and has the ability, to refinance for a period longer than twelve months. At June 30, ~~2019,~~2020, we had ~~$122.8~~$111.4 million in ~~short-term~~ borrowings under the primary credit facility and $0.4 million in letters of credit against the primary credit ~~facility.~~facility, and $91.5 million of the borrowings were classified as long term. Our debt classified as long term at June 30, 2021 declined $51.5 million from June 30, 2020 as we remitted payment of $46.5 million for borrowings under the primary credit facility and reclassified $5.0 million of the borrowings under the primary credit facility to short term as we have the intent and the ability to repay within twelve months.

The Company’s financial covenants under the primary credit facility require:

•a ratio of consolidated total indebtedness minus unencumbered U.S. cash on hand in the United States in excess of $15 million to adjusted consolidated EBITDA, determined as of the end of each of its fiscal quarters for the then most recently ended four fiscal quarters, to not be greater than 3.0 to 1.0, and

•a fixed charge coverage ratio, determined as of the end of each of its fiscal quarters for the then most recently ended four fiscal quarters, to not be less than 1.10 to 1.00.

We were in compliance with the financial covenants during the fiscal year ended June 30, ~~2020.~~

During the current fiscal year, the Company established a 364-day multi-currency revolving credit facility (the “secondary credit facility”) among the Company, as borrower, certain subsidiaries of the Company as guarantors, the lenders party thereto, JPMorgan Chase Bank, National Association, as Administrative Agent, and Bank of America, N.A., as Documentation Agent, which allows for borrowings of up to $30.0 million and has a maturity date of May 18, 2021. This secondary credit facility is to be used for working capital and general corporate purposes, and it is intended to provide additional domestic liquidity at the enterprise level to help support the increased demand in medical assemblies that is attributable to the COVID-19 pandemic. A commitment fee on the unused portion of principal amount of this secondary credit facility is payable at 50.0 basis points per annum.

~~The interest rate on borrowings is dependent on the type of borrowings and will be one of the following two options:~~

~~plus the ABR Loans spread of 1.125%.~~

~~The Company’s financial covenants under this secondary credit facility are the same as the financial covenants listed above for its primary credit facility.~~

Kimball Electronics has foreign credit facilities available to satisfy short-term cash needs at specific foreign locations rather than funding from intercompany sources. These foreign credit facilities can be canceled at any time by either the bank or us. As of June 30, ~~2020,~~2021, we maintained the following foreign credit facilities:

•A Thailand overdraft credit facility which allows for borrowings up to 2.4 million Thai Baht (approximately $0.1 million at June 30, ~~2020~~2021 exchange rates). We had no borrowings outstanding under this ~~foreign~~ credit facility as of June 30, ~~2020~~2021 or June 30, ~~2019. During the current fiscal year, we reduced the allowed maximum borrowings from 90 million Thai Baht to 2.4 million Thai Baht.~~2020.

•An uncommitted revolving credit facility for our Netherlands subsidiary, which allows for borrowings of up to 9.2 million Euro (approximately ~~$10.3~~$10.9 million at June 30, ~~2020~~2021 exchange rates) that can be drawn in Euro, U.S. dollars, or other optional currency. At June 30, 2021 and 2020, we had $3.5 million and $6.7 million, respectively, in ~~borrowings under this facility, and we had $3.4 million~~ borrowings outstanding under this ~~foreign~~ credit ~~facility as of June 30, 2019.~~facility. The facility matures on June 22, ~~2021.~~2022.

•An uncommitted revolving credit facility for our Poland operation, which allows for borrowings up to 5 million Euro (approximately ~~$5.6~~$5.9 million at June 30, ~~2020~~2021 exchange rates) that can be drawn in Euro, U.S. dollars, or Polish Zloty. We had no borrowings outstanding under this ~~foreign~~ credit facility as of June 30, 2021 or June 30, 2020. The facility matures on December 20, ~~2020. During the current fiscal year, we reduced the allowed maximum borrowings from 15 million Euro to 5 million Euro.~~

2021.

During the current fiscal year, ~~we eliminated~~ the ~~uncommitted~~364-day multi-currency revolving credit facility ~~for one of our China operations,~~(the “secondary credit facility”) matured on May 18, 2021, which allowed for borrowings up to ~~$7.5~~$30.0 million. The elimination of the China uncommitted credit facility and the reductions in the borrowings allowed for the Thailand overdraft credit facility and the Poland uncommitted revolving credit facility was a result of entering intoWe did not extend the secondary credit ~~facility.~~facility as it was intended to provide additional domestic liquidity at the enterprise level to help support the increased demand in medical assemblies that is attributable to the COVID-19 pandemic, and we had no borrowings on the secondary credit facility during its term.

Factoring Arrangements

The Company may utilize accounts receivable factoring arrangements with third-party financial institutions in order to extend terms for the customer without negatively impacting our cash flow. These arrangements in all cases do not contain recourse provisions which would obligate us in the event of our customers’ failure to pay. Receivables are considered sold when they are transferred beyond the reach of Kimball Electronics and its creditors, the purchaser has the right to pledge or exchange the

receivables, and we have surrendered control over the transferred receivables. During the fiscal years ended June 30, ~~2020~~2021 and ~~2019,~~2020, we sold, without recourse, ~~$280.7~~$306.3 million and ~~$261.2~~$280.7 million of accounts receivable, respectively. See Note 1 - Business Description and Summary of Significant Accounting Policies of Notes to Consolidated Financial Statements for more information regarding the factoring arrangements.

Due to the COVID-19 pandemic, we are anticipating growth in sales to customers in the medical market in the upcoming quarters as we are currently experiencing a significant increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products. The new secondary credit facility will provide us with liquidity at the enterprise level instead of the subsidiary level, and it will be available to support the increased demand in medical components attributable to COVID-19. We are also hiring additional employees in certain locations to support the increased demand. We are in a solid financial position to be able to meet the increased demand and weather the impact of COVID-19; however, significant uncertainties and risks exist related to the severity and duration of the impact to certain markets, the supply chain, and to global macroeconomic conditions.

We believe our principal sources of liquidity from available funds on hand, cash generated from operations, and the availability of borrowing under our credit facilities, will be sufficient to meet our working capital and other operating needs for at least the next 12 months. The unused borrowings in USD equivalent under all of our credit facilities totaled ~~$77.5~~$100.3 million at June 30, ~~2020.~~2021. We expect to continue to prudently invest in capital expenditures, ~~prudently, particularly~~including for ~~projects, including~~capacity expansions and potential acquisitions, that would help us continue our growth and development as a multifaceted manufacturing solutions company. In fiscal year 2021, we have approved capacity expansions at our Thailand and Mexico facilities. We are in a solid financial position to be able to weather the continuing impact of COVID-19; however, significant uncertainties and risks exist related to the severity and duration of its impact to certain markets, the supply chain, and global macroeconomic conditions.

At June 30, ~~2020,~~2021, our capital expenditure commitments were approximately $28 million, consisting primarily of commitments for the expansions of our Mexico and Thailand facilities, capital related to new program wins, and productivity improvements including automation. We anticipate our available liquidity will be sufficient to fund these capital expenditures.

We have purchase obligations that arise in the normal course of business for items such as raw materials, services, and software acquisitions/license commitments. In certain instances, such as when lead times dictate, we enter into contractual agreements for material in excess of the levels required to fulfill customer orders to help mitigate the potential impact related to component shortages, which require longer lead times. In turn, our material authorization agreements with customers cover a portion of the exposure for material which is purchased prior to having a firm order.

At June 30, 2021, our foreign operations held cash totaling $63.8 million. In December 2017, the U.S. Tax Cuts and Jobs Act (“Tax Reform”) was enacted into law by the United States. Tax Reform imposed a one-time deemed repatriation tax on accumulated unremitted foreign earnings. The Company has made reasonable estimates of certain effects, and therefore, has recorded provisions for net deferred tax assets at the new applicable rate$105.2 million and the ~~one-time deemed repatriation tax on accumulated~~aggregate unremitted earnings of our foreign earnings. As of June 30, 2020, the remaining provision recorded for the one-time deemed repatriation tax was $9.8 million, which was recorded in Long-term income taxes payable on the Consolidated Balance Sheet and is payable through fiscal year 2026.subsidiaries were approximately $313 million. Most of these accumulated unremitted foreign earnings have been invested in active non-U.S. business operations, and ~~it is not anticipated such~~we expect we may only repatriate a minor amount of these earnings ~~will be remitted~~ to the United ~~States.~~States in a tax-efficient manner. Our intent is to permanently reinvest ~~these~~the remaining funds outside of the United ~~States.~~States, and our current plans do not demonstrate a need to repatriate these funds to our U.S. operations. However, if such funds were repatriated, a portion of the funds remitted ~~would~~may be subject to applicable non-U.S. income and withholding taxes. ~~See~~ ~~Note 11 - Income Taxes~~ ~~of Notes to Consolidated Financial Statements for additional information on the deemed repatriation tax and Tax Reform.~~

At June 30, 2020, our capital expenditure commitments were approximately $2 million, consisting primarily of commitments for capacity purposes in anticipation of future growth, including new program wins. We anticipate our available liquidity will be sufficient to fund these capital expenditures. As a result of COVID-19, we expect to increase our capital investments in the upcoming quarters to expand capacities to meet the increased demand for medical assemblies.

On October 21, 2015, the Company’s Board of Directors approved a resolution to authorize an 18-month stock repurchase plan (the “Plan”) to allow the repurchase of up to $20 million of common stock. Then, separately on each of September 29, 2016, August 23, 2017, ~~and~~ November 8, 2018 and November 10, 2020, the Board extended and increased the Plan to allow the repurchase of up to an additional $20 million worth of common stock with no expiration date, which brought the total authorized stock repurchases under the Plan to ~~$80~~$100 million. The Plan may be suspended or discontinued at any ~~time and has been temporarily suspended as a result of the COVID-19 environment.~~time. The extent to which the Company repurchases its shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements, and other corporate considerations, as determined by the Company’s management team. The Company expects to finance the purchases with existing liquidity. The Company has repurchased ~~$76.7~~$79.7 million of common stock under the Plan through June 30, ~~2020.~~

In March 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into law making several changes to the Internal Revenue Code. The changes include, but are not limited to, increasing the limitation on the amount of deductible interest expense, allowing companies to carryback certain net operating losses, and increasing the amount of net operating loss carryforwards that corporations can use to offset taxable income, in addition to allowing companies to defer the payment of certain employer payroll taxes. The tax law changes in the Act did not have a material impact on the Company’s financial results for the fiscal year ended June 30, 2020, and we do not expect the changes to have a material impact on our short or long-term liquidity.2021.

Our ability to generate cash from operations to meet our liquidity obligations could be adversely affected in the future by factors such as general economic and market conditions, lack of availability of raw material components in the supply chain, a decline in demand for our services, loss of key contract customers, unsuccessful integration of acquisitions and new operations, global health emergencies such as the ~~ability of Kimball Electronics to generate profits,~~COVID-19 pandemic, the duration and severity of the COVID-19 pandemic and the related

uncertainties around the financial impact, ~~global health emergencies,~~ and other unforeseen circumstances. In particular, should demand for our customers’ products and, in turn, our services decrease significantly over the next 12 months, the available cash provided by operations could be adversely impacted.

The preceding statements include forward-looking statements under the Private Securities Litigation Reform Act of 1995. Certain factors could cause actual results to differ materially from forward-looking statements.

During fiscal year ~~2020,~~2021, no level 1 or level 2 financial instruments were affected by a lack of market liquidity. For level 1 financial assets, readily available market pricing was used to value the financial instruments. Our foreign currency derivative assets and liabilities, which were classified as level 2, were independently valued using observable market inputs such as forward interest rate yield curves, current spot rates, and time value calculations. To verify the reasonableness of the independently determined fair values, these derivative fair values were compared to fair values calculated by the counterparty banks. Our own credit risk and counterparty credit risk had an immaterial impact on the valuation of the foreign currency derivatives. See Note 13 - Fair Value of Notes to Consolidated Financial Statements for more information.

~~Contractual Obligations~~

~~The following table summarizes the Company’s contractual obligations as of June 30, 2020.~~

Recorded Contractual Obligations: ^(a)

Long-Term Debt Obligations^(b)

Long-Term Income Taxes Payable ^(c)

Other Long-Term Liabilities Reflected on the Balance

Sheet ^{(d) (e) (f)}

Operating Leases ^(g)

Purchase Obligations ^(h)

~~Long-Term Debt Obligations include amounts outstanding on our credit facilities and the accrued interest for these amounts. Refer to~~ ~~Note 8 - Credit Facilities~~ ~~of Notes to Consolidated Financial Statements for more information regarding our credit facilities. The fiscal year 2021 amount was recorded as a current liability.~~

~~U.S. federal income taxes payable for the one-time deemed repatriation tax on certain unremitted earnings of foreign subsidiaries. Refer to~~ ~~Note 11 - Income Taxes~~ ~~of Notes to Consolidated Financial Statements for more information regarding the deemed repatriation tax.~~

~~Refer to~~ ~~Note 7 - Commitments and Contingent Liabilities~~ ~~of Notes to Consolidated Financial Statements for more information regarding certain Other Long-Term Liabilities.~~

~~Refer to~~ ~~Note 20 - Leases~~ ~~of Notes to Consolidated Financial Statements for more information regarding Operating Leases and certain Other Long-Term Liabilities.~~

Off-Balance Sheet Arrangements

~~In limited circumstances, we receive banker’s acceptance drafts from customers to one~~As of our China operations. In turn, we may transfer the acceptance drafts to a supplier in settlement of current accounts payable. These drafts contain certain recourse provisions afforded to the transferee under laws of The People’s Republic of China, and if exercised, our China operation would be required to satisfy the obligation with the transferee as the draft would revert back to our China operation. At June 30, 2020, the drafts transferred and outstanding totaled $0.4 million. No transferee has exercised their recourse rights against us. We also have standby letters of credit entered into in the normal course of business. These arrangements2021, we do not have aany material ~~current effect and are not reasonably likely to have a material future effect on our financial condition, results of operations, liquidity, capital expenditures, or capital resources.~~off-balance sheet arrangements.

~~See~~ ~~Note 1 - Business Description and Summary of Significant Accounting Policies~~ ~~of Notes to Consolidated Financial Statements for more information on the banker’s acceptance drafts and~~ ~~Note 7 - Commitments and Contingent Liabilities~~ ~~of Notes to Consolidated Financial Statements for more information on standby letters of credit. We do not have material exposures to trading activities of non-exchange traded contracts.~~

The preceding statements are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Certain factors could cause actual results to differ materially from forward-looking statements.

Critical Accounting Policies

Kimball Electronics’ Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These principles require the use of estimates and assumptions that affect amounts reported and disclosed in the Consolidated Financial Statements and related notes. Actual results could differ from these estimates and assumptions. Management uses its best judgment in the assumptions used to value these estimates, which are based on current facts and circumstances, prior experience, and other assumptions that are believed to be reasonable. Management believes the following critical accounting policies reflect the more significant judgments and estimates used in preparation of our Consolidated Financial Statements and are the policies that are most critical in the portrayal of our financial position and results of operations. Management has discussed these critical accounting policies and estimates with the Audit Committee of the Company’s Board of Directors and with the Company’s independent registered public accounting firm.

Revenue recognition - Kimball Electronics recognizes revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those services and products. The majority of our revenue is recognized over time as manufacturing services are performed where we manufacture a product with no alternative use and have an enforceable right to payment for performance completed to date. The remaining revenue is recognized when the customer obtains control of the manufactured product. We have elected to account for shipping and handling activities related to contracts with customers as costs to fulfill our promise to transfer the associated products. Accordingly, we record customer payments of shipping and handling costs as a component of net sales and classify such costs as a component of cost of sales. We recognize sales net of applicable sales or value add taxes. Based on estimated product returns and price concessions, a reserve for returns and allowances is recorded at the time revenue is recognized, resulting in a reduction of revenue.

Goodwill and Other Intangible Assets - Goodwill, $12.0 million ~~and $18.1 million~~ as of both June 30, ~~2020~~2021 and ~~June 30, 2019, respectively,~~2020 represents the difference between the purchase price and the related underlying tangible and intangible net asset fair values resulting from business acquisitions. Annually, or if conditions indicate an earlier review is necessary, goodwill is tested at the reporting unit level. If the estimated fair value of the reporting unit is less than the carrying value, goodwill is written down to its estimated fair value. No impairment charges were recorded in fiscal year ~~2020~~2021 resulting from our annual

impairment tests for all reporting units. ~~As a result of impairment indicators that arose during the fourth quarter of~~In fiscal year 2020, atwe reported a $7.9 million goodwill impairment charge for our GES reporting unit, ~~we performed an additional impairment test as~~partially offset by a $1.0 million reduction in income tax expense associated with the deferred tax asset established for the deductible portion of ~~June 30, 2020, which resulted in goodwill impairment of $7.9 million, pre-tax.~~the impaired goodwill.

Other Intangible Assets, ~~$19.3~~$17.0 million and ~~$22.2~~$19.3 million as of June 30, ~~2020~~2021 and ~~June 30, 2019,~~2020, respectively, are reported on the Consolidated Balance Sheets and consist of capitalized software, customer relationships, technology, and trade name. Intangible assets are reviewed for impairment, and their remaining useful lives evaluated for revision, when events or circumstances indicate that the carrying value may not be recoverable over the remaining lives of the assets.

See Note 1 - Business Description and Summary of Significant Accounting Policies of Notes to Consolidated Financial Statements for further discussion of the Company’s goodwill and intangible asset accounting policies, ~~and the adoption of accounting guidance for simplifying the test for goodwill impairment,~~ along with Note 6 - Goodwill and Other ~~Intangibles~~Intangible Assets for further discussion of the calculated ~~impairment charge in~~ fiscal year ~~2020.~~2020 goodwill impairment charge.

Taxes - Deferred income tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. We evaluate the recoverability of our deferred tax assets each quarter by assessing the likelihood of future taxable income and available tax planning strategies that could be implemented to realize our deferred tax assets. If recovery is not likely, we provide a valuation allowance based on our best estimate of future taxable income in the various taxing jurisdictions and the amount of deferred taxes ultimately realizable. Future events could change management’s assessment.

We operate within multiple taxing jurisdictions and are subject to tax audits in these jurisdictions. These audits can involve complex issues, which may require an extended period of time to resolve. However, we believe we have made adequate provision for income and other taxes for all years that are subject to audit. As tax positions are effectively settled, the tax provision will be adjusted accordingly. The liability for uncertain income tax and other tax positions, including accrued interest and penalties on those positions, was ~~$4.5~~$3.0 million and ~~$4.3~~$4.5 million at June 30, ~~2020~~2021 and June 30, ~~2019,~~2020, respectively.

New Accounting Standards

See Note 1 - Business Description and Summary of Significant Accounting Policies of Notes to Consolidated Financial Statements for information regarding New Accounting Standards.

Item 7A - Quantitative and Qualitative Disclosures About Market Risk

Foreign Exchange Rate Risk: Kimball Electronics operates internationally and thus is subject to potentially adverse movements in foreign currency rate changes. Our risk management strategy includes the use of derivative financial instruments to hedge certain foreign currency exposures. Derivatives are used only to manage underlying exposures and are not used in a speculative manner. Further information on derivative financial instruments is provided in Note 14 - Derivative Instruments of Notes to Consolidated Financial Statements. We estimate that a hypothetical 10% adverse change in foreign currency exchange rates from levels at June 30, ~~2020~~2021 relative to non-functional currency balances of monetary instruments, to the extent not hedged by derivative instruments, would not have a material impact on profitability in an annual period.

Interest Rate Risk: Our primary exposure to market risk for changes in interest rates relates to our primary credit facility, described further in Note 8 - Credit Facilities of Notes to Consolidated Financial Statements, as the interest rates paid for borrowings are determined at the time of borrowing based on market indices. Therefore, although we can elect to fix the interest rate at the time of borrowing, the facility does expose us to market risk for changes in interest rates. We estimate that a hypothetical 10% change in interest rates on borrowing levels at June 30, ~~2020~~2021 would not have a material impact of profitability in an annual period. The interest rate on certain borrowings under our credit facilities, including our primary credit facility, are based on LIBOR. The United Kingdom’s Financial Conduct Authority announced that after 2021 it would no longer persuade or compel panel banks to submit the rates required to calculate LIBOR. In March 2021, the administrator of LIBOR, the ICE Benchmark Administration, announced that it will cease publication of (i) the overnight and ~~it is unclear whether~~1, 3, 6, and 12 months U.S. dollar LIBOR settings after June 30, 2023 and (ii) all other LIBOR settings, including the ~~banks currently reporting information used to set~~1 week and 2 months U.S. dollar LIBOR ~~will stop doing so~~settings, after December 31, 2021. If LIBOR is discontinued ~~or if the method of calculating LIBOR changes from its current form,~~and we transition to a new rate, interest rates on our current or future indebtedness may be adversely affected. The Company is monitoring these developments.

Item 8 - Financial Statements and Supplementary Data


INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
		Page No.

~~INDEX TO CONSOLIDATED FINANCIAL STATEMENTS~~
	~~Page No.~~

Management’s Report on Internal Control Over Financial Reporting	3533

Report of Independent Registered Public Accounting Firm		3634

Consolidated Balance Sheets as of June 30, ~~2020~~2021 and ~~2019~~2020		3837

Consolidated Statements of Income for Each of the Three Years in the Period Ended June 30, ~~2020~~2021		3938

Consolidated Statements of Comprehensive Income for Each of the Three Years in the Period Ended June 30, ~~2020~~2021		4039

Consolidated Statements of Cash Flows for Each of the Three Years in the Period Ended June 30, ~~2020~~2021		4140

Consolidated Statements of Share Owners’ Equity for Each of the Three Years in the Period Ended June 30, ~~2020~~2021		4241

Notes to Consolidated Financial Statements		4342

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

The management of Kimball Electronics, Inc. is responsible for establishing and maintaining adequate internal control over financial reporting and for the preparation and integrity of the accompanying financial statements and other related information in this report. The consolidated financial statements of the Company and its subsidiaries, including the footnotes, were prepared in accordance with accounting principles generally accepted in the United States of America and include judgments and estimates, which in the opinion of management are applied on an appropriately conservative basis. We maintain a system of internal and disclosure controls intended to provide reasonable assurance that assets are safeguarded from loss or material misuse, transactions are authorized and recorded properly, and that the accounting records may be relied upon for the preparation of the financial statements. This system is tested and evaluated regularly for adherence and effectiveness by employees who work within the internal control processes and by our staff of internal auditors.

The Audit Committee of the Board of Directors, which is comprised of directors who are not employees of the Company, meets regularly with management, our internal auditors, and the independent registered public accounting firm to review our financial policies and procedures, our internal control structure, the objectivity of our financial reporting, and the independence of the independent registered public accounting firm. The internal auditors and the independent registered public accounting firm have free and direct access to the Audit Committee, and they meet periodically, without management present, to discuss appropriate matters.

Because of inherent limitations, a system of internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective, can only provide reasonable assurance with respect to financial statement preparation and presentation.

These consolidated financial statements are subject to an evaluation of internal control over financial reporting conducted under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer. Based on that evaluation, conducted under the criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, management concluded that our internal control over financial reporting was effective as of June 30, ~~2020.~~2021.



	/s/ DONALD D. CHARRON
			Donald D. Charron
			Chairman of the Board,
			Chief Executive Officer
			August 27, ~~2020~~2021

			/s/ ~~MICHAEL K. SERGESKETTER~~JANA T. CROOM
			~~Michael K. Sergesketter~~Jana T. Croom
			Vice President,
			Chief Financial Officer
			August 27, ~~2020~~2021

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Share Owners and the Board of Directors of Kimball Electronics, Inc.

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Kimball Electronics, Inc. and subsidiaries (the “Company”) as of June 30, ~~2020~~2021 and ~~2019,~~2020, the related consolidated statements of income, comprehensive income, share owners’ equity, and cash flows, for each of the three years in the period ended June 30, ~~2020,~~2021, and the related notes and the ~~schedules~~schedule listed in the Index at Item 15 (collectively referred to as the “financial statements”). We also have audited the Company’s internal control over financial reporting as of June 30, ~~2020,~~2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the financial statements ~~referred to above~~ present fairly, in all material respects, the financial position of the Company as of June 30, ~~2020~~2021 and ~~2019,~~2020, and the results of its operations and its cash flows for each of the three years in the period ended June 30, ~~2020,~~2021, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of June 30, ~~2020,~~2021, based on criteria established in Internal Control - Integrated Framework (2013) issued by COSO.

Basis for Opinions

The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying ~~Management’s Report~~management’s report on ~~Internal Control~~internal control over ~~Financial Reporting.~~financial reporting. Our responsibility is to express an opinion on these financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the ~~U.S.~~US federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our ~~audit~~audits of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Revenue Recognition - Contracts Recognized Over Time - Refer to Notes 1 and 3 to the financial statements

Critical Audit Matter Description

The majority of the Company’s revenue is recognized over time as manufacturing services are performed when the Company manufactures a product to customer specifications with no alternative use and for which the Company has an enforceable right to payment for performance completed to date. The Company generally recognizes revenue over time using costs based input methods to depict the Company’s progress towards meeting its performance obligations, in which judgement is required to evaluate assumptions including the anticipated margins to estimate the corresponding amount of revenue to recognize.

The timing differences of revenue recognition, billings to the Company’s customers, and cash collections from the Company’s customers result in billed accounts receivable and unbilled accounts receivable. Contract assets on the consolidated balance sheets relate to unbilled accounts receivable and occur when revenue is recognized over time as manufacturing services are provided and the billing to the customer has not yet occurred as of the balance sheet date, which are generally transferred to receivables in the next fiscal quarter due to the short-term nature of the manufacturing cycle. The contract asset balance was $45.9 million as of June 30, 2021.

We identified the Company’s revenue recognition over time for contracts with customers as a critical audit matter because of the judgments required to evaluate assumptions including the anticipated margins to estimate the corresponding amount of revenue to recognize and contract assets to record. This required an increased extent of audit effort due to the significant number of contracts on which the Company recognizes revenue over time, and a high degree of auditor judgment when performing procedures to audit management’s estimate of anticipated margins used to recognize revenue over time and evaluating the results of those procedures.

How the Critical Audit Matter Was Addressed in the Audit

Our audit procedures related to management’s estimates of the anticipated margins used to recognize revenue over time and record contract assets included the following, among others:

•We tested the effectiveness of controls over the Company’s recognition of revenues over time and the related contract asset balance, including management’s process for estimating the anticipated margins for products manufactured to customer specifications for which the Company has an enforceable right to payment for performance completed to date.

•We evaluated management’s ability to estimate revenue accurately by comparing actual margins to management’s historical estimates for completed contracts.

•We selected a sample of contracts with customers and performed the following:

◦Evaluated whether the contracts with customers were properly included or excluded in management’s calculation of over time contract revenue based on the terms and conditions of each contract, including whether the Company determined the product has no alternative use and that the Company has an enforceable right to payment for performance completed to date.

◦Compared the transaction prices to the consideration expected to be received based on current rights and obligations under the contracts and any modifications that were agreed upon with the customers.

◦Tested the accuracy and completeness of the costs incurred to date for the respective performance obligations, by comparing the quantities on hand and standard cost per the calculation to the Company’s perpetual inventory information.

◦Evaluated the calculation of the amount of revenue to recognize for the performance obligation by:

▪Evaluating the reasonableness of management’s anticipated margins used in the Company’s calculation of revenue for performance obligations

▪Evaluating the appropriateness and consistency of the methods and assumptions used by management to develop the estimates of anticipated margin at completion

•We tested the mathematical accuracy of management’s calculation of revenue recognized over time and the related contract asset balance.



			/s/ Deloitte & Touche LLP
			DELOITTE & TOUCHE LLP
			Indianapolis, Indiana
			August 27, ~~2020~~2021

We have served as the Company’s auditor since 2014.

KIMBALL ELECTRONICS, INC.

CONSOLIDATED BALANCE SHEETS

(Amounts in Thousands, Except for Share Data)


	June 30, 2021		June 30, 2020
ASSETS
Current Assets:
Cash and cash equivalents	$	106,442	$	64,990
Receivables, net of allowances of $177 and $523, respectively	203,382		180,133
Contract assets	45,863		70,350
Inventories	200,386		219,043
Prepaid expenses and other current assets	27,320		23,891

Total current assets	583,393		558,407
Property and Equipment, net of accumulated depreciation of $264,907 and $236,373, respectively	163,251		154,529
Goodwill	12,011		12,011
Other Intangible Assets, net of accumulated amortization of $35,813 and $32,756, respectively	17,008		19,343
Other Assets	38,398		30,539
Total Assets	$	814,061	$	774,829

LIABILITIES AND SHARE OWNERS’ EQUITY
Current Liabilities:
Current portion of borrowings under credit facilities	$	26,214	$	26,638
Accounts payable	216,544		203,703

Accrued expenses	58,016		42,264
Total current liabilities	300,774		272,605
Other Liabilities:
Long-term debt under credit facilities, less current portion	40,000		91,500
Long-term income taxes payable	8,854		9,765
Other long-term liabilities	22,461		21,594
Total other liabilities	71,315		122,859
Share Owners’ Equity:
Preferred stock-no par value
Shares authorized: 15,000,000 Shares issued: None	—		—
Common stock-no par value
Shares authorized: 150,000,000 Shares issued: 29,430,000	—		—
Additional paid-in capital	308,123		306,808

Retained earnings	208,969		152,178
Accumulated other comprehensive loss	(4,883)		(10,551)
Treasury stock, at cost:
Shares: 4,473,000 and 4,443,000, respectively	(70,237)		(69,070)
Total Share Owners’ Equity	441,972		379,365
Total Liabilities and Share Owners’ Equity	$	814,061	$	774,829

June 30,
2020 June 30,
2019
ASSETS
Current Assets:
Cash and cash equivalents $ 64,990
$ 49,276
Receivables, net of allowances of $523 and $270, respectively 180,133
225,555
Contract Assets 70,350
51,929
Inventories 219,043
203,840
Prepaid expenses and other current assets 23,891
24,713
Total current assets 558,407
555,313
Property and Equipment, net of accumulated depreciation of $236,373 and $216,955, respectively 154,529
143,629
Goodwill 12,011
18,104
Other Intangible Assets, net of accumulated amortization of $32,756 and $29,874, respectively 19,343
22,188
Other Assets 30,539
24,877
Total Assets $ 774,829
$ 764,111

LIABILITIES AND SHARE OWNERS’ EQUITY

Current Liabilities:

Current portion of borrowings under credit facilities $ 26,638
$ 34,713
Accounts payable 203,703
197,001
Accrued expenses 42,264
43,196
Total current liabilities 272,605
274,910
Other Liabilities:

Long-term debt under credit facilities, less current portion 91,500
91,500
Long-term income taxes payable 9,765
9,765
Other long-term liabilities 21,594
18,082
Total other liabilities 122,859
119,347
Share Owners’ Equity:

Preferred stock-no par value

Shares authorized: 15,000,000
Shares issued: none
—
—
Common stock-no par value
Shares authorized: 150,000,000
Shares issued: 29,430,000
—
—
Additional paid-in capital 306,808
305,917
Retained earnings 152,178
133,982
Accumulated other comprehensive loss (10,551 ) (7,628 )
Treasury stock, at cost:
Shares: 4,443,000 and 4,011,000, respectively (69,070 ) (62,417 )
Total Share Owners’ Equity 379,365
369,854
Total Liabilities and Share Owners’ Equity $ 774,829
$ 764,111

See Notes to Consolidated Financial Statements

KIMBALL ELECTRONICS, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Amounts in Thousands, Except for Per Share Data)


	Year Ended June 30
	2021		2020		2019
Net Sales	$	1,291,807	$	1,200,550	$	1,181,844
Cost of Sales	1,173,772		1,116,709		1,093,438
Gross Profit	118,035		83,841		88,406
Selling and Administrative Expenses	52,704		43,920		46,653
Other General Income	(372)		—		(307)

Goodwill Impairment	—		7,925		—
Operating Income	65,703		31,996		42,060
Other Income (Expense):
Interest income	102		60		62
Interest expense	(2,165)		(4,421)		(4,069)
Non-operating income	7,929		2,103		1,483
Non-operating expense	(1,515)		(4,581)		(1,051)
Other income (expense), net	4,351		(6,839)		(3,575)
Income Before Taxes on Income	70,054		25,157		38,485
Provision for Income Taxes	13,263		6,961		6,927
Net Income	$	56,791	$	18,196	$	31,558

Earnings Per Share of Common Stock:
Basic	$	2.26	$	0.72	$	1.22
Diluted	$	2.24	$	0.71	$	1.21

Average Number of Shares Outstanding:
Basic	25,088		25,243		25,857
Diluted	25,284		25,428		26,082

Year Ended June 30
2020 2019 2018
Net Sales $ 1,200,550
$ 1,181,844
$ 1,072,061
Cost of Sales 1,116,709
1,093,438
986,031
Gross Profit 83,841
88,406
86,030
Selling and Administrative Expenses 43,920
46,653
43,992
Other General Income —
(307 ) —
Goodwill Impairment 7,925
—
—
Operating Income 31,996
42,060
42,038
Other Income (Expense):

Interest income 60
62
73
Interest expense (4,421 ) (4,069 ) (527 )
Non-operating income 2,103
1,483
3,647
Non-operating expense (4,581 ) (1,051 ) (456 )
Other income (expense), net (6,839 ) (3,575 ) 2,737
Income Before Taxes on Income 25,157
38,485
44,775
Provision for Income Taxes 6,961
6,927
28,023
Net Income $ 18,196
$ 31,558
$ 16,752

Earnings Per Share of Common Stock:
Basic $ 0.72
$ 1.22
$ 0.63
Diluted $ 0.71
$ 1.21
$ 0.62

Average Number of Shares Outstanding:
Basic 25,243
25,857
26,745
Diluted 25,428
26,082
27,007

See Notes to Consolidated Financial Statements

KIMBALL ELECTRONICS, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Amounts in Thousands)


	Year Ended June 30, 2021						Year Ended June 30, 2020						Year Ended June 30, 2019
	Pre-tax		Tax		Net of Tax		Pre-tax		Tax		Net of Tax		Pre-tax		Tax		Net of Tax
Net Income					$	56,791					$	18,196					$	31,558
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	$	5,671	$	—	$	5,671	$	(1,046)	$	—	$	(1,046)	$	(2,491)	$	—	$	(2,491)
Postemployment actuarial change	(718)		212		(506)		122		(35)		87		447		(108)		339

Derivative gain (loss)	335		(221)		114		(2,079)		509		(1,570)		3,337		(699)		2,638
Reclassification to (earnings) loss:


Derivatives	814		(101)		713		(64)		(22)		(86)		(1,066)		209		(857)

Amortization of actuarial change	(428)		104		(324)		(406)		98		(308)		(472)		114		(358)
Other Comprehensive Income (Loss)	$	5,674	$	(6)	$	5,668	$	(3,473)	$	550	$	(2,923)	$	(245)	$	(484)	$	(729)
Total Comprehensive Income					$	62,459					$	15,273					$	30,829

Year Ended June 30, 2020 Year Ended June 30, 2019 Year Ended June 30, 2018
Pre-tax Tax Net of Tax Pre-tax Tax Net of Tax Pre-tax Tax Net of Tax
Net Income $ 18,196
$ 31,558
$ 16,752
Other Comprehensive Income (Loss):
Foreign currency translation adjustments $ (1,046 ) $ —
$ (1,046 ) $ (2,491 ) $ —
$ (2,491 ) $ 2,519
$ —
$ 2,519
Postemployment severance actuarial change 122
(35 ) 87
447
(108 ) 339
533
(188 ) 345
Derivative gain (loss) (2,079 ) 509
(1,570 ) 3,337
(699 ) 2,638
(2,669 ) 704
(1,965 )
Reclassification to (earnings) loss:
Derivatives (64 ) (22 ) (86 ) (1,066 ) 209
(857 ) 1,668
(213 ) 1,455
Amortization of actuarial change (406 ) 98
(308 ) (472 ) 114
(358 ) (358 ) 140
(218 )
Other Comprehensive Income (Loss) $ (3,473 ) $ 550
$ (2,923 ) $ (245 ) $ (484 ) $ (729 ) $ 1,693
$ 443
$ 2,136
Total Comprehensive Income

$ 15,273

$ 30,829

$ 18,888

See Notes to Consolidated Financial Statements

KIMBALL ELECTRONICS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Amounts in Thousands)


	Year Ended June 30
	2021		2020		2019
Cash Flows From Operating Activities:
Net income	$	56,791	$	18,196	$	31,558
Adjustments to reconcile net income to net cash provided by (used for) operating activities:
Depreciation and amortization	34,020		30,872		28,873
Loss (gain) on sales of assets	66		69		(4)

Deferred income tax and other deferred charges	(5,783)		(1,070)		(1,541)
Deferred tax valuation allowance	165		979		20
Goodwill impairment	—		7,925		—
Stock-based compensation	3,907		4,039		5,678


Net working capital adjustment on acquisition	—		3,785		—
Other, net	520		159		431
Change in operating assets and liabilities:
Receivables	(28,391)		41,928		(36,535)
Contract assets	24,487		(18,421)		(8,688)
Inventories	18,589		(15,053)		(35,094)
Prepaid expenses and other assets	(1,729)		(1,519)		(6,284)
Accounts payable	14,599		3,622		8,001
Accrued expenses and taxes payable	12,854		(2,703)		6,837
Net cash provided by (used for) operating activities	130,095		72,808		(6,748)
Cash Flows From Investing Activities:
Capital expenditures	(38,382)		(38,364)		(24,665)
Proceeds from sales of assets	513		158		1,036
Payments for acquisitions, net of cash acquired	—		—		(43,889)
Purchases of capitalized software	(970)		(385)		(1,178)


Other, net	43		109		(13)
Net cash used for investing activities	(38,796)		(38,482)		(68,709)
Cash Flows From Financing Activities:
Proceeds from credit facilities	—		—		91,500
Payments on credit facilities	(46,500)		—		(12,843)
Additional net change in revolving credit facilities	(5,768)		(8,083)		26,415
Settlements on previous year acquisition	2,957		—		—


Repurchases of common stock	(2,996)		(8,794)		(23,431)
Payments related to tax withholding for stock-based compensation	(771)		(1,012)		(1,766)

Debt issuance costs	—		(45)		(445)
Net cash (used for) provided by financing activities	(53,078)		(17,934)		79,430
Effect of Exchange Rate Change on Cash and Cash Equivalents	3,231		(678)		(1,125)
Net Increase in Cash and Cash Equivalents	41,452		15,714		2,848
Cash and Cash Equivalents at Beginning of Year	64,990		49,276		46,428
Cash and Cash Equivalents at End of Year	$	106,442	$	64,990	$	49,276

Year Ended June 30
2020 2019 2018
Cash Flows From Operating Activities:
Net income $ 18,196
$ 31,558
$ 16,752
Adjustments to reconcile net income to net cash provided by (used for) operating activities:

Depreciation and amortization 30,872
28,873
26,376
(Gain) loss on sales of assets 69
(4 ) (7 )
Deferred income tax and other deferred charges (1,070 ) (1,541 ) 1,213
Deferred tax valuation allowance 979
20
(638 )
Goodwill impairment 7,925
—
—
Stock-based compensation 4,039
5,678
5,299
Net working capital adjustment on acquisition 3,785
—
—
Other, net 159
431
487
Change in operating assets and liabilities:
Receivables 41,928
(36,535 ) (2,876 )
Contract assets (18,421 ) (8,688 ) —
Inventories (15,053 ) (35,094 ) (55,769 )
Prepaid expenses and other assets (1,519 ) (6,284 ) 5,092
Accounts payable 3,622
8,001
33,272
Accrued expenses and taxes payable (2,703 ) 6,837
10,999
Net cash provided by (used for) operating activities 72,808
(6,748 ) 40,200
Cash Flows From Investing Activities:

Capital expenditures (38,364 ) (24,665 ) (25,876 )
Proceeds from sales of assets 158
1,036
261
Payments for acquisitions, net of cash acquired —
(43,889 ) —
Purchases of capitalized software (385 ) (1,178 ) (643 )
Other, net 109
(13 ) 44
Net cash used for investing activities (38,482 ) (68,709 ) (26,214 )
Cash Flows From Financing Activities:

Proceeds from credit facilities —
91,500
—
Payments on credit facilities —
(12,843 ) —
Additional net change in revolving credit facilities (8,083 ) 26,415
(1,542 )
Repurchases of common stock (8,794 ) (23,431 ) (9,553 )
Payments related to tax withholding for stock-based compensation (1,012 ) (1,766 ) (1,508 )
Debt issuance costs (45 ) (445 ) —
Net cash (used for) provided by financing activities (17,934 ) 79,430
(12,603 )
Effect of Exchange Rate Change on Cash and Cash Equivalents (678 ) (1,125 ) 490
Net Increase in Cash and Cash Equivalents 15,714
2,848
1,873
Cash and Cash Equivalents at Beginning of Year 49,276
46,428
44,555
Cash and Cash Equivalents at End of Year $ 64,990
$ 49,276
$ 46,428

See Notes to Consolidated Financial Statements

KIMBALL ELECTRONICS, INC.

CONSOLIDATED STATEMENTS OF SHARE OWNERS’ EQUITY

(Amounts in Thousands, Except for Share Data)


	Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Total Share Owners’ Equity

Amounts at June 30, 2018	$	304,215	$	99,374	$	(6,899)	$	(41,163)	$	355,527
Net income			31,558						31,558
Other comprehensive income (loss)					(729)				(729)
Cumulative effect of accounting change			3,050						3,050
Issuance of non-restricted stock (4,000 shares)	28						44		72
Compensation expense related to stock compensation plans	5,569								5,569
Performance share issuance (203,000 shares)	(3,895)						2,133		(1,762)

Repurchase of Common Stock (1,320,000 shares)							(23,431)		(23,431)
Amounts at June 30, 2019	$	305,917	$	133,982	$	(7,628)	$	(62,417)	$	369,854
Net income			18,196						18,196
Other comprehensive income (loss)					(2,923)				(2,923)

Issuance of non-restricted stock (4,000 shares)	22						48		70
Compensation expense related to stock compensation plans	3,948								3,948
Performance share issuance (184,000 shares)	(3,047)						2,061		(986)
Deferred share issuance (3,000 shares)	(32)						32		—
Repurchase of Common Stock (623,000 shares)							(8,794)		(8,794)
Amounts at June 30, 2020	$	306,808	$	152,178	$	(10,551)	$	(69,070)	$	379,365
Net income			56,791						56,791
Other comprehensive income (loss)					5,668				5,668

Issuance of non-restricted stock (4,000 shares)	19						47		66
Compensation expense related to stock compensation plans	3,850								3,850
Performance share issuance (156,000 shares)	(2,524)						1,752		(772)
Deferred share issuance (3,000 shares)	(30)						30		—
Repurchase of Common Stock (193,000 shares)							(2,996)		(2,996)
Amounts at June 30, 2021	$	308,123	$	208,969	$	(4,883)	$	(70,237)	$	441,972

Additional Paid-In Capital Retained Earnings Accumulated Other Comprehensive Income (Loss) Treasury Stock Total Share Owners’ Equity

Amounts at June 30, 2017 $ 302,483
$ 82,671
$ (9,084 ) $ (33,798 ) $ 342,272
Net income 16,752
16,752
Other comprehensive income (loss) 2,136
2,136
Tax Reform impact (49 ) 49
—
Issuance of non-restricted stock
(8,000 shares)
65
90
155
Compensation expense related to stock compensation plans 5,138
5,138
Performance share issuance (174,000 shares) (3,471 ) 1,963
(1,508 )
Repurchase of Common Stock
(488,000 shares)
(9,418 ) (9,418 )
Amounts at June 30, 2018 $ 304,215
$ 99,374
$ (6,899 ) $ (41,163 ) $ 355,527
Net income 31,558
31,558
Other comprehensive income (loss) (729 ) (729 )
Cumulative effect of accounting change 3,050
—
3,050
Issuance of non-restricted stock
(4,000 shares)
28
44
72
Compensation expense related to stock compensation plans 5,569
5,569
Performance share issuance (203,000 shares) (3,895 ) 2,133
(1,762 )
Repurchase of Common Stock
(1,320,000 shares)
(23,431 ) (23,431 )
Amounts at June 30, 2019 $ 305,917
$ 133,982
$ (7,628 ) $ (62,417 ) $ 369,854
Net income 18,196
18,196
Other comprehensive income (loss) (2,923 ) (2,923 )
Issuance of non-restricted stock
(4,000 shares)
22
48
70
Compensation expense related to stock compensation plans 3,948
3,948
Performance share issuance (184,000 shares) (3,047 ) 2,061
(986 )
Deferred share issuance (3,000 shares) (32 ) 32
—
Repurchase of Common Stock
(623,000 shares)
(8,794 ) (8,794 )
Amounts at June 30, 2020 $ 306,808
$ 152,178
$ (10,551 ) $ (69,070 ) $ 379,365

See Notes to Consolidated Financial Statements

KIMBALL ELECTRONICS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 Business Description and Summary of Significant Accounting Policies

Business Description:

Kimball Electronics, Inc. (also referred to herein as “Kimball Electronics,” the “Company,” “we,” “us,” or “our”) is a global, multifaceted manufacturing solutions provider. We provide contract electronics manufacturing services (“EMS”) and diversified manufacturing services, including engineering and supply chain support, to customers in the automotive, medical, industrial, and public safety end markets. We offer a package of value that begins with our core competency of producing ~~“durable electronics”~~durable electronics and includes our set of robust processes and procedures that help us ensure that we deliver the highest levels of quality, reliability, and service throughout the entire life cycle of our customers’ products. We further offer diversified contract manufacturing services for non-electronic components, medical devices, medical disposables, precision molded plastics, and production automation, test, and inspection equipment. We are well recognized by customers and industry trade publications for our excellent quality, reliability, and innovative service.

The Company acquired GES Holdings, Inc., Global Equipment Services and Manufacturing, Inc., and its subsidiaries (collectively referred to as “GES”) on October 1, 2018, which specialize in design, production, and servicing of automation, test, and inspection equipment for industrial applications in the semiconductor, electronics, and life sciences industries.

Principles of Consolidation:

The Consolidated Financial Statements include the accounts of all domestic and foreign subsidiaries. All significant intercompany balances and transactions have been eliminated in the consolidation. The operating results of the GES acquisition are included in the Consolidated Financial Statements beginning as of the acquisition date of October 1, 2018.

Use of Estimates:

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts included in the Consolidated Financial Statements and related note disclosures. While efforts are made to assure estimates used are reasonably accurate based on management’s knowledge of current events, actual results could differ from those estimates. We have made estimates and assumptions considering the ~~impacts~~impact of the ~~global emergence of~~ COVID-19 pandemic on our business. These estimates may change as new events occur and more information is obtained.

Segment Information:

Kimball Electronics has business units located in the United States, China, Mexico, Poland, Romania, and Thailand, and each of these business units qualify as operating segments. In addition, GES has operations located in the United States, China, India, Japan, and Vietnam. The GES operations qualify as a single operating segment with its group results regularly reviewed by our chief operating decision maker, which is our Chief Executive Officer.

Our operating segments meet the aggregation criteria under the current accounting guidance for segment reporting. As of June 30, ~~2020,~~2021, all of our operating segments provide contract manufacturing services, including engineering and supply chain support, for the production of electronic assemblies and other products including medical devices, medical disposables, precision molded plastics, and automation, test, and inspection equipment primarily in automotive, medical, industrial, and public safety applications, to the specifications and designs of our customers. The nature of the products, the production process, the type of customers, and the methods used to distribute the products have similar ~~characteristics.~~characteristics across all our operating segments. Each of our operating segments service customers in multiple markets, and many of our customers’ programs are manufactured and serviced by multiple operating segments. We leverage global processes such as component procurement and customer pricing that provide commonality and consistency among the various regions in which we operate. All of our operating segments have similar long-term economic characteristics, and as such, have been aggregated into one reportable segment.

Revenue Recognition:

We recognize revenue in accordance with the standard issued by the Financial Accounting Standards Board (“FASB”), Revenue from Contracts with Customers and all the related ~~amendments (“New Revenue Guidance”).~~amendments. Our revenue from contracts with customers is generated primarily from manufacturing services provided for the production of electronic assemblies, components, medical devices, medical disposables, precision molded plastics, and automation, test, and inspection equipment built to customer’s specifications. Our customer agreements are generally not for a definitive term but continue for the relevant product’s life cycle. Typically, our customer agreements do not commit the customer to purchase our services until a purchase order is provided, which is generally short term in nature. Customer purchase orders primarily have a single performance obligation. Generally, the prices stated in the customer purchase orders are agreed upon prices for the manufactured product and do not vary over the term of the order, and therefore, the majority of our contracts do not contain variable consideration. In limited circumstances, we may enter into a contract ~~where~~which contains minimum quantity thresholds to cover our capital costs, and we may offer our customer a rebate for specific volume thresholds or other incentives; in these cases, the rebates or incentives are accounted for as variable consideration.

The majority of our revenue is recognized over time as manufacturing services are performed as we manufacture a product to customer specifications with no alternative use and we have an enforceable right to payment for performance completed to date. The remaining revenue for manufacturing services is recognized when the customer obtains control of the product, typically either upon shipment or delivery of the product dependent on the terms of the contract, and the customer is able to direct the use of and obtain substantially all of the remaining benefits from the asset. We generally recognize revenue over time using costs based input methods, in which judgment is required to evaluate assumptions including ~~the total estimated costs~~anticipated margins to ~~determine our progress towards contract completion and to calculate~~estimate the corresponding amount of revenue to recognize. ~~Estimated costs~~Costs used as a basis for estimating anticipated margins include material, direct and indirect labor, and appropriate applied overheads. Anticipated margins are determined based on historical or quoted customer pricing. Costs based input methods are considered a faithful depiction of our efforts and progress toward satisfying our performance obligations for manufacturing services and for which we believe we are entitled to payment for performance completed to date. The cumulative effect of revisions to estimates related to net contract revenues or costs are recorded in the period in which the revisions to estimates are identified and the amounts can be reasonably estimated.

We have elected to account for shipping and handling activities related to contracts with customers as costs to fulfill our promise to transfer the associated services and products. Accordingly, we record customer payments of shipping and handling costs as a component of net sales and classify such costs as a component of cost of sales. We recognize sales net of applicable sales or value add taxes. Based on estimated product returns and price concessions, a reserve for returns and allowances is recorded at the time revenue is recognized, resulting in a reduction of net revenue.

Direct incremental costs to obtain and fulfill a contract are capitalized as a contract asset only if they are material, expected to be recovered, and are not accounted for in accordance with other guidance. Incidental items that are immaterial in the context of the contract are recognized as expense in the period incurred.

On July 1, 2018, we adopted the New Revenue Guidance for all contracts using the modified retrospective transition method. Prior to fiscal year 2019, we recognized revenue when persuasive evidence of an arrangement existed, delivery occurred, the sales price was fixed or determinable, and collectability was reasonably assured. Delivery was not considered to have occurred until the title and the risk of loss passed to the customer according to the terms of the contract. Title and risk of loss were considered transferred upon shipment to or receipt at our customers’ locations, or in limited circumstances, as determined by other specific sales terms of the transaction.

Cash and Cash Equivalents:

Cash equivalents consist primarily of highly liquid investments with original maturities of three months or less at the time of acquisition. Cash and cash equivalents consist of bank accounts and money market funds. Bank accounts are stated at cost, which approximates fair value, and money market funds are stated at fair value.

~~Notes Receivable and~~ Trade Accounts Receivable:

The Company’s ~~notes receivable and~~ trade accounts receivable are recorded per the terms of the agreement or sale, and accrued interest is recognized when earned. We determine on a case-by-case basis the cessation of accruing interest, the resumption of accruing interest, the method of recording payments received on nonaccrual receivables, and the delinquency status for our limited number of notes receivable.

Our policy for estimating the allowance for credit losses on trade accounts ~~receivable and notes~~ receivable includes analysis of such items as aging, credit worthiness, payment history, and historical bad debt experience. Management uses these specific analyses in conjunction with an evaluation of the general economic and market conditions to ~~determine the final allowance for~~estimate expected credit ~~losses on the trade accounts receivable and notes receivable.~~losses. Management believes that historical loss information

generally provides a basis for its assessment of expected credit losses. Trade accounts ~~receivable and notes~~ receivable are written off after exhaustive collection efforts occur and the receivable is deemed uncollectible. ~~Our limited amount~~See section entitled “New Accounting Standards” below for information on the adoption of ~~notes receivable allows management to monitor~~ the ~~risks,~~new accounting standard for the measurement of credit ~~quality indicators, collectability, and probability of impairment on an individual basis.~~losses. Adjustments to the allowance for credit losses are recorded in ~~selling~~Selling and ~~administrative expenses.~~Administrative Expenses on our Consolidated Statements of Income.

In the ordinary course of business, customers periodically negotiate extended payment terms on trade accounts receivable. Customary terms require payment within 30 to 45 days, with any terms beyond 45 days being considered extended payment terms. We ~~may~~ utilize ~~accounts receivable~~ factoring arrangements with third-party financial institutions for certain of our accounts receivables in order to extend terms for the customer without negatively impacting our cash flow. These arrangements in all cases do not contain recourse provisions which would obligate us in the event of our customers’ failure to pay. Receivables are considered sold

when they are transferred beyond the reach of Kimball Electronics and its creditors, the purchaser has the right to pledge or exchange the receivables, and we have surrendered control over the transferred receivables. During fiscal years 2021, 2020, ~~2019,~~ and ~~2018,~~2019, we sold, without recourse, $306.3 million, $280.7 million, ~~$261.2 million,~~ and ~~$181.5~~$261.2 million of accounts receivable, respectively. Factoring fees were $1.2 million, $1.9 million, ~~$1.7 million,~~ and ~~$1.1~~$1.7 million during fiscal years 2021, 2020, ~~2019,~~ and ~~2018,~~2019, respectively, and were included in Selling and Administrative ~~Expense~~Expenses on the Consolidated Statements of Income.

One of our China operations, in limited circumstances, may receive banker’s acceptance drafts from customers as payment on account. The banker’s acceptance drafts are non-interest bearing and primarily mature within six months from the origination date. The Company has the ability to sell the drafts at a discount or transfer the drafts in settlement of current accounts payable prior to the scheduled maturity date. These drafts, which totaled ~~$7.1 million and $4.2~~less than $0.1 million at June 30, ~~2020~~2021 and ~~2019, respectively,~~$7.1 million at June 30, 2020, are reflected in Receivables on the Consolidated Balance Sheets until the banker’s drafts are sold at a discount, transferred in settlement of current accounts payable, or cash is received at maturity. Banker’s acceptance drafts sold at a discount or transferred in settlement of current accounts payable during fiscal years 2021, 2020, and 2019 ~~and 2018~~ were $1.8 million, $6.8 million, ~~$2.7 million,~~ and ~~$5.5~~$2.7 million, respectively. See Note 7 - Commitments and Contingent Liabilities of Notes to Consolidated Financial Statements for more information on banker’s acceptance drafts.

Inventories:

Inventories are stated at the lower of cost and net realizable value. Cost includes material, labor, and applicable manufacturing overhead. Costs associated with underutilization of capacity are expensed as incurred. Inventories are valued using the first-in, first-out (“FIFO”) method. Inventories are adjusted for excess and obsolete inventory. Evaluation of excess inventory includes such factors as anticipated usage, inventory turnover, inventory levels, and product demand levels. Factors considered when evaluating obsolescence include the age of on-hand inventory and reduction in value due to damage, design changes, or cessation of product lines.

Property, Equipment, and Depreciation:

Property and equipment are stated at cost less accumulated ~~depreciation. Depreciation is provided~~depreciation and depreciated over the estimated useful life of the assets using the straight-line ~~method for financial reporting purposes. Major maintenance activities and improvements are capitalized; other~~method. Generally, maintenance and repairs are ~~expensed.~~expensed as incurred. Depreciation and expenses for maintenance and repairs are included in both Cost of Sales and Selling and Administrative Expense on the Consolidated Statements of Income.

Impairment of Long-Lived Assets:

We perform reviews for impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Impairment is recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. When an impairment is identified, the carrying amount of the asset is reduced to its estimated fair value. Assets to be disposed of are recorded at the lower of net book value or fair market value less cost to sell at the date management commits to a plan of disposal. Impairment of long-lived assets was not material during fiscal years 2021, 2020, ~~2019,~~ and ~~2018.~~2019.

Goodwill:

Goodwill represents the difference between the purchase price and the related underlying tangible and intangible net asset fair values resulting from business acquisitions. Annually, or if conditions indicate an earlier review is necessary, goodwill is assessed or tested at the reporting unit level. If the estimated fair value of the reporting unit is less than the carrying value, goodwill is written down to its estimated fair value. ~~See section entitled “New Accounting Standards” below for more information on the adoption of accounting guidance for simplifying the test for goodwill impairment.~~

To test for goodwill impairment, we use a combination of the Income Approach and the Market Approach. The discounted cash flow method (Income Approach) uses forecasted information based on management’s strategic plans and projections. Discount

rates are developed using a weighted average cost of capital (“WACC”) methodology. The WACC represents the blended average required rate of return for equity and debt capital based on observed market return data and company specific risk factors. In the Market Approach, fair value is determined using transactional evidence for similar publicly traded equity. See Note 6 - Goodwill and Other Intangible Assets of Notes to Consolidated Financial Statements for more information on ~~the June 30, 2020 GES~~our goodwill impairment ~~test.~~tests.

Other Intangible Assets:

Other Intangible Assets reported on the Consolidated Balance Sheets consist of capitalized software, customer relationships, technology, and trade name. Intangible assets are reviewed for impairment, and their remaining useful lives evaluated for revision, when events or circumstances indicate that the carrying value may not be recoverable over the remaining lives of the assets. Internal-use software is stated at cost less accumulated amortization and is amortized using the straight-line method.

During the software application development stage, capitalized costs include external consulting costs, cost of software licenses, and could include internal payroll and payroll-related costs for employees who are directly associated with a software project. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred. We have not recognized impairment on other intangible assets during fiscal years 2021, 2020, ~~2019,~~ or ~~2018.~~2019.

Leases:

The Company leases certain office, manufacturing, and warehouse facilities under operating leases, in addition to land on which certain office and manufacturing facilities resides. These operating leases expire from fiscal year 2022 to 2057. Operating lease costs and cash payments for operating leases are immaterial to the Consolidated Statements of Income and our Consolidated Statements of Cash Flows. Lease right-of-use assets and lease liabilities each totaled $1.6 million and $2.0 million at June 30, 2021 and June 30, 2020, respectively. Lease right-of-use assets are included in Other Assets and lease liabilities are included in Accrued expenses and Other long-term liabilities on the Consolidated Balance Sheets. The future undiscounted operating lease payments as of June 30, 2021 were $0.7 million, $0.3 million, $0.2 million, $0.1 million, and $0.1 million for the five years ended June 30, 2026, and $0.3 million thereafter.

Research and Development:

The costs of research and development are expensed as incurred. Research and development costs were approximately, in millions, $21, $17, ~~$15,~~ and ~~$11~~$15 in fiscal years 2021, 2020, ~~2019,~~ and ~~2018,~~2019, respectively.

Insurance and Self-insurance:

We are self-insured up to certain limits for general liability, workers’ compensation, and certain domestic employee health benefits including medical, short-term disability, and dental, with the related liabilities included in the accompanying financial statements. Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims, and other analyses, which are based on historical information along with certain assumptions about future events. Approximately 20% of the workforce is covered under self-insured medical and short-term disability plans. At June 30, ~~2020~~2021 and ~~2019,~~2020, accrued liabilities for self-insurance exposure were ~~$1.6~~$1.1 million and ~~$1.7~~$1.6 million, respectively.

The remainder of our workforce not covered by self-insured plans have medical and disability coverage through either our external plans or government plans. Insurance benefits are not provided to retired employees.

Income Taxes:

Deferred income tax assets and liabilities, recorded in Other Assets and Other long-term liabilities, respectively, in the Consolidated Balance Sheets, are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. We evaluate the recoverability of deferred tax assets each quarter by assessing the likelihood of future taxable income and available tax planning strategies that could be implemented to realize our deferred tax assets. If recovery is not likely, we provide a valuation allowance based on our best estimate of future taxable income in the various taxing jurisdictions and the amount of deferred taxes ultimately realizable. Future events could change management’s assessment.

We operate within multiple taxing jurisdictions and are subject to tax audits in these jurisdictions. These audits can involve complex uncertain tax positions, which may require an extended period of time to resolve. A tax benefit from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. We maintain a liability for uncertain income tax and other tax positions, including accrued interest and penalties on those positions. As tax positions are effectively settled, the tax liability is adjusted accordingly. We recognize interest and penalties related to unrecognized tax benefits in Provision for Income Taxes on the Consolidated Statements of Income. See Note 11 - Income Taxes of Notes to Consolidated Financial Statements for more information on income taxes.

Concentrations of Credit Risk:

We have business and credit risks associated with our ~~customers concentrated in the automotive, medical, industrial, and public safety industries.~~customers. The Company monitors credit quality and associated risks of receivables on an individual basis based on criteria such as financial stability of the party and collection experience in conjunction with general economic and market conditions.

A summary of significant customers’ net sales and trade receivables as a percentage of consolidated net sales and consolidated trade receivables is as follows:


	Net Sales			Trade Receivables
	Year Ended June 30			As of June 30
	2021	2020	2019	2021	2020
Nexteer Automotive	17%	14%	12%	24%	17%
Philips	15%	16%	14%	*	*
ZF	*	*	12%	11%	*


* amount is less than 10% of total

Net Sales Trade Receivables
Year Ended June 30 As of June 30
2020 2019 2018 2020 2019
Philips 16% 14% 13% * *
ZF * 12% 15% * 14%
Nexteer Automotive 14% 12% 13% 17% 16%
Regal Beloit Corporation * * * * 10%

* amount is less than 10% of total

Off-Balance Sheet Risk:

Off-balance sheet arrangements are limited to banker’s acceptance drafts transferred with recourse provisions at one of the Company’s China operations and standby letters of credit entered into in the normal course of business as described in Note 7 - Commitments and Contingent Liabilities of Notes to Consolidated Financial Statements.

Other General Income:

Other General Income in fiscal ~~year~~years 2021 and 2019 consisted of $0.4 million and $0.3 million, respectively, resulting from payments received related to class action lawsuits in which Kimball Electronics was a class ~~member.~~member, partially offset by lawsuit settlement accruals and payments in fiscal year 2021. We recorded no Other General Income during fiscal ~~years 2020 and 2018.~~year 2020.

Non-operating Income and Expense:

Non-operating income and expense include the impact of such items as foreign currency rate movements and related derivative gain or loss, fair value adjustments on supplemental employee retirement plan (“SERP”) investments, government subsidies, bank charges, and other miscellaneous non-operating income and expense items that are not directly related to operations. The gain or loss on SERP investments is offset by a change in the SERP liability that is recognized in Selling and Administrative Expense. Non-operating income in fiscal year 2021 included $4.8 million in net gains from foreign currency rate movements and related derivative gain or loss. Non-operating expense in fiscal year 2020 included a $3.8 million ~~final~~ net working capital adjustment recorded after the end of the measurement period of the GES acquisition that was determined through the dispute resolution procedure provided for under the terms of the asset purchase agreement. See Note 2 - Acquisition of Notes to Consolidated Financial Statements for more information on the net working capital adjustment.

Foreign Currency Translation:

The Company predominantly uses the U.S. dollar and Euro as its functional currencies. Foreign currency assets and liabilities are remeasured into functional currencies at end-of-period exchange rates, except for nonmonetary assets and equity, which are remeasured at historical exchange rates. Revenue and expenses are remeasured at the weighted average exchange rate during the fiscal year, except for expenses related to nonmonetary assets, which are remeasured at historical exchange rates. Gains and losses from foreign currency remeasurement are reported in Non-operating income or expense on the Consolidated Statements of Income.

For business units whose functional currency is other than the U.S. dollar, the translation of functional currency statements to U.S. dollar statements uses end-of-period exchange rates for assets and liabilities, weighted average exchange rates for revenue and expenses, and historical rates for equity. The resulting currency translation adjustment is recorded in Accumulated Other Comprehensive Income (Loss), as a component of Share Owners’ Equity.

Derivative Instruments and Hedging Activities:

Derivative financial instruments are recognized on the balance sheet as assets and liabilities and are measured at fair value. Changes in the fair value of derivatives are recorded each period in earnings or Accumulated Other Comprehensive Income (Loss), depending on whether a derivative is designated and effective as part of a hedge transaction, and if it is, the type of hedge transaction. Hedge accounting is utilized when a derivative is expected to be highly effective upon execution and continues to be highly effective over the duration of the hedge transaction. Hedge accounting permits gains and losses on derivative instruments to be deferred in Accumulated Other Comprehensive Income (Loss) and subsequently included in earnings in the periods in which earnings are affected by the hedged ~~item, or when the derivative is determined to be ineffective.~~item. We use derivatives primarily for forward purchases of foreign currency to manage exposure to the variability of cash flows, primarily related to the foreign exchange rate risks

inherent in forecasted transactions denominated in foreign

currency. Cash receipts and cash payments related to derivative instruments are recorded in the same category as the cash flows from the items being hedged on the Consolidated Statements of Cash Flows. See ~~section entitled “New Accounting Standards” below for information on the adoption of new derivative guidance and~~ Note 14 - Derivative Instruments of Notes to Consolidated Financial Statements for more information on derivative instruments and hedging activities.

Stock-Based Compensation:

As described in Note 10 - Stock Compensation Plans of Notes to Consolidated Financial Statements, the Company maintains the 2014 Stock Option and Incentive Plan, which allows for the issuance of incentive stock options, stock appreciation rights, restricted shares, unrestricted shares, restricted share units, or performance shares and performance units for grant to officers and other key employees, and to members of the Board of Directors who are not employees. The Company also maintains the Kimball Electronics, Inc. Non-Employee Directors Stock Compensation Deferral Plan (the “Deferral Plan”), which allows Non-Employee Directors to elect to defer all, or a portion of, their retainer fees in stock. We recognize the cost resulting from share-based payment transactions using a fair-value-based method. The estimated fair value of outstanding performance shares is based on the stock price at the date of the grant. Stock-based compensation expense is recognized for the portion of the award for which performance targets have been established and is expected to vest. The Company has elected to account for forfeitures by reversing the compensation costs at the time a forfeiture occurs.

New Accounting Standards:

Adopted in Fiscal Year ~~2020:~~2021:

In ~~February~~June 2016, the Financial Accounting Standards Board (“FASB”) issued guidance on leases with subsequent amendments to this new guidance in January 2018, July 2018, and December 2018. The new guidance requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by those leases and requires additional qualitative and quantitative disclosures. Under previous guidance, only capital leases were recognized on the balance sheet. We adopted this standard on July 1, 2019, the beginning of our first quarter of fiscal year 2020, under the modified retrospective method. As allowed by the July 2018 amendment, the Company has not recast the comparative periods.

We elected the “package of practical expedients,” which permits us not to reassess under the new standard our prior conclusions about lease identification, classification, and initial direct costs. We also elected the short-term lease recognition exemption, permitting us not to recognize right-of-use assets and lease liabilities for leases with a term of 12 months or less and do not include a purchase option whose exercise is reasonably certain.

Lease assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our estimated incremental borrowing rate, unless the implicit rate is readily determinable. The estimated incremental borrowing rate is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.

The adoption resulted in the recognition of $2.6 million of right-of-use assets and lease liabilities on our Condensed Consolidated Balance Sheet, primarily for our real estate operating leases, on the adoption date. The adoption did not have a material effect on our results of operations or cash flows. There was no cumulative-effect adjustment to equity. See ~~Note 20 - Leases~~ ~~of Notes to Consolidated Financial Statements for more information on leases.~~

In August 2017, the FASB issued guidance on Derivatives and Hedging. The pronouncement expands and refines hedge accounting, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements, and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The Company adopted this during the first quarter of fiscal year 2020 with an immaterial effect on our Consolidated Financial Statements.

In January 2017, the FASB issued guidance for Intangibles - Goodwill and Other, which simplifies the goodwill impairment test by eliminating the requirement to compare the implied fair value of goodwill with its carrying amount as part of step two of the goodwill impairment test. An entity should perform its goodwill impairment tests by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, not to exceed the total amount of goodwill allocated to that reporting unit. The guidance is effective for annual or interim goodwill impairment tests in fiscal years beginning after December 15, 2019 with early adoption allowed and should be applied on a prospective basis. The Company elected to early adopt this guidance beginning in the fourth quarter of fiscal year 2020, and applied to its fourth quarter goodwill impairment tests discussed in ~~Note 6 - Goodwill and Other Intangible Assets~~.

~~Not Yet Adopted:~~

~~In June 2016, the FASB~~ issued guidance on the Measurement of Credit Losses on Financial Instruments, which replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to ~~inform~~estimate credit ~~loss estimates. The guidance is effective for fiscal years beginning after December 15, 2019 and early adoption is permitted.~~losses. We ~~will adopt~~adopted this standard effective July 1, 2020, the beginning of our first quarter of fiscal year 2021, and the adoption ~~will~~did not have a material effect on our ~~consolidated financial statements.~~Consolidated Financial Statements.

In August 2018, the FASB issued guidance on Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement. This new guidance amends the accounting for implementation, setup, and other upfront costs incurred in a cloud computing hosting arrangement. The amendment aligns the requirement for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendment also requires companies to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement, including options to extend the agreement that is in control of the customer. ~~The guidance is effective for~~We adopted this standard prospectively during the first quarter of fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The guidance is to be adopted either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We plan to adopt prospectively effective July 1, 2020,year 2021, and the adoption ~~of this standard will~~did not have a material effect on our ~~consolidated financial statements.~~Consolidated Financial Statements.

Not Yet Adopted:

In December 2019, the FASB issued guidance on Simplifying the Accounting for Income Taxes, intended to simplify various aspects related to the accounting for income taxes. ~~The guidance is~~We will adopt this standard effective ~~for fiscal years beginning after December 15, 2020~~July 1, 2021, and ~~for interim periods within those fiscal years. Early adoption is permitted. We are currently evaluating the impact of~~ the adoption of this guidance will not have a material impact on our consolidated financial statements.

Note 2 ~~Acquisitions~~Acquisition

On October 1, 2018, the Company completed the acquisition of GES Holdings, Inc., Global Equipment Services and Manufacturing, Inc., and its subsidiaries (collectively referred to as “GES”). The acquisition included purchasing substantially all of the assets and assuming certain liabilities of GES Holdings, Inc., Global Equipment Services and Manufacturing, Inc., GES Infotek Pvt. Ltd., (India), GES Japan KK, Global Equipment Services and Manufacturing (Suzhou) Co., Ltd., (China), Suzhou Global Equipment Services and Trading Co., Ltd. (China), and acquiring 100% of the capital stock of Global Equipment Services & Manufacturing Vietnam Company Limited.

This acquisition supported the Company’s strategy for growth and diversification into a multifaceted manufacturing solutions company. GES specializes in design, production, and servicing of automation, test, and inspection equipment for industrial applications in the semiconductor, electronics, and life sciences industries.

Incremental costs expensed as incurred directly related to the acquisition ~~has totaled $2.2 million, of which~~included $0.8 million and $0.5 million ~~and $0.9 million were expensed~~ during the fiscal years ended June 30, 2020 ~~2019,~~ and ~~2018,~~2019, respectively. These costs were recorded in Selling and Administrative Expenses on our Consolidated Statements of Income. The operating results of this acquisition are included in the Company’s consolidated financial statements beginning on the acquisition date of October 1, 2018. ~~The acquisition was primarily funded with the Company’s primary credit facility.~~

The GES acquisition was accounted for as a business combination. The Company recorded a net adjusted purchase price of $42.4 million which included a reduction for a net working capital adjustment of $7.6 million. The net working capital adjustment was disputed by the sellers, and in July 2020, it was determined, through the dispute resolution procedure provided for under the terms of the asset purchase agreement, the final net working capital adjustment to be $3.8 million. As a result, for fiscal year 2020, after the end of the twelve-month measurement period, the Company recorded a $3.8 million pre-tax charge in the Non-operating expense line on the Consolidated Statements of Income. The twelve-month measurement period ended on September 30, 2019.

The following table summarizes the final purchase price allocation to assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess allocated to goodwill. Measurement period adjustments during the first quarter of fiscal year 2020 included a reduction of $2.0 million to Property and Equipment as a result of additional information obtained related to the valuation of certain equipment as of the acquisition date and a $0.2 million reduction in Other long-term liabilities to adjust deferred tax liabilities on the equipment. These measurement period adjustments to the purchase price allocation in the first quarter of fiscal year 2020 increased Goodwill by $1.8 million. For tax purposes, $8.9 million of the goodwill in the following table is expected to be deductible. See ~~Note 1 – Business Description and Summary of Significant Accounting Policies~~ ~~and~~ ~~Note 6 - Goodwill and Other Intangible Assets~~ ~~of Notes to Consolidated Financial Statements for information on subsequent testing and measurement of Goodwill.~~

(Amounts in Thousands) October 1, 2018
Cash $ 2,257
Receivables 15,656
Inventories 6,454
Prepaid expenses and other current assets 1,424
Property and Equipment 7,037
Other Intangible Assets 19,259
Other Assets 498
Goodwill 13,745
Total assets acquired $ 66,330

Borrowings under Credit Facilities $ 12,843
Accounts payable 4,113
Accrued expenses 1,340
Other long-term liabilities 5,653
Total liabilities assumed $ 23,949
Net assets acquired $ 42,381

Income tax liabilities, indirect tax liabilities, and liabilities for unrecognized tax benefits, including interest and penalties, of $4.2 million were recorded as of October 1, 2018 related to pre-closing tax periods of Global Equipment Services & Manufacturing Vietnam Company Limited of which $3.9 million was recorded in Other long-term liabilities and $0.3 million was included in Accrued expenses. This reflects management’s best assessment of the estimated taxes, interest, and penalties as of the acquisition date that are more likely than not to be paid, or for indirect taxes the probable amounts due to the tax authorities, including interest and penalties, under the applicable laws in the various jurisdictions. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is significantly different from our current estimate of the tax liabilities. Included in the Receivables line above is a related indemnification asset of $4.2 million for these estimated tax liabilities. The seller has agreed to indemnify the buyer in the purchase agreements for all taxes allocable to all pre-closing tax periods.

Other Intangible Assets include the estimated fair values for finite-lived intangible assets acquired and are listed in the table below along with their estimated useful lives which are being amortized on a straight-line basis.

(Amounts in Thousands)
Estimated
Fair Value

Estimated useful life
(years)
Software $ 379
3 to 7
Technology 5,060
5
Trade name 6,369
10
Customer relationships 7,451
15
Total other intangible assets $ 19,259

Note 3 Revenue from Contracts with Customers

Our revenue from contracts with customers is generated primarily from manufacturing services provided for the production of electronic assemblies, electronic and non-electronic components, medical devices, medical disposables, precision molded plastics, and automation, test, and inspection equipment in automotive, medical, industrial, and public safety applications, to the specifications and designs of our customers.

The following table disaggregates our revenue by end market vertical for fiscal years 2021, 2020, and 2019:


	Year Ended						Year Ended
(Amounts in Millions)	2020			2019		(Amounts in Millions)	2021		2020		2019
Vertical Markets:						Vertical Markets:
Automotive	$	457.4		$	474.3	Automotive	$	551.5	$	457.4	$	474.3
Medical	397.8			367.5		Medical	384.8		397.8		367.5
Industrial	271.0			255.9		Industrial	293.7		271.0		255.9
Public Safety	56.2			66.2		Public Safety	48.1		56.2		66.2
Other	18.2		��	17.9		Other	13.7		18.2		17.9
Total net sales	$	1,200.6		$	1,181.8	Total net sales	$	1,291.8	$	1,200.6	$	1,181.8

For fiscal years 2021, 2020, and 2019, approximately 89%, 78%, and 70% of our net sales, respectively, were recognized over time as manufacturing services were performed under a customer contract on a product with no alternative use and for which we have an enforceable right to payment for performance completed to date. The remaining sales revenues were ~~primarily~~ recognized at a point in time when the customer obtained control of the ~~manufactured product. Revenue recognized for tooling, excess inventory, and other services was not material for fiscal year 2020 and 2019.~~products.

The timing differences of revenue recognition, billings to our customers, and cash collections from our customers result in billed accounts receivable and unbilled accounts receivable. Contract assets on the Consolidated Balance Sheets relate to unbilled accounts receivable and occur when revenue is recognized over time as manufacturing services are provided and the billing to the customer has not yet occurred as of the balance sheet date, which are generally transferred to receivables in the next fiscal quarter due to the short-term nature of the manufacturing cycle. Contract assets were ~~$70.4~~$45.9 million and ~~$51.9~~$70.4 million as of June 30, ~~2020~~2021 and ~~2019,~~2020, respectively.

In limited circumstances, the Company may receive payments from customers in advance of the satisfaction of performance obligations primarily for tooling or other miscellaneous services or costs. These advance payments are recognized as contract liabilities until the performance obligations are completed and are included in Accrued expenses on the Consolidated Balance Sheets, which amounted to ~~$7.1~~$7.6 million and ~~$6.3~~$7.1 million as of June 30, 2021 and 2020, respectively. Our performance obligations are short term in nature and ~~2019, respectively.~~therefore our contract liabilities are all expected to be settled within twelve months.

Inventories were valued using the lower of first-in, first-out (“FIFO”) cost and net realizable value. Inventory components were as follows at June 30:


(Amounts in Thousands)	2021		2020
Finished products	$	769	$	4,529
Work-in-process	5,149		3,577
Raw materials	194,468		210,937
Total inventory	$	200,386	$	219,043

(Amounts in Thousands) 2020 2019
Finished products $ 4,529
$ 2,708
Work-in-process 3,577
4,119
Raw materials 210,937
197,013
Total inventory $ 219,043
$ 203,840

Note 5 Property and Equipment

Major classes of property and equipment consist of the following at June 30:


(Amounts in Thousands)	2020			2019			(Amounts in Thousands)	2021		2020
Land and land use rights	$	11,792		$	11,836		Land and land use rights	$	14,978	$	11,792
Buildings and improvements	80,606			78,508			Buildings and improvements	84,096		80,606
Machinery and equipment	278,858			255,978			Machinery and equipment	309,731		278,858
Construction-in-progress	19,646			14,262			Construction-in-progress	19,353		19,646
Total	$	390,902		$	360,584		Total	$	428,158	$	390,902
Less: Accumulated depreciation	(236,373		)	(216,955		)	Less: Accumulated depreciation	(264,907)		(236,373)
Property and equipment, net	$	154,529		$	143,629		Property and equipment, net	$	163,251	$	154,529

The useful lives used in computing depreciation are based on estimated service lives for classes of property, as follows:

Depreciation of property and equipment totaled, in millions, $30.7 for fiscal year 2021, $27.7 for fiscal year 2020, and $26.3 for fiscal year ~~2019, and $25.5 for fiscal year 2018.~~2019.

Note 6 Goodwill and Other Intangible Assets

A summary of goodwill is as follows:


(Amounts in Thousands)
Balance as of June 30, 2019
Goodwill	$	30,930
Accumulated impairment	(12,826)
Goodwill, net	18,104
Purchase Accounting Adjustments	1,832
Impairment	(7,925)
Balance as of June 30, 2020
Goodwill	32,762
Accumulated impairment	(20,751)
Goodwill, net	12,011



Balance as of June 30, 2021
Goodwill	32,762
Accumulated impairment	(20,751)
Goodwill, net	$	12,011

(Amounts in Thousands)
Balance as of June 30, 2018
Goodwill $ 19,017
Accumulated impairment (12,826 )
Goodwill, net 6,191
Goodwill Acquired 11,913
Balance as of June 30, 2019
Goodwill 30,930
Accumulated impairment (12,826 )
Goodwill, net 18,104
Purchase Accounting Adjustments 1,832
Impairment (7,925 )
Balance as of June 30, 2020
Goodwill 32,762
Accumulated impairment (20,751 )
Goodwill, net $ 12,011

GES’s annual goodwill impairment test date is April 30th. Subsequent to our annual test date in fiscal year 2020, we identified an indicator of impairment related to future anticipated revenues, which triggered an additional impairment test as of June 30, 2020. The June 30, 2020 test (the “GES impairment test”) resulted in a $7.9 million goodwill impairment charge, partially offset by a $1.0 million reduction in income tax expense associated with the deferred tax asset established for the deductible portion of the impaired goodwill.

For the GES impairment test, we used an independent, third-party valuation specialist to assist in the determination of fair value for the GES reporting unit. We used a combination of the Income Approach, using a discounted cash flow model, and the Market Approach, based on projected fiscal year 2021 results. ~~Significant assumptions include:~~

We also used the independent, third-party valuation specialist to assist in the GES annual impairment test for fiscal year 2021, using a combination of the Income Approach and the Market Approach ~~each weighted at 50%~~

~~Terminal growth rate of 3%~~

The forecast assumptions are considered management’s best projections for the outlook of this business but are uncertain, and potential events or circumstances, such as not receiving the award of certain identified new business programsApril 30, 2021; therefore, no goodwill impairment was recognized in fiscal year 2021 and beyond, not realizing revenue growth projections from new and existing customers and markets, and not achieving forecasted operating margins, could have a negative effect on GES’s estimated fair value and result in additional impairment charges that could be material to the Consolidated Financial Statements. Other macroeconomic events or circumstances, such as a sustained downturn in global economies or the industries GES serves, also could negatively affect estimated fair values.2021.

A summary of other intangible assets subject to amortization is as follows:

During fiscal years 2021, 2020, ~~2019,~~ and ~~2018,~~2019, amortization expense of other intangible assets was, in millions, $3.3, $3.2, ~~$2.6,~~ and ~~$0.9,~~$2.6, respectively. Amortization expense in future periods is expected to be, in millions, $3.2, $3.1, ~~$3.0, $2.9, $2.1,~~$2.2, $1.6, and ~~$1.6~~$1.5 in the five years ending June 30, ~~2025,~~2026, and ~~$6.6~~$5.4 thereafter. The estimated useful life of internal-use software ranges from 3 to 10 years. The amortization period for the customer relationships, technology, and trade name intangible assets is 15 years, 5 years, and 10 years, respectively. We have no intangible assets with indefinite useful lives which are not subject to amortization.

~~Substantially all the customer relationships, technology, and trade name intangible assets were acquired in fiscal year 2019 as a result of the GES acquisition. See~~ ~~Note 2 - Acquisitions~~ ~~of Notes to Consolidated Financial Statements for more information on this acquisition. No customer relationships, technology, and trade name intangible assets were acquired in fiscal year 2020.~~

Intangible assets are reviewed for impairment, and their remaining useful lives evaluated for revision, when events or circumstances indicate that the carrying value may not be recoverable over the remaining lives of the assets. During the fourth quarter of fiscal year 2020, as a result of the indicator of impairment that led to goodwill impairment, we determined that the carrying amount of the GES long-lived asset group, including their other intangible assets, may not be recoverable. As a result, we tested the GES long-lived asset group for recoverability as of June 30, 2020. The test resulted in no impairment as the undiscounted cash flows of the GES long-lived asset group exceeded the carrying amount.

Significant judgment was used in performing the impairment test, including the use of customer relationships as the primary asset to determine the remaining useful life of the asset group, and the assumptions around the undiscounted cash flows of the asset group. If the estimated undiscounted cash flows related to GES’s long-lived assets are not realized, an impairment charge may result, which could be material to the Consolidated Financial Statements.

Note 7 Commitments and Contingent Liabilities

As of June 30, ~~2020~~2021 and ~~2019,~~2020, we had no guarantees issued which were contingent on the future performance of another entity. Standby letters of credit may be issued to third-party suppliers and insurance institutions and can only be drawn upon in the event of the Company’s failure to pay its obligations to the beneficiary. We had a maximum financial exposure from unused standby letters of credit totaling $0.4 million as of both June 30, ~~2020~~2021 and ~~2019.~~2020. We do not expect circumstances to arise that would require us to perform under any of these arrangements and believe that the resolution of any claims that might arise in the future, either individually or in the aggregate, would not materially affect our consolidated financial statements. Accordingly, no liability has been recorded as of June 30, ~~2020~~2021 and ~~2019~~2020 with respect to the standby letters of credit. We also may enter into commercial letters of credit to facilitate payments to vendors and from customers.

Banker’s Acceptance Drafts:

One of the Company’s China operations, in limited circumstances, receives banker’s acceptance drafts from customers as settlement for their trade accounts receivable. We in turn may transfer the acceptance drafts to a supplier of ours in settlement of current accounts payable. These drafts contain certain recourse provisions afforded to the transferee under laws of The People’s Republic of China. If a transferee were to exercise its available recourse rights, the draft would revert back to our China operation and we would be required to satisfy the obligation with the transferee. At June 30, ~~2020~~2021 and ~~2019,~~2020, the drafts transferred and outstanding totaled ~~$0.4~~$0.1 million and ~~$0.9~~$0.4 million, respectively. No transferee has exercised their recourse rights against us. For additional information on banker’s acceptance drafts, see Note 1 – Business Description and Summary of Significant Accounting Policies of Notes to Consolidated Financial Statements.

The Company provides only assurance-type warranties for a limited time period, which cover workmanship and assures the product complies with specifications provided by or agreed upon with the customer. We maintain a provision for limited warranty repair or replacement of products manufactured and sold, which has been established in specific manufacturing contract agreements. We estimate product warranty liability at the time of sale based on historical repair or replacement cost trends in conjunction with the length of the warranty offered. Management refines the warranty liability periodically based on changes in historical cost trends and in certain cases where specific warranty issues become known. Product warranty liability is recorded in Accrued expenses and Other long-term liabilities on the Consolidated Balance Sheets.

Changes in the product warranty ~~accrual~~liability during fiscal years 2021, 2020, ~~2019,~~ and ~~2018~~2019 were as follows:

Note 8 Credit Facilities

Credit facilities consisted of the following:

Primary credit facility (1)

Thailand overdraft credit facility (2)

Netherlands revolving credit facility (3)

Poland revolving credit facility (4)

Primary credit facility ⁽¹⁾

Secondary credit facility⁽²⁾

Thailand overdraft credit facility ⁽³⁾

Netherlands revolving credit facility ⁽⁴⁾

Poland revolving credit facility ⁽⁵⁾

Long-term debt under credit facilities, less current portion ⁽⁶⁾

The interest rate on borrowings is dependent on the type of borrowings and will be one of the following two options:

a.JPMorgan’s prime rate;

b.1% per annum above the Adjusted LIBO Rate (as defined under the primary credit facility); or

•a fixed charge coverage ratio, determined as of the end of each of its fiscal quarters for the then most recently ended four fiscal quarters, to not be less than 1.10 to 1.00.

~~plus the ABR Loans spread of 1.125%.~~

~~The Company also maintains an uncommitted revolving credit facility for our Poland operation, which allows for borrowings up to 5 million~~ ~~Euro~~ (approximately $5.6 million at June 30, 2020 exchange rates) that can be drawn in Euro, U.S. dollars, or Polish Zloty. The availability of funds under this uncommitted facility is at the sole discretion of the bank. Proceeds from the facility are to be used for general working capital purposes. Interest on borrowing under this facility is charged at a rate of interest dependent on the denomination of the currency borrowed. The facility matures on December 20, 2020.

The weighted-average interest rate on borrowings outstanding under the credit facilities at June 30, ~~2020~~2021 and June 30, ~~2019~~2020 were ~~2.5%~~2.0% and ~~4.5%~~2.5%, respectively. Cash payments for interest on borrowings in fiscal years 2021, 2020, ~~2019,~~ and ~~2018~~2019 were, in millions, $2.5, $4.9, ~~$3.0,~~ and ~~$0.4,~~$3.0, respectively. Capitalized interest expense was immaterial during fiscal years 2021, 2020, ~~2019,~~ and ~~2018.~~2019.

Note 9 Employee Benefit Plans

Defined Contribution Retirement Plans:

The Company maintains a trusteed defined contribution retirement plan which is in effect for substantially all domestic employees meeting the eligibility requirements. The Company also maintains a supplemental employee retirement plan (“SERP”) for executives and other key employees which enables them to defer cash compensation on a pre-tax basis in excess of IRS limitations. The SERP is structured as a rabbi trust, and therefore, assets in the SERP portfolio are subject to creditor claims in the event of bankruptcy.

The discretionary employer contribution for domestic employees is determined annually by the Compensation and Governance Committee of the Company’s Board of Directors. Total expense related to employer contributions to the domestic retirement plans was, in millions, $1.9, $2.4, ~~$2.1,~~ and ~~$2.0~~$2.1 for fiscal years 2021, 2020, ~~2019,~~ and ~~2018,~~2019, respectively.

Defined Benefit Postemployment Plans:

The Company established and maintains severance plans for all domestic employees and other postemployment plans for certain foreign subsidiaries. There are no statutory requirements for the Company to contribute to the plans, nor do employees contribute to the plans. The plans hold no assets. Benefits are paid using available cash on hand when eligible employees meet plan qualifications for payment.

As of June 30, ~~2020~~2021 and ~~2019,~~2020, total obligations under these plans were ~~$4.2~~$5.4 million and ~~$3.4~~$4.2 million, respectively, of which ~~$3.6~~$4.6 million and ~~$3.1~~$3.6 million were long term and ~~$0.6~~$0.8 million and ~~$0.3~~$0.6 million were short term. Of the total obligation at June 30, ~~2020~~2021 and ~~2019,~~2020, domestic plans were ~~$1.1~~$1.2 million and ~~$1.5~~$1.1 million and foreign plans were ~~$3.1~~$4.2 million and ~~$1.9~~$3.1 million, respectively. Actuarial (gain) loss is recorded in Accumulated Other Comprehensive (Income) Loss and amortized into net period benefit cost on a straight-line basis over the average remaining service period of employees expected to receive benefits under the plans. Net periodic benefit cost recognized for these plans in fiscal years 2021, 2020, and 2019 ~~and 2018~~ were $0.4 million, $0.3 million, ~~$0.8 million,~~ and ~~$0.3~~$0.8 million, respectively.

Note 10 Stock Compensation Plans

A stock compensation plan was created and adopted by the Company’s Board of Directors (the “Board”) on October 3, 2014. The Kimball Electronics, Inc. 2014 Stock Option and Incentive Plan (the “Plan”) allows for the issuance of up to 4.5 million shares and may be awarded in the form of incentive stock options, stock appreciation rights, restricted shares, unrestricted shares, restricted share units, or performance shares and performance units. The Plan is a ten-year plan with no further awards allowed to be made under the Plan after October 1, 2024.

On October 20, 2016, the Board approved a nonqualified deferred stock compensation plan, the Kimball Electronics, Inc. Non-Employee Directors Stock Compensation Deferral Plan (the “Deferral Plan”), which allows Non-Employee Directors to elect to defer all, or a portion of, their retainer fees in stock until retirement or termination from the Board or death. The Deferral Plan allows for issuance of up to 1.0 million shares of the Company’s common stock.

Pre-tax stock compensation charged against income in fiscal years 2021, 2020, and 2019 ~~and 2018~~ was $3.9 million, $4.0 million, ~~$5.7 million,~~ and ~~$5.3~~$5.7 million, respectively. These costs are included in Selling and Administrative Expenses.

The Company awards performance shares to officers and other key employees. ~~Under these~~The annual performance share awards granted prior to fiscal year 2016, a number of shares will be issued to each participant based upon the attainment of the applicable bonus percentage calculated under the Company’s profit sharing incentive bonus plan as applied to a total potential share award made andare approved by the Compensation and Governance Committee of the Board. Under these awards, ~~granted in and subsequent to fiscal year 2016, a number of~~ shares will be issued to each participant based upon a combination of the bonus percentage attainment component, ~~above, adjusted to~~calculated as a three-year average bonus percentage under the Company’s profit sharing incentive bonus plan, and a growth attainment component, which is the Company’s growth in sales revenue based on comparison of its three-year compounded annual growth rate (“CAGR”) with the Electronics Manufacturing Services Industry’s three-year CAGR.

Performance shares are vested when shares of the Company’s Common Stock are issued shortly after the end of the fiscal year in which the performance measurement period is complete. Certain outstanding performance shares are applicable to performance measurement periods in future fiscal years and will be measured at fair value when the performance targets are established in future fiscal years. The contractual life of performance shares ~~ranges from one year to five~~is three years. If a participant is not employed on the date shares are issued, the performance share award is forfeited, except in the case of death, retirement at age 62 or older, total permanent disability, or certain other circumstances described in the Plan.

A summary of the Company’s performance share activity during fiscal year ~~2020~~2021 is presented below:

As of June 30, ~~2020,~~2021, there was approximately ~~$4.3~~$3.8 million of unrecognized compensation cost related to performance shares, based on the latest estimated attainment of performance goals. That cost is expected to be recognized over annual performance periods ending August ~~2020~~2021 through August ~~2022,~~2023, with a weighted average vesting period of ~~ten~~eleven months. The fair value of performance shares is based on the stock price at the date of grant. During fiscal years 2021, 2020, and 2019, respectively, 239,194, 253,483, and ~~2018, respectively, 253,483,~~ 292,175 ~~and 255,757~~ performance shares vested at a fair value of ~~$3.9~~$4.1 million, $3.9 million, and ~~$2.9~~$3.9 million. The performance shares vested represent the total number of shares vested prior to the reduction of shares withheld to satisfy tax withholding obligations. The number of outstanding shares presented in the above table, the amounts of unrecognized compensation, and the weighted average period include performance shares awarded that are applicable to future performance measurement periods and will be measured at fair value when the performance targets are established in future fiscal years.

Unrestricted shares may be granted to employees and members of the Board as consideration for services rendered. Unrestricted share grants do not have vesting periods, holding periods, restrictions on sale, or other restrictions. The fair value of unrestricted shares is based on the stock price at the date of the award. During fiscal years 2021, 2020, ~~2019,~~ and ~~2018,~~2019, respectively, the Company granted a total of 4,235, 4,258, ~~4,236,~~ and ~~7,694~~4,236 unrestricted shares at an average grant date fair value of $15.35, $16.99, ~~$17.69,~~ and ~~$20.15~~$17.69 for a total fair value of $0.1 million ~~$0.1 million, and $0.2 million.~~for each of these fiscal years. Unrestricted shares were awarded to non-employee members of the Board as compensation for director’s fees, including directors’ elections to receive unrestricted shares in lieu of cash payment. Director’s fees are expensed over the period that directors earn the compensation. Unrestricted shares were also awarded to a key employee which were expensed immediately.

Restricted Share Units:

Restricted share units (“RSUs”) may be granted to employees as consideration for services rendered. RSUs are participating securities and upon vesting, the outstanding number of RSUs are converted to shares of common stock. RSUs are expensed over the contractual vesting period as earned. If the employment of a holder of an RSU terminates before the RSU has vested for any reason other than death, retirement, or total permanent disability, the RSU will be forfeited. During fiscal year 2021, the Company granted 3,322 RSUs to new key employees at an average grant date fair value of $19.63 for a total fair value of $0.1 million. No RSUs were granted during fiscal years 2020 and 2019. The contractual life of the RSUs is one year or less.

Deferred Share Units:

Deferred share units may be granted to non-employee members of the Board under the Deferral Plan as compensation for the portion of their annual retainer fees resulting from their election to receive deferred share units in lieu of cash payment or unrestricted shares. Director’s fees are expensed over the period that directors earn the compensation. Deferred share units are participating securities and are payable in common stock in a lump sum or installments in accordance with deferral elections upon a director’s retirement or termination from the Board or death. During fiscal years 2021, 2020, and 2019, respectively, 37,132, 32,950, and ~~2018, respectively, 32,950,~~ 32,758 ~~and 12,159~~ deferred share units were granted to non-employee members of the Board at an average grant date fair value of $15.35, $17.30, ~~$17.40,~~ and ~~$20.15~~$17.40 for a total fair value of $0.6 million ~~$0.6 million, and $0.2 million.~~for each of these fiscal years. During fiscal year ~~2020,~~2021, 2,754 shares of common stock were issued under the Deferral Plan to a former non-employee member of the Board in accordance with their deferral election at an average fair value of $17.51.

Note 11 Income Taxes

The U.S. Tax Cuts and Jobs Act (“Tax Reform”) was enacted into law on December 22, ~~2017. Tax Reform makes~~2017, making broad and complex changes to the U.S. tax code, for which complete guidance may have not yet been issued. Tax Reform, in addition to other changes, ~~included, but were not limited to, (i) reducing the U.S. corporate statutory tax rate, (ii) requiring~~required a one-time transition tax on certain unremitted earnings of foreign subsidiaries that is payable over an eight-year ~~period, (iii) eliminating U.S. federal income taxes on dividends from foreign subsidiaries,~~period. As of both June 30, 2021 and ~~(iv) bonus depreciation that will allow~~2020, the remaining provision recorded for ~~full expensing of qualifying property. Tax Reform reduces~~ the ~~U.S. corporate statutory~~one-time deemed repatriation tax ~~rate from 35% to 21%. For our~~was $9.8 million, payable through fiscal year ended June 30, 2018, we had a blended U.S. corporate tax rate of 28.1%, which was based on the applicable tax rates before and after Tax Reform and the number of days in the fiscal year. The aggregate unremitted earnings of the Company’s foreign subsidiaries were approximately $270 million as of June 30, 2020. Most of these accumulated unremitted foreign earnings have been invested in active non-U.S. business operations, and it is not anticipated such earnings will be remitted to the United States. Our intent is to permanently reinvest these funds outside of the United States. However, if such funds were repatriated, a portion of the funds remitted may be subject to applicable non-U.S. income and withholding taxes.

~~Accounting guidance provided a measurement period of one year from the Tax Reform enactment date, during which a company could complete the accounting for the impacts of Tax Reform. In accordance~~2026, with the accounting guidance, the Company recorded provisional tax expense of $17.8 million related to Tax Reform for fiscal year 2018, including $4.4 million for the revaluation of the net deferred tax assets and $13.4 million for the deemed repatriation tax.

In accordance with the expiration of the one-year measurement period, the Company completed the assessment of the income tax effects of Tax Reform in fiscal year 2019. In finalizing the tax expense resulting from Tax Reform, the Company reversed $0.4 million of previous tax expense for the deemed repatriation tax. At June 30, 2020, $9.8 million islong-term portion recorded in Long-term income taxes payable on the Consolidated Balance ~~Sheet for~~Sheets. As of June 30, 2021, $0.9 million of the remaining deemed repatriation ~~tax.~~tax is short term and is recorded in Accrued expenses on the Consolidated Balance Sheet.

Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

The components of the deferred tax assets and liabilities as of June 30, ~~2020~~2021 and ~~2019,~~2020, were as follows:


(Amounts in Thousands)	2021		2020
Deferred Tax Assets:
Receivables	$	95	$	145
Inventory	1,726		1,894
Employee benefits	282		224
Deferred compensation	8,732		5,338
Other current liabilities	1,115		265

Tax credit carryforwards	3,388		2,445

Goodwill	1,328		1,608
Net operating loss carryforward	2,037		2,398


Miscellaneous	5,496		4,020
Valuation Allowance	(1,802)		(1,637)
Total asset	$	22,397	$	16,700
Deferred Tax Liabilities:
Other intangible assets	$	1,210	$	1,313
Property and equipment	869		1,211

Net foreign currency gains	2		22
Miscellaneous	659		581
Total liability	$	2,740	$	3,127
Net Deferred Income Taxes	$	19,657	$	13,573

(Amounts in Thousands) 2020 2019
Deferred Tax Assets:

Receivables $ 145
$ 105
Inventory 1,894
1,914
Employee benefits 224
193
Deferred compensation 5,338
6,149
Other current liabilities 265
1,275
Tax credit carryforwards 2,445
1,638
Goodwill 1,608
268
Net operating loss carryforward 2,398
2,339
Net foreign currency losses —
11
Miscellaneous 4,020
2,970
Valuation Allowance (1,637 ) (658 )
Total asset $ 16,700
$ 16,204
Deferred Tax Liabilities:
Other intangible assets $ 1,313
$ 1,412
Property and equipment 1,211
1,116
Net foreign currency gains 22
—
Miscellaneous 581
477
Total liability $ 3,127
$ 3,005
Net Deferred Income Taxes $ 13,573
$ 13,199

Income tax benefits associated with the net operating loss carryforwards expire from fiscal year 2023 to 2040. Income tax benefits associated with tax credit carryforwards primarily expire from fiscal year ~~2021~~2022 to ~~2029.~~2030. A valuation allowance was provided as of June 30, ~~2020~~2021 and ~~2019~~2020 for deferred tax assets related to certain state credits of, in millions, ~~$1.6~~$1.8 and ~~$0.7,~~$1.6, respectively. Except as reserved for in the valuation allowance, we believe our tax credit and net operating loss carryforwards are more likely than not to be realized in the future.

The components of income before taxes on income are as follows:



			Years
Buildings and improvements			5 to 40
Machinery and equipment			3 to 11
Land use rights			39
Leasehold improvements			Lesser of Useful Life or Term of Lease


	June 30, 2020						June 30, 2019							June 30, 2021						June 30, 2020
(Amounts in Thousands)	Cost		Accumulated Amortization		Net Value		Cost		Accumulated Amortization		Net Value		(Amounts in Thousands)	Cost		Accumulated Amortization		Net Value		Cost		Accumulated Amortization		Net Value
Capitalized Software	$	32,052	$	27,851	$	4,201	$	32,015	$	27,124	$	4,891	Capitalized Software	$	32,774	$	28,751	$	4,023	$	32,052	$	27,851	$	4,201
Customer Relationships	8,618		2,014		6,604		8,618		1,506		7,112		Customer Relationships	8,618		2,520		6,098		8,618		2,014		6,604
Technology	5,060		1,777		3,283		5,060		766		4,294		Technology	5,060		2,790		2,270		5,060		1,777		3,283
Trade Name	6,369		1,114		5,255		6,369		478		5,891		Trade Name	6,369		1,752		4,617		6,369		1,114		5,255
Other Intangible Assets	$	52,099	$	32,756	$	19,343	$	52,062	$	29,874	$	22,188	Other Intangible Assets	$	52,821	$	35,813	$	17,008	$	52,099	$	32,756	$	19,343


(Amounts in Thousands)	2021		2020		2019
Product Warranty Liability at the beginning of the year	$	647	$	958	$	656
Additions to warranty accrual (including changes in estimates)	21		(271)		361
Settlements made (in cash or in kind)	(58)		(40)		(59)
Product Warranty Liability at the end of the year	$	610	$	647	$	958



(Amounts in Thousands)	2020			2019			2018
Product Warranty Liability at the beginning of the year	$	958		$	656		$	593
Additions to warranty accrual (including changes in estimates)	(271		)	361			346
Settlements made (in cash or in kind)	(40		)	(59		)	(283		)
Product Warranty Liability at the end of the year	$	647		$	958		$	656



	06/30/2015		06/30/2016		06/30/2017		06/30/2018		06/30/2019		06/30/2020
Kimball Electronics, Inc.	$	100.00	$	85.83	$	123.71	$	125.43	$	111.31	$	92.80
NASDAQ Stock Market (U.S.)	$	100.00	$	98.26	$	126.07	$	155.85	$	167.93	$	213.18
Peer Group Index	$	100.00	$	102.20	$	146.73	$	132.06	$	119.36	$	121.80


	Three Months Ended						Three Months Ended
	June 30, 2020	March 31, 2020	December 31, 2019	September 30, 2019	June 30, 2019		June 30, 2021	March 31, 2021	December 31, 2020	September 30, 2020	June 30, 2020
DSO	50	55	54	50	59	DSO	53	57	58	51	50
CAD	22	21	18	16	15	CAD	14	17	19	19	22
PDSOH	76	67	66	65	64	PDSOH	61	56	58	64	76
APD	67	62	62	58	61	APD	64	64	60	58	67
CCD	81	81	76	73	77	CCD	64	66	75	76	81


b.	~~1% per annum above the Adjusted LIBO Rate (as defined under the primary credit facility); or~~


c.	~~1/2 of 1% per annum above the Federal Funds Effective Rate (as defined under the primary credit facility);~~



	Payments Due During Fiscal Years Ending June 30
(Amounts in Millions)	Total		2021		2022-2023		2024-2025		Thereafter
Recorded Contractual Obligations: ^(a)
Long-Term Debt Obligations^(b)	$	118.8	$	27.3	$	—	$	91.5	$	—
Long-Term Income Taxes Payable ^(c)	9.8		—			1.9		4.6		3.3
Other Long-Term Liabilities Reflected on the Balance Sheet ^{(d) (e) (f)}	17.0		2.9			2.8		1.2		10.1
Operating Leases ^(g)	2.2		0.8			0.8		0.2		0.4
Unrecorded Purchase Obligations:
Purchase Obligations ^(h)	452.9		441.2			11.6		0.1		—
Total	$	600.7	$	472.2	$	17.1	$	97.6	$	13.8


~~(a)~~	~~As of June 30, 2020, we had no material Capital Lease Obligations.~~


~~(b)~~	~~Long-Term Debt Obligations include amounts outstanding on our credit facilities and the accrued interest for these amounts. Refer to~~ ~~Note 8 - Credit Facilities~~ ~~of Notes to Consolidated Financial Statements for more information regarding our credit facilities. The fiscal year 2021 amount was recorded as a current liability.~~


~~(c)~~	~~U.S. federal income taxes payable for the one-time deemed repatriation tax on certain unremitted earnings of foreign subsidiaries. Refer to~~ ~~Note 11 - Income Taxes~~ ~~of Notes to Consolidated Financial Statements for more information regarding the deemed repatriation tax.~~


~~(d)~~	~~The timing of payments of certain items included on the Other Long-Term Liabilities Reflected on the Balance Sheet line above is estimated based on the following assumptions:~~


~~(e)~~	Excludes $6.2 million of deferred tax and other liabilities related to long-term unrecognized tax benefits which are not tied to a contractual obligation and for which we cannot make a reasonably reliable estimate of the period of future payments.


a.	~~JPMorgan’s prime rate;~~


a.	~~JPMorgan’s prime rate;~~


~~(f)~~	~~Refer to~~ ~~Note 7 - Commitments and Contingent Liabilities~~ ~~of Notes to Consolidated Financial Statements for more information regarding certain Other Long-Term Liabilities.~~


~~(g)~~	~~Refer to~~ ~~Note 20 - Leases~~ ~~of Notes to Consolidated Financial Statements for more information regarding Operating Leases and certain Other Long-Term Liabilities.~~



	June 30, 2020			June 30, 2019
ASSETS
Current Assets:
Cash and cash equivalents	$	64,990		$	49,276
Receivables, net of allowances of $523 and $270, respectively	180,133			225,555
Contract Assets	70,350			51,929
Inventories	219,043			203,840
Prepaid expenses and other current assets	23,891			24,713
Total current assets	558,407			555,313
Property and Equipment, net of accumulated depreciation of $236,373 and $216,955, respectively	154,529			143,629
Goodwill	12,011			18,104
Other Intangible Assets, net of accumulated amortization of $32,756 and $29,874, respectively	19,343			22,188
Other Assets	30,539			24,877
Total Assets	$	774,829		$	764,111

LIABILITIES AND SHARE OWNERS’ EQUITY
Current Liabilities:
Current portion of borrowings under credit facilities	$	26,638		$	34,713
Accounts payable	203,703			197,001
Accrued expenses	42,264			43,196
Total current liabilities	272,605			274,910
Other Liabilities:
Long-term debt under credit facilities, less current portion	91,500			91,500
Long-term income taxes payable	9,765			9,765
Other long-term liabilities	21,594			18,082
Total other liabilities	122,859			119,347
Share Owners’ Equity:
Preferred stock-no par value
Shares authorized: 15,000,000 Shares issued: none	—			—
Common stock-no par value
Shares authorized: 150,000,000 Shares issued: 29,430,000	—			—
Additional paid-in capital	306,808			305,917
Retained earnings	152,178			133,982
Accumulated other comprehensive loss	(10,551		)	(7,628		)
Treasury stock, at cost:
Shares: 4,443,000 and 4,011,000, respectively	(69,070		)	(62,417		)
Total Share Owners’ Equity	379,365			369,854
Total Liabilities and Share Owners’ Equity	$	774,829		$	764,111



	Year Ended June 30, 2020									Year Ended June 30, 2019									Year Ended June 30, 2018
	Pre-tax			Tax			Net of Tax			Pre-tax			Tax			Net of Tax			Pre-tax			Tax			Net of Tax
Net Income							$	18,196								$	31,558								$	16,752
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	$	(1,046	)	$	—		$	(1,046	)	$	(2,491	)	$	—		$	(2,491	)	$	2,519		$	—		$	2,519
Postemployment severance actuarial change	122			(35		)	87			447			(108		)	339			533			(188		)	345
Derivative gain (loss)	(2,079		)	509			(1,570		)	3,337			(699		)	2,638			(2,669		)	704			(1,965		)
Reclassification to (earnings) loss:
Derivatives	(64		)	(22		)	(86		)	(1,066		)	209			(857		)	1,668			(213		)	1,455
Amortization of actuarial change	(406		)	98			(308		)	(472		)	114			(358		)	(358		)	140			(218		)
Other Comprehensive Income (Loss)	$	(3,473	)	$	550		$	(2,923	)	$	(245	)	$	(484	)	$	(729	)	$	1,693		$	443		$	2,136
Total Comprehensive Income							$	15,273								$	30,829								$	18,888



(Amounts in Thousands)	October 1, 2018
Cash	$	2,257
Receivables	15,656
Inventories	6,454
Prepaid expenses and other current assets	1,424
Property and Equipment	7,037
Other Intangible Assets	19,259
Other Assets	498
Goodwill	13,745
Total assets acquired	$	66,330

Borrowings under Credit Facilities	$	12,843
Accounts payable	4,113
Accrued expenses	1,340
Other long-term liabilities	5,653
Total liabilities assumed	$	23,949
Net assets acquired	$	42,381



(Amounts in Thousands)	Estimated Fair Value		Estimated useful life (years)
Software	$	379	3 to 7
Technology	5,060		5
Trade name	6,369		10
Customer relationships	7,451		15
Total other intangible assets	$	19,259



(Amounts in Thousands)
Balance as of June 30, 2018
Goodwill	$	19,017
Accumulated impairment	(12,826		)
Goodwill, net	6,191
Goodwill Acquired	11,913
Balance as of June 30, 2019
Goodwill	30,930
Accumulated impairment	(12,826		)
Goodwill, net	18,104
Purchase Accounting Adjustments	1,832
Impairment	(7,925		)
Balance as of June 30, 2020
Goodwill	32,762
Accumulated impairment	(20,751		)
Goodwill, net	$	12,011


	Unused Borrowings at		Borrowings Outstanding at		Borrowings Outstanding at
(Amounts in Millions, in U.S Dollar Equivalents)	June 30, 2021		June 30, 2021		June 30, 2020
Primary credit facility (1)	$	86.9	$	62.7	$	111.4
Thailand overdraft credit facility (2)	0.1		—		—
Netherlands revolving credit facility (3)	7.4		3.5		6.7
Poland revolving credit facility (4)	5.9		—		—
Total credit facilities	$	100.3	66.2		118.1
Less: current portion			(26.2)		(26.6)
Long-term debt under credit facilities, less current portion (5)			$	40.0	$	91.5


	~~The Company had $0.4 million in letters of credit contingently committed against the primary credit facility at both June 30, 2020 and 2019.~~


~~(6)~~	The amount of Long-term debt under credit facilities, less current maturities reflects the borrowings on the primary credit facility that the Company intends, and has the ability, to refinance for a period longer than twelve months. The primary credit facility matures on July 27, 2023.


						Number of Shares	Weighted Average Grant Date Fair Value
Performance shares outstanding at July 1, 2020					Performance shares outstanding at July 1, 2020	443,536	$	16.58
	Number of Shares		Weighted Average Grant Date Fair Value
Performance shares outstanding at July 1, 2019	447,260		$	17.16
Granted	252,878		$	14.39	Granted	250,837	$	13.67
Vested	(253,483	)	$	15.47	Vested	(239,194)	$	16.99
Forfeited	(3,119	)	$	11.87	Forfeited	(20,280)	$	15.98
Performance shares outstanding at June 30, 2020	443,536		$	16.58
Performance shares outstanding at June 30, 2021					Performance shares outstanding at June 30, 2021	434,899	$	14.71


	June 30, 2021
(Amounts in Thousands)	Level 1		Level 2		Total
Assets
Cash equivalents	$	1,540	$	—	$	1,540
Derivatives: foreign exchange contracts	—		1,468		1,468

Trading securities: mutual funds held in nonqualified SERP	12,644		—		12,644
Total assets at fair value	$	14,184	$	1,468	$	15,652
Liabilities
Derivatives: foreign exchange contracts	$	—	$	1,702	$	1,702
Total liabilities at fair value	$	—	$	1,702	$	1,702


Fair Values of Derivative Instruments on the Consolidated Balance Sheets
	Asset Derivatives					Liability Derivatives
		Fair Value As of					Fair Value As of
(Amounts in Thousands)	Balance Sheet Location	June 30 2021		June 30 2020		Balance Sheet Location	June 30 2021		June 30 2020
Derivatives Designated as Hedging Instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	$	1,158	$	517	Accrued expenses	$	1,549	$	2,054

Derivatives Not Designated as Hedging Instruments:
Foreign exchange contracts	Prepaid expenses and other current assets	310		224		Accrued expenses	153		80

Total derivatives		$	1,468	$	741		$	1,702	$	2,134


The Effect of Derivative Instruments on Other Comprehensive Income (Loss)
	June 30
(Amounts in Thousands)	2021		2020		2019
Amount of Pre-Tax Gain or (Loss) Recognized in Other Comprehensive Income (Loss) (OCI) on Derivatives:
Foreign exchange contracts	$	335	$	(2,079)	$	3,337


	At or For the Year Ended June 30
(Amounts in Thousands)	2021		2020		2019
Net Sales:
United States	$	359,839	$	346,376	$	321,805
Poland	268,129		244,107		251,635
Mexico	265,476		232,135		282,400
China	180,405		159,746		146,332
Thailand	100,478		124,415		113,276
Other Foreign	117,480		93,771		66,396
Total net sales	$	1,291,807	$	1,200,550	$	1,181,844
Long-Lived Assets:
United States	$	47,499	$	48,190	$	43,887
Mexico	43,792		36,548		31,238
Poland	31,412		32,670		29,736
Romania	15,273		17,707		19,546
China	15,228		10,405		12,138
Other Foreign	14,070		13,210		11,975
Total long-lived assets	$	167,274	$	158,730	$	148,520


(Amounts in thousands, except per share data)	Year Ended June 30
	2021		2020		2019
Basic and Diluted Earnings Per Share:
Net Income	$	56,791	$	18,196	$	31,558
Less: Net Income allocated to participating securities	84		24		32
Net Income allocated to common Share Owners	$	56,707	$	18,172	$	31,526

Basic weighted average common shares outstanding	25,088		25,243		25,857


Dilutive effect of average outstanding stock compensation awards	196		185		225
Dilutive weighted average shares outstanding	25,284		25,428		26,082

Earnings Per Share of Common Stock:
Basic	$	2.26	$	0.72	$	1.22
Diluted	$	2.24	$	0.71	$	1.21


Reclassifications from Accumulated Other Comprehensive Income (Loss)								Reclassifications from Accumulated Other Comprehensive Income (Loss)
	Year Ended June 30						Affected Line Item in the		Year Ended June 30				Affected Line Item in the
(Amounts in Thousands)	2020			2019			Consolidated Statements of Income	(Amounts in Thousands)	2021		2020		Consolidated Statements of Income
Derivative Gain (Loss) ⁽¹⁾	$	64		$	1,061		Cost of Sales	Derivative Gain (Loss) (1)	$	(814)	$	64	Cost of Sales
	—			5			Non-operating income (expense), net		—		—		Non-operating income (expense), net
	22			(209		)	Benefit (Provision) for Income Taxes		101		22		Benefit (Provision) for Income Taxes
	$	86		$	857		Net of Tax		$	(713)	$	86	Net of Tax
Postemployment Benefits:								Postemployment Benefits:

Amortization of Actuarial Gain (Loss) ⁽²⁾	$	406		$	472		Non-operating income	Amortization of Actuarial Gain (Loss) (2)	$	428	$	406	Non-operating income
	(98		)	(114		)	Benefit (Provision) for Income Taxes		(104)		(98)		Benefit (Provision) for Income Taxes
	$	308		$	358		Net of Tax		$	324	$	308	Net of Tax

Total Reclassifications for the Period	$	394		$	1,215		Net of Tax	Total Reclassifications for the Period	$	(389)	$	394	Net of Tax



(Amounts in Thousands)
Operating lease right-of-use assets (included in Other Assets)	$	2,025
Operating lease liability, current (included in Accrued expenses)	$	817
Operating lease liability, noncurrent (included in Other long-term liabilities)	$	1,208
Weighted average remaining lease term in years - operating leases	4.7
Weighted average discount rate - operating leases	3.3		%



(Amounts in Thousands)
2021	$	832
2022	655
2023	95
2024	95
2025	95
Thereafter	380
Total undiscounted lease payments	$	2,152
Less: imputed interest	127
Total lease liabilities	$	2,025



	Three Months Ended
(Amounts in Thousands, Except for Per Share Data)	September 30		December 31		March 31		June 30
Fiscal Year 2020:
Net Sales	$	313,385	$	307,084	$	293,925	$	286,156
Gross Profit	22,193		20,511		20,212		20,925
Goodwill Impairment	—		—		—		7,925
Operating Income	11,115		8,684		10,588		1,609
Net Income (Loss)	6,598		6,612		6,259		(1,273		)
Basic Earnings (Loss) Per Share	$	0.26	$	0.26	$	0.25	$	(0.05	)
Diluted Earnings (Loss) Per Share	$	0.26	$	0.26	$	0.25	$	(0.05	)
Fiscal Year 2019:
Net Sales	$	265,620	$	284,149	$	313,454	$	318,621
Gross Profit	18,186		20,444		26,554		23,222
Operating Income	7,032		10,212		14,497		10,319
Net Income	5,069		7,115		11,849		7,525
Basic Earnings Per Share	$	0.19	$	0.27	$	0.46	$	0.30
Diluted Earnings Per Share	$	0.19	$	0.27	$	0.46	$	0.29